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Abstract 
Stem cell balance of proliferation, differentiation and self-renewal, is regulated 
by the microenvironment in which they reside, termed the stem cell niche 
(Schofield, 1978). Niche microenvironments provide physical and functional 
regulatory cues that control fundamental cell intrinsic and extrinsic mechanisms. 
In adults, the process of haematopoiesis is sustained by a population of 
haematopoietic stem cells (HSCs) that are found primarily in the bone marrow 
(BM) (Jagannathan-Bogdan and Zon, 2013). The BM niche also houses populations 
of mesenchymal stromal and perivascular cells (MSPCs), that are themselves 
regulated by the niche, and are fundamental cellular constituents in HSC 
regulation (Pinho and Frenette, 2019).  
Both HSCs and MSPCs hold enormous clinical potential. HSCs have the ability to 
reconstitute the entire blood and immune system (Jagannathan-Bogdan and Zon, 
2013), whereas MSPCs contain immunosuppression capacity and have the ability 
to regenerate damaged and diseased tissue (Caplan, 1991; Uccelli et al., 2008). 
However, there are still important hurdles that must be overcome before the 
potential of these cells are fully realised. The regenerative capacity of these stem 
cells is quickly lost upon ex vivo culture, meaning achieving clinically relevant 
numbers of cells is challenging (Dalby et al., 2018; Zon, 2008).  
Although BM MSPCs (such as nestin+ MSPCs) contain HSC support activity, their 
ability to maintain HSCs ex vivo is only modest due to loss of expression of these 
niche factors in culture (Kunisaki et al., 2013; Nakahara et al., 2019). The absence 
of sustained self-renewal or maintenance of the stem cell phenotype could be 
related to the lack of integration of biophysical and biochemical cues required for 
stem cell regulation, provided by the native BM niche microenvironment in vivo. 
This has led to a focus on biomaterial and engineering strategies that aim to 
recapitulate BM niche properties in vitro (Müller et al., 2014). It is envisaged that 
bioengineered artificial niches will offer protocols for ex vivo expansion and 
maintenance of HSCs without the need for high risk protocols (e.g. genetic 
manipulations (Nakahara et al., 2019)), but also platforms on which to study the 
fundamental mechanisms that control self-renewal in both HSCs and MSPCs in the 
niche. 
iii 
In this thesis, biomaterial strategies were employed to mimic aspects of the BM 
niche microenvironment. First retention of HSC support activity in a population of 
MSPCs was investigated and the metabolic mechanisms that may support this 
phenotype were probed. The ability of the system to support HSC maintenance in 
vitro was then assessed. Poly(ethyl acrylate) (PEA) is a polymer that causes 
spontaneous unfolding of the extracellular matrix protein (ECM) fibronectin (FN). 
These physiological-like networks expose key binding sites on the FN molecule, 
which can be harnessed for cell adhesion and growth factor tethering (Cheng et 
al., 2018; Llopis-hernández et al., 2016). Noting that low-stiffness matrices 
support nestin expression in MSPCs (Engler et al., 2006), a key niche marker 
(Kunisaki et al., 2013; Pinho et al., 2013), low-stiffness collagen hydrogels were 
introduced into the system. We were able to use this system to promote a 
population of nestin+ MSPCs that express key HSC support factors and were able 
to maintain a population of HSCs in vitro. The nestin+ MSPCs utilise hypoxic-like 
metabolic mechanisms in response to low-stiffness, that may be important in 
retaining this BM niche-like phenotype in long term in vitro culture.  
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Chapter 1 Introduction 
Stem cells are defined by their ability to self-renew and produce specialised 
progeny (Lane et al., 2014). Consequently, they hold great clinical potential as 
the cell source for the regeneration of aged, injured and diseased tissues. 
However, despite the remarkable potential their use is currently hindered as 
functionality is lost when they are removed from their in vivo regulatory 
microenvironment – termed the stem cell niche (Schofield, 1978). It is therefore 
a significant goal to engineer new culture environments that recapitulate 
strategies used by stem cell niches in vivo, that promote differentiation of stem 
cells into specialised cell types and maintain adult stem cells throughout life, 
without a loss of ‘stemness’ (Lutolf et al., 2009).  
The bone marrow (BM) stem cell niche has a key role in regulating haematopoiesis 
and is home to two major clinically relevant sources of adult stem cells (ASCs); 
mesenchymal stromal and perivascular cells (MSPCs) and haematopoietic stem 
cells (HSCs) (Pinho and Frenette, 2019). This specialised microenvironment is 
comprised of heterogenous populations of cells types, alongside physical and 
chemical characteristics that are fundamental to its function (Mendelson and 
Frenette, 2014; Morrison and Scadden, 2014; Pinho and Frenette, 2019). This 
chapter will give an overview of stem cell niches, with focus on the BM niche. It 
will then explore how biomaterial strategies can be employed to direct stem cell 
behaviour by closely mimicking niche properties, and how these approaches have 
provided insight into fundamental stem cell mechanisms. Finally, it will describe 
the aims and objectives of this thesis.  
1.1 Stem Cell Niches  
Stem cells are the focus of many applications in regenerative medicine because 
of their ability to self-renew and to generate differentiated progeny (Lane et al., 
2014). There are three main categories of stem cells; embryonic stem cells (ESCs) 
that are derived in culture from pre-implantation embryos, they are pluripotent 
as they have the ability to differentiate into all cell types in the body, generating 
diverse tissues (Martello and Smith, 2014). Most adult tissues retain resident stem 
cells (ASCs), these are multipotent, specialised and essential for tissue 
maintenance and repair throughout life (Wagers and Weissman, 2004). Finally, 
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pluripotent stem cells can be generated by reprogramming adult cells through the 
induction of a small number of specific genes, these are known as induced 
pluripotent stem cells (iPSCs) (Yu et al., 2007).  
In adulthood, tissue homeostasis and regeneration are critically dependent on 
both the self-renewal and the differentiation capacity of ASCs. These unique 
properties mean the potential clinical applications of ASCs are vast, for example 
in the treatment of injury due to trauma and to treat various genetic diseases and 
cancers.  
A central strategy in regenerative medicine is to transplant stem cells or their 
differentiated derivatives into patients. Perhaps of greatest success are HSC 
transplants (HSCT), which for over 50 years have been extracting HSCs from the 
BM to restore the haematopoietic system of cancer patients after chemotherapy, 
for the treatment of genetic blood disorders such as thalassemia (Gaziev et al., 
2005), and more recently in the treatment of autoimmune diseases such as 
multiple sclerosis (Radaelli et al., 2014).  
Other validated adult cell therapies include transplantation of cultured sheets of 
autologous epidermal cells to repair burn injuries (Wood et al., 2006), ex vivo-
expanded autologous chondrocytes to repair cartilage defects (Oldershaw, 2012), 
and co-transplantation of immunomodulatory mesenchymal stromal cells (MSCs) 
to augment graft-versus-host disease in procedures such as islet transplant (Ito et 
al., 2010). These examples involve cells from adult tissues, but there have also 
been recent advancements in the application of pluripotent stem cells towards 
the clinic; human ESCs differentiated into retinal pigment epithelium to treat age-
related blindness is currently in clinical trials (Da Cruz et al., 2018), and neuronal 
precursors generated from iPSCs were recently shown to restore function when 
implanted into a primate model of Parkinson’s disease (Kikuchi et al., 2017).  
The future of the use of stem cells for regenerative medicine is promising, 
however inherent hurdles still need to be overcome to harness their full 
therapeutic potential. The clinical application of ASCs which are easily harvested 
from adult tissues such as BM or fat, is currently limited, as in contrast to their 
embryonic counterparts ASCs will spontaneously differentiate in culture, only 
retaining their unique functions if they are in contact with an instructive 
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microenvironment (Donnelly et al., 2018; Lane et al., 2014; Lutolf et al., 2009). 
This specialised local microenvironment, the stem cell niche, was first described 
four decades ago by Schofield and refers to the extrinsic physical and functional 
factors of the localised microenvironment, which stem cells integrate in concert 
with induced cell-intrinsic regulatory networks to mediate cellular behaviour – 
balancing self-renewal and differentiation in response to physiological demands 
(Schofield, 1978) (Figure 1-1).  
 
Figure 1-1 Parameters of the stem cell niche. Niches are multi-faceted and complex 
microenvironments that are specific to function. However principle parameters of these 
environments are shared throughout multiple tissue types. Generally, they are comprised of 
physical and dynamic factors such as heterologous cellular components and cell-cell 
interactions, secreted and membrane-bound factors, immunological activation and response, 
extracellular matrix (ECM) protein components and structure, physical and architectural 
parameters, oxygen tension and metabolic regulation. Adapted from (Donnelly et al., 2018) 
with permissions.  
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Schofield’s original article hypothesized that retention of transplanted HSCs 
ability to self-renew depends upon the environment provided by neighbouring non-
HSC cells, and that progeny of these stem cells will differentiate unless they 
occupy a similar ‘niche’ (Schofield, 1978). Since this description of the BM niche 
for HSCs, stem cell niches have been described in several adult tissues, including 
intestine (Yen and Wright, 2006), skin (Tumbar et al., 2004) and the nervous 
system (Fuentealba et al., 2012). With this, Schofield’s original concept of the 
niche has been extended to include many aspects of the stem cell 
microenvironment. Key components include direct interactions between stem 
cells and neighbouring heterologous cell types, secreted and membrane-bound 
factors, extracellular matrix (ECM) protein composition and architecture, physical 
parameters such as stiffness and shear stress, inflammation and scarring and 
environmental factors such as local oxygen tensions (Figure 1-1)(Lane et al., 
2014).  
To better harness the therapeutic potential of ASCs, fundamental questions 
regarding the cell-intrinsic and cell-extrinsic regulation of stem cell functions still 
need to be addressed. Understanding how and what factors in niches result in the 
balance between differentiation and self-renewal of the stem cell pool would 
allow us to better exploit these cells for clinical use, and for the development of 
more humanised in vitro models that recreate tissue complexity. The 
development of such de-novo niches would reduce costly animal testing and also 
present simplified experimental systems in which to investigate processes 
fundamental to stem cell regulation. 
1.2 Bone Marrow Architecture 
The BM is the primary site of haematopoiesis, a continuous process of blood-cell 
production throughout the life-span of mammals (Jagannathan-Bogdan and Zon, 
2013). Haematopoiesis orchestrates the balance between self-renewal, 
differentiation and proliferation of HSCs in the BM, followed by egress of mature 
progeny with specialised functions into the circulating blood (Mendelson and 
Frenette, 2014). An adult human is estimated to generate ~4-5 x 1011 
haematopoietic cells per day (Kaushansky, 2006), and as such, the production of 
blood requires a highly regulated and responsive system to ensure haematopoietic 
homeostasis throughout life. Dysregulation of haematopoiesis can lead to 
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myeloproliferative diseases or leukaemia if self-renewal is unrestrained, or 
depletion of the stem cell pool if self-renewal is insufficient (Bonnet, 2005).   
The BM microenvironment is integral in HSC homeostasis, it maintains and directs 
self-renewal and differentiation of both HSCs and MSCs (Pinho and Frenette, 
2019). Located in the cancellous portions of long bones, BM is a complex and 
dynamic organ, containing a central marrow cavity that is surrounded by 
vascularised and innervated bone. Minute projections of bone (trabeculae) are 
found throughout the metaphysis providing a large surface area so that many cells 
are in close proximity to the bone surface (Figure 1-2) (Morrison and Scadden, 
2014). The endosteum is at the interface of the bone surface and the marrow, it 
is covered by bone-lining osteoblasts and bone-resorbing osteoclasts. There is a 
rich supply of arterioles and sinusoids near the endosteum. Arterioles carrying 
oxygen, nutrients and growth factors (GFs) into the BM feed into sinusoidal 
vessels, which coalesce as a central sinus to form the venous circulation (Figure 
1-2). Sinusoids are specialised vessels that allow cells to pass in and out of 
circulation, the connection between arterioles and the sinusoidal network 
preferentially occurs adjacent to the endosteal surface (Ehninger and Trumpp, 
2011; Mendelson and Frenette, 2014; Morrison and Scadden, 2014; Pinho and 
Frenette, 2019).  
 
Figure 1-2 Bone marrow structure. Bone marrow is a complex organ that regulates 
haematopoiesis. A. Minute projections of bone (trabeculae) are found throughout the 
metaphysis, this creates a large surface area and means many cells are in close proximity to 
the bone surface. B. The endosteum is the interface between the bone and bone marrow. The 
bone marrow is well vascularised, containing nutrient/oxygen carrying arteries, which feed 
into sinusoids that form the central venous circulation. Sinusoids are specialised vessels that 
allow cells to pass in and out of circulation. Adapted with permissions from (Morrison and 
Scadden, 2014).  
A B
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Local cues from the BM microenvironment, termed the BM or HSC niche, alongside 
long-range humoral and neural signals integrate to regulate HSC activity. Since 
Schofield’s seminal 1978 article, referring to the niche as the regulatory unit 
balancing HSC self-renewal and differentiation, the field has grown rapidly; 
considerably so in the last ten years as imaging, computational techniques and 
functional genetic tools have advanced, providing a better understanding of the 
in situ BM microenvironment (Pinho and Frenette, 2019).  
The BM niche is now regarded as a complex and dynamic tissue, comprised of a 
heterogenous cellular, molecular and physical environment (Morrison and 
Scadden, 2014). Imaging techniques combined with conditional deletion of crucial 
regulatory factors from candidate niche cell types in mouse models have identified 
distinct BM niche constituents, including both HSC-progeny and non-
haematopoietic cell types (Pinho and Frenette, 2019). Although, as the literature 
currently stands, there is a paradoxical situation where almost all cellular 
constituents of the BM have been proposed to contribute to HSC regulation and 
niche homeostasis. The situation is further complicated by both the HSC and 
stromal stem cell populations of the BM being functionally and molecularly 
heterogenous. This has led to the proposition that distinct niches exist for distinct 
subpopulations of HSCs (Boulais and Frenette, 2015; Mendelson and Frenette, 
2014; Morrison and Scadden, 2014).  
1.3 Bone Marrow Resident Stem Cells 
The BM comprises several key cell types, including several types of stem cell, that 
are themselves regulated by the niche microenvironment and, in turn, are integral 
in the regulation of haematopoiesis.  
1.3.1 Mesenchymal stromal cells 
MSCs, first discovered in 1974, are ASCs that reside in many organs and tissues of 
the body, including the BM, adipose tissue and umbilical cord (Friedenstein, 1976). 
MSCs are multipotent and produce cells of mesenchymal lineage, including 
osteoblasts, chondrocytes, adipocytes and myoblasts (Figure 1-3)(Caplan, 1991). 
They are important in healing and tissue regeneration, have immunomodulatory 
capacity and are crucial in the support of HSCs in the bone marrow niche.  
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Figure 1-3 Model of the organization of MSCs. Multipotent stem cells exist in homeostasis 
between quiescence and an activated state. Activation, and entry to the cell cycle, occurs 
upon tissue damage or other physiological stimuli. Upon activation (regenerative demand), 
multipotent progenitor cells with transit amplification capacity arise. These progenitors are 
the precursors to the tissue-specific mature cells, for example osteoblasts, adipocytes and 
chondrocytes in the MSC compartment. The activated stem cell and its daughter cells 
differentiate or can return to a quiescent state once the tissue repair or other physiological 
process is complete. This homeostasis between quiescence and self-renewal is tightly 
regulated to avoid transformations and to retain a viable stem cell pool throughout the life of 
the organism. Adapted from (Donnelly et al., 2018) with permissions. 
MSCs are most commonly isolated from the BM, despite only comprising 0.001 – 
0.01 % of the total BM cell number (Banfi et al., 2000). Although these cells can 
be expanded ex vivo, a loss of differentiation capacity is associated with long-
term culture (Zaim et al., 2012). Adipose tissue offers a viable alternative MSC 
source, as it is easily obtained in larger quantities and avoids donor site morbidity 
or pain associated with BM extraction (Schneider et al., 2017). However, 
identification of MSCs is complex in part due to this ability to be obtained from 
multiple tissues, and several subsets exist even within the same tissues that 
exhibit subtle, yet significant, biological differences. A position statement from 
the International Society for Cellular Therapy (ISCT) has defined the minimal 
criteria for MSCs as: (i) MSCs must be plastic-adherent when maintained in 
standard culture; (ii) MSCs must express CD105, CD73, and CD90, and lack 
expression of CD45, CD34, CD14 or CD11b, CD79a or CD19 and HLA-DR surface 
molecules (cluster of differentiation; CD. Human leukocyte antigen-DR isotype; 
HLA-DR); (iii) MSCs must be able to differentiate into osteoblasts, adipocytes and 
chondrocytes under standard in vitro differentiating conditions (Dominici et al., 
2006) (Figure 1-3). No single marker associated with MSC ‘stemness’ has been 
agreed, instead many ‘proxy’ identifiers for subsets of MSCs with differing 
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functions are utilised. The markers most commonly used as identifiers or for 
isolation of MSC subsets and are shown in Table 1-1.  
Table 1-1 Markers associated with mesenchymal stem cell phenotype subsets.  
Marker Protein  Biological properties Reference 
CD90+ Thy-1, glycosylated 
membrane protein 
Cell-cell and cell-matrix 
interactions. 
(Dominici et al., 
2006) 
CD44+ Cell-surface 
glycoprotein 
Cell-cell interactions, 
adhesion, migration. 
(Herrera et al., 
2007) 
CD140a+ Platelet derived 
growth factor 
receptor-a 
(PDGFRa) 
HSC supportive. Express 
nestin. 
(Pinho et al., 
2013) 
CD51+ Integrin av HSC supportive. Express 
nestin. 
(Pinho et al., 
2013) 
CD271+ Low-affinity nerve 
growth factor 
receptor (NGFR) 
Isolates 
immunosuppressive 
MSCs from BM but not 
adipose tissue. 
(Álvarez-Viejo et 
al., 2015; Lv et 
al., 2014; Mo et 
al., 2016) 
CD73+ 5’-nucleotidase (5’-
NT) 
Enzyme, conversion of 
AMP to adenosine. 
(Dominici et al., 
2006) 
CD105+ Endoglin Cell adhesion. (Dominici et al., 
2006) 
CD106+ Vascular cell 
adhesion molecule 
(VCAM) 
Cell adhesion. (Yang et al., 
2013) 
CD166+ Activated leukocyte 
cell adhesion 
molecule (ALCAM) 
Cell adhesion. (Rojewski et al., 
2008) 
STRO1+ Cell surface 
receptor 
Promote angiogenesis. 
May not support HSC 
engraftment.  
(Lv et al., 2014; 
Mo et al., 2016) 
 
1.3.1.1 MSCs in the clinic 
MSCs are easily harvested from autologous tissues such as the BM and are 
amenable to in vitro cell culture, therefore allowing growth of significant cell 
numbers in the lab - provided the correct cues are employed. These two factors, 
alongside their multilineage potential and immunomodulatory properties have 
made MSCs an attractive target for regenerative medicine and therapeutic 
applications (Figure 1-4). However, since their discovery in 1974 there have been 
less clinical success stories than first imagined, owing to limitations such as batch-
to-batch variability and poor definition. Highlighting that further understanding 
of fundamental and basic mechanisms need to be understood to harvest the full 
potential of these cells (Dalby et al., 2018; Donnelly et al., 2018).  
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Figure 1-4 Therapeutic potential of MSCs. Unique biological properties of MSCs supporting 
their clinical application include: the ability to secrete soluble factors that regulate 
surrounding cells, ability to modulate the immune response, multi-lineage differentiation 
capacity and the ability to migrate to sites of injury. Adapted from (Squillaro et al., 2016). This 
figure was created using Servier Medical Art, licensed under a Creative Commons Attribution 
3.0 Generic License. 
Currently, a search on www.clinicaltrials.gov for ‘mesenchymal stem cells’ 
returns 955 studies (accessed 16/05/2019). These trials range from the use of both 
allogenic or autologous MSCs for orthopaedic applications (bone regeneration), to 
the treatment of chronic conditions (e.g. liver failure, diabetes), tumour homing 
and to offset graft-versus-host disease. One example of an autologous MSC-based 
product currently in advanced clinical trials is ‘Bonofill’, which harvests adipose-
derived MSCs and combines with a 3D mineralised scaffold to engineer ‘custom’ 
bone grafts for use in maxillofacial bone augmentations and regeneration 
(ClinicalTrials.gov identifier: NCT02153268, reviewed in (Paduano et al., 2017)).   
1.3.2 Pericytes 
Pericytes, originally defined by their anatomical location, are perivascular stellate 
cells that encircle the endothelium of small vessels and have been identified in 
nearly all vascularised tissues (Crisan et al., 2008). Originally thought to play a 
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major role in vascular support, pericytes gained renewed interest when over a 
decade ago they were identified as the in vivo origin of the MSC (Crisan et al., 
2008). Using a defined set of markers, the landmark paper by Crisan et al, 
identified perivascular cells from diverse human tissues, such as BM, adipose, 
brain, pancreas and placenta. They then validated that these pericytes display 
hallmark characteristics of in vitro MSCs; such as adherence to plastic, MSC marker 
expression and multilineage differentiation capacity for osteogenic, 
chondrogenic, adipogenic and myogenic lineages (Figure 1-5)(Crisan et al., 2008). 
 
Figure 1-5 Pericytes and MSCs share surface markers and differentiation capacity.  Both 
unique and shared markers (in brackets) are shown. 
The markers used to identify pericytes are all present on other cell types, hence 
there is no single ‘pericyte-marker’, however there are well-defined combinations 
of surface antigens that are now routinely used for their identification (Sá da 
Bandeira et al., 2016). CD146, or melanoma cell adhesion molecule (MCAM), is 
highly expressed on pericytes and is an adhesion molecule involved in the 
interaction between endothelial cells and pericytes (Ishikawa et al., 2014). CD146 
expression is also found on smooth muscle cells, endothelial cells and some T and 
B lymphocytes, and so negative expression of the markers CD31, CD34 
(endothelial/haematopoietic), CD56 (myogenic) and CD45 (haematopoietic) are 
commonly used to isolate pericytes from various tissues (i.e. CD146+CD31-CD34-
CD45-CD56-). Several other markers are associated with pericytes, such as a-SMA 
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(a-smooth muscle actin) and NG2 (chondroitin sulphate proteoglycan 4), these are 
summarised in Table 1-2. However, it should be noted that varying expression of 
these markers have been observed in pericytes from different tissues, at different 
time points in development and discrepancies exist even within pericytes isolated 
from the same tissue (Crisan et al., 2008; Kunisaki et al., 2013; Sá da Bandeira et 
al., 2016). It has been suggested a-SMA and NG2 expression can be used to 
discriminate between pericytes associated with arterioles (NG2+ a-SMA+), 
capillaries (NG2+ a-SMA-) and venules (NG2- a-SMA+) (Crisan et al., 2008; Nehls 
and Drenckhahn, 1991). 
Since the study by Crisan et al, it has been contentiously thought that pericytes 
are the in situ equivalent of the MSC. Many studies have supported this model, 
showing that transplanted purified perivascular cells and genetically traced 
pericytes contribute to tissue-specific lineages in vivo (Chen et al., 2014; 
Dellavalle et al., 2007; Feng et al., 2011; Gortiz et al., 2011). Pericytes with 
heterogeneous sets of markers have also been implicated as key components 
supporting HSCs in the BM. CD146 expressing perivascular cells from the BM were 
initially shown by Sacchetti et al, to regenerate bone and stroma, establishing a 
functional haematopoietic microenvironment upon transplantation in vivo 
(Sacchetti et al., 2007). Then, more recently, nestin+ pericytes have been shown 
to regulate HSC quiescence, and LepR+ pericytes shown to regulate HSC activation 
(discussed in detail in Table 1-3) (Kunisaki et al., 2013). In much of the literature 
related to the BM niche, the terms perivascular cell/pericyte/mesenchymal 
stem/stromal cell are often used indiscriminately and interchangeably, adding 
further uncertainties and complexity to the area.  
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Table 1-2 Markers associated with pericyte phenotype.  
Marker Protein Biological properties Reference 
CD146+ melanoma cell 
adhesion molecule 
(MCAM) 
Pericyte-endothelial cell 
interaction. 
(Crisan et al., 
2008; Pinho et 
al., 2013; 
Sacchetti et al., 
2007) 
NG2+ Chondroitin 
sulphate 
proteoglycan 4 
Expressed during 
vascular morphogenesis.  
(Crisan et al., 
2008; Kunisaki et 
al., 2013; 
Ozerdem et al., 
2001) 
Nes+ Nestin Intermediate filament 
protein type IV. 
Expressed in arteriolar-
associated pericytes. 
(Kunisaki et al., 
2013; Pinho et 
al., 2013) 
PDGFR-a+ Platelet derived 
growth factor 
receptor a 
Interacts with PDGFA, 
PDGFB, integrin b3, 
caveolin-1 and nexin. 
(Crisan et al., 
2008; Sá da 
Bandeira et al., 
2016) 
PDGFR-b+ Platelet derived 
growth factor 
receptor b 
Interacts with PDGFA 
and PDGFB. Expression 
restricted to pericytes 
and smooth muscle in 
adults. Not a suitable 
marker during 
embryogenesis. Role 
during capillary 
sprouting.  
(Crisan et al., 
2008; Guimaraes-
Camboa et al., 
2017) 
CD51+ Integrin av HSC supportive.  (Pinho et al., 
2013) 
LepR+ Leptin receptor Expressed in sinusoidal-
associated pericytes. 
(Ding et al., 2012; 
Kunisaki et al., 
2013) 
a-SMA+ a-smooth muscle 
actin 
Expressed in pericytes, 
smooth muscle cells and 
myofibroblasts. 
(Crisan et al., 
2008; Sá da 
Bandeira et al., 
2016) 
CD45- Protein tyrosine 
phosphatase 
receptor type C 
Transmembrane protein 
expressed on all 
haematopoietic cells 
(Crisan et al., 
2008) 
CD34- Transmembrane 
glycoprotein 
Expressed in 
haematopoietic and 
endothelial cells. 
Involved in cell-cell 
adhesion 
(Crisan et al., 
2008) 
CD56- Neural cell 
adhesion molecule 
(NCAM) 
Myogenic and neural 
marker 
(Crisan et al., 
2008) 
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However, it should be noted that in a study in 2017 Guimaraes-Camboa et al, 
challenged the idea of pericytes as MSC equivalents. Here they identified Tbx18 
as a gene specifically expressed in pericytes in many adult organs, including brain, 
heart, skeletal muscle and adipose tissue. By generating a transgenic mouse line 
expressing an inducible Cre recombinase in Tbx18-expressing cells they performed 
lineage tracing of this marker in pericyte progeny during aging and tissue repair 
over the course of 2 years. Surprisingly, they found that Tbx18 lineage-derived 
cells maintain their perivascular identity, suggesting pericytes do not give rise to 
other tissue specific cell types in these organs, in the context of both aging and 
tissue repair. Implying strongly, that these cells do not behave as MSCs in the 
organs studied (Guimaraes-Camboa et al., 2017).  
The Guimaraes-Camboa et al, study raises important questions. By demonstrating 
that cells possessing all the hallmarks of MSCs in vitro can lack any MSC potential 
in vivo, this challenges the established idea of pericytes as the origin of MSCs, and 
also of the existence of MSCs in many adult organs that have been identified 
through transplantation studies, as such further work will be needed to fully 
understand and define the MSC both in their native environment and as 
therapeutic tools (Cano et al., 2017).  
Due to the contention in definition and identity of MSCs/pericytes, this thesis will 
use the term mesenchymal stromal and perivascular cells (MSPCs) to refer to the 
heterogenous BM perivascular and stromal cell populations. Where appropriate, 
the populations will be specifically defined as MSCs or pericytes.  
1.3.2.1 Pericytes in the clinic 
Pericytes hold similar properties for tissue regeneration and immunosuppression 
as that identified for other MSC subsets. They have been highlighted as candidates 
for orthopaedic applications and adipose-derived pericytes are currently in clinical 
trials for osteoarthritic treatments (Pak et al., 2017). However due to their 
vascular origin, many pre-clinical applications for pericytes have focussed on their 
potential for therapeutic vasculogenesis (Riu et al., 2017), or in the treatment of 
heart disease (Avolio et al., 2015).  
Chapter 1 Introduction  14 
1.3.3 Haematopoietic stem cells 
Of all the known stem cell types, HSCs are the best characterised and studies of 
haematopoiesis have provided critical information into other areas of stem cell 
biology in development, homeostasis and reprogramming (Orkin and Zon, 2008). 
HSCs can self-renew and differentiate, forming the mature progeny that make up 
the haematopoietic system; mature blood cells are predominantly short lived, 
meaning stem cells are required throughout the lifetime of the organism to 
replenish multilineage progenitors and the precursors committed to individual 
haematopoietic lineages (Figure 1-6) (Orkin and Zon, 2008). HSCs are tightly 
controlled by cues from the BM niche microenvironment in order to maintain 
homeostasis, during which most HSCs are quiescent (Passegué et al., 2005). They 
sit at the top of a hierarchy of progenitors that become progressively restricted 
to produce precursors of uni-lineage differentiation potential and of mature blood 
cells, including red blood cells, megakaryocytes, myeloid cells 
(monocyte/macrophage and neutrophil) and lymphocytes (Figure 1-6).  
 
Figure 1-6 Haematopoietic development including identifying surface markers for HSCs and 
progenitor cells. Long-term repopulating HSCs progressively lose self-renewal capacity, 
progressively restricting differentiation potential, until they retain the ability to differentiate 
down one lineage, either lymphoid or myeloid. This progressive restriction eventually leads 
to the formation of mature blood cells that contribute to the haematopoietic system. HSC; 
haematopoietic stem cell. This figure was created using Servier Medical Art, licensed under 
a Creative Commons Attribution 3.0 Generic License. 
HSCs either self-renew or generate multipotent progenitors (MPPs), which retain 
short-term multilineage repopulation potential (Yamamoto et al., 2013). MPPs 
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give rise to lineage committed progenitors of common lymphoid (CLP) and 
common myeloid progenitors (CMP). CMP give rise to granulocyte/monocyte and 
megakaryocyte/erythrocyte progenitors (MEP), which differentiate ultimately to 
platelets and red blood cells (Hao et al., 2001; Manz et al., 2002) (Figure 1-6).  
First identified in 1961 through transplantation studies HSCs have since been 
widely researched, providing a solid foundation in which to study the cells. HSCs 
are characterised by their capacity to reconstitute the entire blood system of a 
recipient (Eaves, 2015). Isolation and lineage tracing of HSCs is routinely carried 
out by flow cytometry where a series of cell surface markers have been well-
defined for each development stage of haematopoiesis, highlighted in Figure 1-6 
(Chao et al., 2008). HSCT experiments have led to classification of two-distinct 
HSC populations: short-term engrafting (ST-HSC) and long-term engrafting (LT-
HSC). LT-HSCs contribute to peripheral blood for up to 6 months, and can be 
transferred to new hosts by secondary transplantation; whereas, ST-HSCs can 
produce blood cells for up to 3 months post-HSCT (Zon, 2008).  
1.3.3.1 Clinical demand for HSCs 
Autologous HSCT is the current standard treatment for many haematological 
conditions; such as Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, multiple 
myeloma, sickle cell anaemia and autoimmune diseases such as multiple sclerosis 
(Mendelson and Frenette, 2014; Radaelli et al., 2014). Transplantable HSCs can 
be obtained from BM, peripheral blood and umbilical cord blood (UCB). BM and BM 
transplants have been the standard source for many years (Figure 1-7), however 
it is now becoming increasingly common to pharmacologically mobilize HSCs out 
of the marrow, then isolate from peripheral blood (Mendelson and Frenette, 
2014).  
Autologous transplants are the gold standard method as they avoid immune 
rejection, which ultimately leads to delayed engraftment, graft-versus-host 
disease and graft rejection. Although this is often not possible as it requires HSCs 
to be obtained before the clinical need, i.e. pre-malignancy. Therefore, the use 
of donor HSCs, known as allogenic transplants, are routinely employed and have 
high success rates providing a human leukocyte antigens- (HLA) matched donor is 
available (Park and Seo, 2012).  
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Figure 1-7 The estimated annual numbers of haematopoietic stem cells transplant (HSCT) 
recipients in the USA. Graph shows increasing incidence and therefore need for HSCT. 
Reproduced with permissions from (D’Souza and Fretham, 2018).  
However, difficulties in finding suitable adult allogenic donors alongside low cell 
yields from cord blood has focussed investigations into methods of stem cell 
expansion (Hofmeister et al., 2007). Ex vivo HSC expansion is itself difficult due 
to an inability to retain these cells in synthetic culture environments for 
significant time periods. Once HSCs are removed from the niche microenvironment 
their self-renewal capacity is lost quickly, cells robustly proliferate and 
spontaneously differentiate in a matter of days rendering them clinically 
ineffective (Boitano et al., 2010). Further to this, although HSCT are successfully 
used to treat cancers and are seeing great success in clinical trials for treatment 
of other diseases, there remains an unmet demand for matched donors (Figure 
1-7). There is focus on strategies to counteract poor HSC survival in culture and 
to increase HSC yield, these include complex and expensive media formulations 
(Murray et al., 1999), the use of small molecules that promote ex vivo HSC and 
progenitor expansion (Boitano et al., 2010; Goessling et al., 2009) and material 
and engineering strategies that aim to recapitulate aspects of the in vivo niche 
(Müller et al., 2014), several of which are summarised in Table 1-5. 
 
Autologous HSCT Allogeneic HSCT
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1.4 The Bone Marrow Niche 
The exact location and composition of the BM niche remains a major topic of 
debate in the field. Direct visualisation of the BM would be essential to fully 
understand HSC activity and define bona fide niches in situ. However, this is a 
major challenge owing to a lack of exclusive markers for identifying and tracking 
HSCs and other stromal niche cells, and due to the calcified nature of bone. 
However, the distribution of HSCs within the BM is not random, it has been 
demonstrated that there are specific cellular components in each environment 
that are indispensable regulators of HSC activity (Pinho and Frenette, 2019). 
Initial reports traced homing of transplanted green fluorescent protein (GFP)-
marked HSCs and haematopoietic stem and progenitor cells (HSPCs) in the mouse 
BM, and suggested that quiescent LT-HSCs preferentially localised near the 
endosteal surface, whereas mature lineage-committed cells were redistributed 
throughout the central marrow region; suggesting an endosteal niche for HSCs (Lo 
Celso et al., 2009; Nilsson et al., 2001; Xie et al., 2009; Zhang et al., 2003). 
However, the endosteum is highly vascularised with arterioles that are proximal 
to the endosteal surface, and sinusoids that are distributed throughout the cavity, 
it has therefore been suggested that HSCs may be interacting with both endosteal 
and vascular niche components simultaneously (Nombela-Arrieta et al., 2013).  
As such, as imaging techniques have advanced, it has been demonstrated that the 
endosteal model was perhaps over simplified, and that in the trabecular bone the 
endosteum is enriched with arterioles that are in tight association with adrenergic 
nerves fibres and are ensheathed with nestin+ MSPCs, to which subsets of dormant 
LT-HSCs have been shown to localise (Kunisaki et al., 2013). This is referred to as 
the arteriolar niche. Putative HSCs have also been identified to be located close 
to sinusoids (Kiel et al., 2005). Leptin receptor(LepR)+ MSPCs are localised close 
to sinusoidal vessels and these are thought to support more active HSCs, referred 
to as the sinusoidal niche (Boulais and Frenette, 2015).  
These observations give rise to the current model of the niche, in which the 
endosteum/arteriolar niche houses quiescent HSCs, with more active cycling HSCs 
located around the sinusoid, and is illustrated in Figure 1-8 (Ehninger and Trumpp, 
2011; Pinho and Frenette, 2019).  
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Figure 1-8 HSC niche locations. Osteoblasts secrete HSC maintenance factors TPO and OPN, 
and HSCs located near the endosteum are also in close proximity to arterioles that are lined 
with endothelial cells and MSPCs that are Neshigh or NG2+ which secrete CXCL12 and SCF. 
This niche zone is thought to regulate quiescent HSCs. Sympathetic nerves regulate HSC 
mobilization. The sinusoidal zone is where more active HSCs reside, close to Neslow or LepR+ 
or CXCL12-abundant reticular cells (CAR cells), that also secrete SCF and CXCL12.  
The subtle differences in localisation reported support the notion that functional 
quiescent and active niches may exist in close proximity. But elucidating the 
precise location of HSCs and the signals responsible for maintaining 
haematopoietic homeostasis remains challenging, due to current limitations of in 
situ imaging approaches (Kokkaliaris et al., 2012), and the rarity of bona fide HSCs 
within the marrow (<1:50,000 marrow cells) (Morrison and Scadden, 2014).  
1.4.1 Bone marrow niche cellular constituents 
The bone marrow is comprised of a heterogeneous population of cell types, various 
haematopoietic and non-haematopoietic cells have a proposed role in HSC 
regulation; MSPC subsets, endothelial cells, osteoblasts and sympathetic nerve 
fibres.  
MSPCs resident in the BM have been identified as major niche components; both 
the niche microenvironment is required for MSPC maintenance and MSPCs are 
Sympathetic 
nerve fibre
OsteoclastOsteoblast
Arteriole
SCF
CXCL12
Sinusoid
Neslow or
LepR+ or 
CAR cell
Nestin+ NG2+
CD146+ MSPC
OPN
TPO
CXCL12
SCF
HSC
HSC
Endothelial cell
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required as niche constituents for the maintenance of HSCs. Many subsets of BM 
resident cells with MSPC-like properties have been identified at various locations 
within the niche. A landmark study by Méndez-Ferrer et al., 2010 identified a 
stromal nestin-expressing cell population that are perivascular, enriched for MSC 
activity and express high levels of factors required for HSC maintenance (Méndez-
Ferrer et al., 2010). Similarly, a population of sinusoidal adipo-osteogenic 
progenitor cells expressing high amounts of HSC maintenance factor CXCL12 (C-X-
C motif chemokine 12), CAR cells (CXCL12-abundant reticular cells) (Omatsu et 
al., 2010; Sugiyama et al., 2006), and of perivascular (sinusoidal) LepR+ MSPCs 
have been implicated to have a major role in regulation of haematopoiesis in the 
niche (Ding et al., 2012; Zhou et al., 2015). These cell types all show overlapping 
properties and functions within MSCs, pericytes and other stromal stem cell 
compartments.  
There is currently evidence for virtually all BM cell types playing major roles in 
HSC maintenance, and the situation is further complicated by the fact that the 
HSC pool is itself heterogenous. The current evidence and roles of the major BM 
constituent cells are described in detail in Table 1-3. 
 
 
Table 1-3 Cellular contributions to the bone marrow niche.  OPN; osteopontin, TPO, thrombopoietin, SCF; stem cell factor, ANGPT1; angiopoietin 1, 
VCAM1: vascular cell adhesions molecules 1, G-CSF; granulocyte colony-stimulating factor, SNS; sympathetic nerve signals, TGFb; transforming growth 
factor b, SMAD; small mothers against decapentaplegic.  
Cell type Role in the bone marrow niche References  
Osteolineage cells • Early studies suggested HSCs are enriched in the endosteal regions of bone and 
locate preferentially at bone surface. (First cell population linking BM to HSC 
regulation). 
• Could support HSPC expansion in vitro. 
• Increase in BM osteoblastic cells leads to HSC expansion via Notch ligand Jagged1 in 
vivo. 
• Primitive HSCs adhere to OPN via integrin b1 in vitro and OPN negatively regulates 
HSC pool size. 
• HSCs interact directly with N-cadherin positive osteoblasts which regulate niche 
size, although this has been disputed.  
• Osteoblasts produce HSC maintenance factor TPO. Whether they are the major 
functional source of this has been disputed. TPO found to act systemically from 
hepatocytes.  
(Calvi et al., 2003; 
Decker et al., 2018; 
Gong, 1978;  
Kiel et al., 2009;  
Nilsson et al., 2005;  
Qian et al., 2007; 
Taichman et al., 1996; 
Yoshihara et al., 2007; 
Zhang et al., 2003) 
Nestin+ stromal 
cells 
• Perivascular Nes-GFP+ cells associate tightly with nerves and HSCs, are enriched for 
MSC activity.  
• Express high levels of HSC maintenance factors CXCL12, SCF, ANGPT1, OPN and 
VCAM1. 
• Perivascular Nestin+ cells express high levels of HSC niche associated genes. 
• Rare nestin+ perivascular cells expressing pericyte marker NG2 are associated with 
arterioles and a subset of quiescent HSCs in vivo. 
(Asada et al., 2017; 
Kunisaki et al., 2013; 
Méndez-Ferrer et al., 
2010;  
Pinho et al., 2013) 
 
LepR+ stromal 
cells 
• Main source of AGPT1 in BM. 
• Perivascular LepR+ cells produce SCF and CXCL12 in the BM. 
• Approximately 90% of Lepr-Cre+ cells overlap with CAR cells. 
• Lepr-Cre+ cells also represent a large subset of Nes-GFP+ cells.  
• Deletion of SCF from LepR+ cells reduces HSC numbers. 
(Asada et al., 2017; 
Ding et al., 2012; 
Kunisaki et al., 2013; 
Yue et al., 2016; Zhou 
et al., 2015, 2014) 
 
CAR cells • Sinusoidal stromal cells expressing high amounts of CXCL12. 
• Adipo-osteogenic progenitors have elevated levels of early commitment markers 
such as RUNX2, OSX and PPARγ. 
• CAR cell ablation reduces number of LT-HSCs in vivo.  
• Major producers of SCF.   
(Omatsu et al., 2010; 
Sugiyama et al., 2006) 
Endothelial cells • Express low levels of CXCL12 in BM. 
• cxcl12 deletion from endothelial cells depletes HSCs but has no effect on early 
progenitors.  
• Express Notch ligands that regulate LT-HSCs. 
• Arterial, but not sinusoidal, BM endothelial cells secrete SCF.  
(Butler et al., 2010;  
Ding and Morrison, 
2013; Greenbaum et 
al., 2013; Xu et al., 
2018) 
Adipocytes • Negatively regulate HSC function. 
• Inhibition of adipogenesis with a PPARγ antagonist after BM transplantation leads 
to faster recovery. 
• Adiponectin, an adipocyte secreted protein, impairs proliferation of HSPCs in vitro.  
• BM adipocytes increase with aging and impair niche function. 
(Naveiras et al., 2009; 
Saraiva et al., 2017; 
Yokota et al., 2000) 
Sympathetic nerve 
cells  
• Sympathetic nerves innervate the BM.  
• G-CSF stimulated HSC egression from the BM requires SNS.  
• SNS regulate bone CXCL12 G-CSF stimulated production. 
• SNS target nestin+ BM cells through b3-adrenergic receptor (which nestin+ cells 
express) to mediate circadian oscillations of CXCL12 and HSC egression.  
• Nonmyelinating Schwann cells (glial cells insulating sympathetic nerves along 
arteries) promote HSC quiescence through activation of TGFb and SMAD signalling.  
(Katayama et al., 2006; 
Lucas et al., 2008; 
Méndez-Ferrer et al., 
2010, 2008;  
Yamazaki et al., 2011) 
Chapter 1 Introduction  22 
 
1.4.2 Secreted niche factors 
Secreted factors, such as GFs and cytokines, contribute to HSC maintenance within 
the BM niche (Mendelson and Frenette, 2014). Cytokines are small proteins that 
are active in cell signalling, they are produced by many cell types and are 
recognised by cells through cell surface receptors (Bazan, 1990). Cytokine 
recognition triggers intracellular signalling cascades that ultimately influence cell 
behaviour, they are fundamental in the immune response and during development 
as well as in the BM microenvironment (Mendelson and Frenette, 2014). There are 
several cytokines important for attracting, activating and maintaining HSCs in the 
niche, and these are discussed in detail in Table 1-4.  
Table 1-4 Cytokines and secreted factors associated with HSC regulation in the BM niche.  
MPL, myeloproliferative leukaemia protein; VLA-4, Very Late Antigen-4. 
Niche 
factor 
HSC 
receptor 
Producing cell 
type 
Effect on HSCs References 
CXCL12 
 
CXCR4 CAR cells 
Nestin+ 
perivascular cells 
LepR+ stromal cells 
Endothelial cells 
Maintenance 
and retention  
(Greenbaum et al., 
2013; Matsuzaki et 
al., 2014; Méndez-
Ferrer et al., 2010; 
Omatsu et al., 
2010; Pinho et al., 
2013; Sugiyama et 
al., 2006) 
SCF KIT CAR cells 
Nestin + 
perivascular cells 
LepR+ stromal cells 
Endothelial cells 
Maintenance (Ding et al., 2012; 
Kunisaki et al., 
2013; Omatsu et 
al., 2010; Xu et al., 
2018; Zhou et al., 
2014) 
TPO MPL  Osteoblasts Maintenance (Qian et al., 2007; 
Yoshihara et al., 
2007) 
OPN CD44, 
multiple 
integrins 
Osteoblasts  
Nestin+ 
perivascular cells 
 
Quiescence  (Nilsson et al., 
2005; Pinho et al., 
2013; Stier et al., 
2005) 
VCAM1 VLA-4  
Integrin 
a4b1 
Endothelial cells 
Nestin+ 
perivascular cells 
Retention (Frenette et al., 
1998; Pinho et al., 
2013) 
ANGPT-1 Tie2 Osteoblasts 
LepR+ stromal cells 
 
Quiescence (Arai et al., 2004; 
Zhou et al., 2015) 
However, two of the best studied cytokines that are known to be non-cell-
autonomously required for HSC maintenance are CXCL12 (Nagasawa et al., 1996) 
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and SCF (stem cell factor) (Ogawa et al., 1991), which bind to their receptors 
CXCR4 (C-X-C chemokine receptor type 4) and KIT on HSCs, respectively. CXCL12 
and SCF are expressed by different cells types in the BM (Table 1-3 and Table 1-4), 
and several studies have attempted to find the most abundant source/s, primarily 
using conditional deletion of Cxcl12 (Asada et al., 2017; Ding and Morrison, 2013; 
Greenbaum et al., 2013) and Scf (Asada et al., 2017; Ding et al., 2012) by Cre-
mediated recombination in candidate niche cells. Effects observed on HSC 
frequency and function in multiple studies are varied, and together suggest no 
one cell type is responsible for major cytokine production. More likely HSCs reside 
in a niche in which multiple cell types collectively contribute to maintenance 
factor expression to support and regulate BM HSCs (Pinho and Frenette, 2019).  
1.4.3 Bone marrow ECM 
In the BM, the ECM is secreted primarily by stromal cells and is composed mainly 
of collagens type I-XI, other non-collagenous ECM proteins such as fibronectin 
(FN), laminin, tenascin and elastin make up 10 -15 % of total bone protein 
(Clarke, 2008). The endosteal region is particularly enriched for collagen I and 
FN, whereas the distribution changes to become more laminin dense towards the 
BM vasculature (Figure 1-9) (Nilsson et al., 1998). Proteoglycans, with their large 
glycosaminoglycan (GAG) sidechains, such as hyaluronic acid (HA), perlecan and 
heparin, are also important for BM ECM integrity (Klamer and Voermans, 2014). 
The ECM provides a dynamic network to sequester secreted GFs and cytokines, 
establishing functional GF/cytokine gradients, and important domains that 
control cell properties such as adherence, migration and proliferation.  
Gradients of cellular and ECM protein composition across the niche impact the 
biophysical environment to which MSPCs and HSCs are exposed (Choi and Harley, 
2017; Clarke, 2008; Nilsson et al., 1998). These differences in composition 
ultimately produce gradients in matrix stiffness, although the in situ stiffness of 
BM has proved difficult to measure. Efforts to characterise stiffness by rheology 
fall short due to techniques often requiring destructive sample preparation, 
meaning the intact cavity cannot be analysed. Recently, one study used three 
different but complementary techniques and found the cavity possessed a large 
amount of heterogeneity, but produced an effective Young’s modulus ranging 
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from 0.25 – 24.7 kPa (Jansen et al., 2015). This has led to the proposed 
biophysical model of the BM niche demonstrated in Figure 1-9. 
 
Figure 1-9 Proposed biophysical ECM contributions to niche-mediated HSC regulation. 
Collagens are distributed throughout the BM, whereas the endosteal region has a high FN 
content with increased stiffness, and the vascular region has a high laminin content with low 
stiffness. This is thought to correlate to distinct environments within the BM niche that 
regulate HSC function, where quiescent HSCs are maintained in the endosteal zones, and 
active HSCs in the sinusoidal zones. Adapted from (Choi and Harley, 2017). 
Due to the non-adherent nature of HSCs, their interactions with the ECM was 
largely neglected in the literature until recently. Some studies observed 
haematopoietic perturbation using mutation studies of BM niche ECM components, 
indicating the ECM as a key regulatory factor both directly and indirectly. For 
example, mutations in collagen X indirectly attenuate haematopoiesis via 
disruption of the endochondral ossification process (Sweeney et al., 2011). 
However, HSCs have been shown to interact with other cells and matrix 
components via transmembrane protein receptors, such as integrins (Choi and 
Harley, 2017). In fact, laminin-binding integrin-a6 (ITGA6/CD49f) is now routinely 
used to isolate populations of very rare LT-HSCs (Klamer and Voermans, 2014).  
A recent study showed direct influence of different ECM ligands on HSC phenotype, 
by culturing HSCs in either collagen I, FN or laminin rich environments they were 
able to map changes in HSC functional capacity through lineage specification. 
Specific integrin activation was shown to impact early fate specification of HSCs 
in this system, with activation of the integrin avb1 selectively maintaining early 
LN, Col Col, FN FN, Col
HSC quiescence
Activation Maintenance
Stiffness
0.25 kPa 24.71 10
Sinusoid Bone
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myeloid progenitors, whereas activation of integrin avb3 pointed to erythroid 
specification (Choi and Harley, 2017). Other studies have also highlighted that 
expression of multiple integrins are found to be differentially regulated during the 
development and regeneration of the BM, this suggests that HSC cell-matrix 
interactions during discrete stages of haematopoiesis may be crucial in 
orchestrating HSC homeostasis (Choi and Harley, 2017; Klamer and Voermans, 
2014). 
These studies highlight that modulating the ECM to represent the in vivo 
composition is an important factor for stem cell regulation. Many studies have 
focused on controlling ECM characteristics, and therefore microenvironmental 
mechanics, in order to control stem cell behaviour in vitro and determine its role 
in vivo. This will be discussed in detail in section 1.5.  
1.4.4 The hypoxic niche 
Low oxygen tension (hypoxia) is a hallmark shared by different niches that is 
thought to be important for maintaining stem cell quiescence (Mohyeldin et al., 
2010). Adult tissues experience a wide range of oxygen tensions that are vastly 
different from inhaled oxygen tensions of 21% (160 mmHg), the partial pressure of 
O2 (pO2) progressively decreases after it enters the lungs and travels throughout 
the body in the blood. By the time it reaches organs and tissues pO2 levels are 
around 2 - 9% (1 - 65 mmHg), extremely different to those considered ‘normoxic’ 
(Brahimi-Horn and Pouysségur, 2007; Mohyeldin et al., 2010). Such normoxic 
conditions (21% O2) are conventionally used in standard cell-culture, although 
some argue that 2 -9% oxygen concentrations should become standard practice to 
represent physiological normoxia (Mohyeldin et al., 2010). However, the precise 
levels of oxygen a given cell may experience in vivo is challenging to assay, not 
only due to difficulties in direct measurements, but also due to subtle 
heterogeneities in oxygen tensions within tissues, so physiological normoxia for 
cells within the same tissue, and during pathological conditions, may differ.  
The BM is a highly vascularised organ, although despite this it exhibits relatively 
low oxygen tension. Initially, support for the ‘hypoxic niche’ largely came from 
indirect measurements such as expression of hypoxia inducible factor 1-a (HIF1a) 
and related genes and proteins, or from detection of surrogate markers that bind 
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at low pO2 (such as pimonidazole) (Mohyeldin et al., 2010); further support came 
from an in silico model that proposed the existence of very steep oxygen gradients 
forming hypoxic zones at short distances from the blood vessels (Chow et al., 
2009, 2001). It was initially assumed that the endosteal zones of the BM would be 
the most hypoxic, evidenced through location of quiescent LT-HSCs that displayed 
hypoxic phenotypes, and that the central vascularised cavity was less hypoxic and 
housed activated HSCs (Parmar et al., 2007). However, no direct measurement of 
local oxygen tension within the BM had been reported until 2014, and this study 
contradicted this previous model (Spencer et al., 2014).  
To measure absolute pO2 Spencer et al, developed two-photon phosphorescence 
lifetime microscopy specifically for non-invasive live animal imaging. Using this 
method, they confirmed that although densely perfused, the overall pO2 in the BM 
cavity was low (ranging from 1.5 – 4.2% oxygen). Measurements at distinct BM sites 
revealed heterogeneities and a steep internal gradient of local oxygen tension. 
Unexpectedly, based on the previously proposed models, the deep sinusoidal 
regions (>40 um from bone) had the lowest pO2 (~1.3-2.4%), compared to the 
endosteal zone which exhibits a slightly increased oxygen gradient (1.8-2.9%) 
(Spencer et al., 2014). The endosteal zone is perfused with small vessels (Kunisaki 
et al., 2013; Méndez-Ferrer et al., 2010), and these vessels are always upstream 
of and drain into sinusoidal vessels, suggesting arterial characteristics (Spencer et 
al., 2014).  
The local hypoxia within the BM microenvironment has been shown to be integral 
to augment niche functionality in HSCs themselves and in influencing other niche 
constituents. HSCs retain quiescence and balance differentiation through 
adaptation and utilisation of the low pO2 of the BM; through tight regulation of 
HIF1a quiescent HSCs drive a strict metabolic profile that relies heavily on 
anaerobic glycolysis rather than mitochondrial oxidative phosphorylation 
(OXPHOS) (Simsek et al., 2010; Takubo et al., 2010). The initial hypothesis that 
the endosteal zone of the BM housed the lowest pO2 and most quiescent HSCs, was 
demonstrated to be incorrect by the Spencer et al, study. Slight increase in pO2 
was measured for arterioles that were nestin+ and close to the endosteum, and 
nestin+ vessels have been documented to harbour quiescent HSCs (Kunisaki et al., 
2013; Spencer et al., 2014), although it could be possible that the oxygen tension 
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is lower just outside of the relatively thick arterioles (Boulais and Frenette, 2015). 
The role of hypoxia on stem cell metabolism is discussed in more detail and 
investigated in Chapter 5. 
1.5 Engineering Stem Cell Niches for Differentiation and 
Self-Renewal 
Many challenges remain about what niche components are fundamental for 
retaining stem cell properties – how, when and what is being controlled, and for 
what purpose? Aims to address these challenges rely on advances in technologies 
that will allow the recapitulation of niches outside the body. These technologies 
will offer greater insight into components, and cell-intrinsic and -extrinsic 
interactions that regulate stem cells in specific microenvironments. This will allow 
a further understanding of what challenges must be first overcome to exploit these 
cells using biotechnological expansion approaches for therapeutic potential. 
Advances in biomaterial strategies are providing an interesting platform on which 
to answer such questions, with the ability to construct and manipulate ‘de novo’ 
niches and harness the differentiation potential of stem cells ex vivo, fundamental 
mechanisms and robust and reproducible clinical applications are being elucidated 
(Donnelly et al., 2018). 
Biomaterial (surfaces, tissue engineering scaffolds), biofabrication (microfluidics, 
3D bioprinting) and bioreactor (physiological environment) techniques hold the 
potential to allow construction, deconstruction and investigation into the 
important components of cellular microenvironments. Such approaches could 
evolve the development of both reductionist stem cell interfaces allowing high 
throughput analysis and discovery and non-animal technologies (NATs) that 
recreate tissue complexity and reduce costly/inefficient animal experimentation. 
Niche microenvironments, such as the BM, are however highly complex and 
multifactorial, as illustrated in Figure 1-1. 
By recapitulating aspects of stem cell niches, biomaterials have developed our 
understanding of cell-substrate interactions and of fundamental mechanisms and 
signalling pathways utilised by stem cells during differentiation and self-renewal. 
This allows us to consider important factors when harnessing stem cells for use in 
regenerative medicine and in targeting in vivo niches.  
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1.5.1 Mechanotransduction 
To understand how properties of the biomaterial interface, such as stiffness, 
topography and chemistry can regulate cell behaviour, we must first consider how 
cells sense and adapt to forces and physical constraints imposed by the ECM and 
other microenvironmental cues. Cell membrane receptors are a vital part of how 
cells interact with their environment and perceive changes in the physio-chemical 
milieu - the binding of receptors to ligands is highly specific, but other factors can 
influence both the binding and the downstream effects of receptor binding. 
Receptor activation may be required for ligand binding, for example, clustering 
or phosphorylation. The ligand may need to be released from the surrounding ECM 
by degrading or distorting the matrix, or the downstream signalling effects from 
several receptor types can interact in a synergistic or inhibitory manner (Monteiro 
A. et al., 2018). This process in which cells convert the mechanical stimuli they 
sense, into biochemical signals that lead to cell response is termed 
mechanotransduction. 
Cell adherence to substrates is typically through integrins, transmembrane 
receptors that tether to the ECM, thus connecting the extracellular environment 
to the cytoskeleton (Kasemo and Lausmaa, 1988). Integrins are heterodimeric 
proteins (containing a and b subunits) that specifically ligate to peptide motifs on 
ECM proteins, for example the integrin avb3 binds the well-known arginine, glycine 
and aspartic acid (RGD) tripeptide present on many ECM proteins (Pierschbacher 
and Ruoslahti, 1984). There are many different combinations of integrin a and b 
subunits, and these are specific to different types of ECM proteins and adhesion 
domains (Hynes, 2002). Different cell types will produce different types of 
integrins, contributing to differing cellular responses to the environment 
(Monteiro A. et al., 2018).  
After integrins bind to the ECM there is a process of integrin clustering into 
supramolecular complexes called focal adhesions. Focal adhesions contain a 
number of structural and signalling molecules that link the ECM to the actin 
cytoskeleton (Jansen et al., 2017; Vicente-Manzanares and Horwitz, 2011). Super-
resolution microscopy has determined the molecular architecture of focal 
adhesions – in which integrins and actin are separated by a ~40 nm core region 
that consists of partially overlapping protein specific layers. Talin tethers span 
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these layers to regulate the ultra-structures, and to form integrin-talin-actin 
complexes that work as mechanical linkages, demonstrated in Figure 1-10 
(Kanchanawong et al., 2010; Liu et al., 2015).  
 
Figure 1-10 Model of focal adhesion molecular architecture.  Schematic shows integrins 
bound to the ECM and the three overlapping layers of the focal adhesion core linking the ECM 
to the actin cytoskeleton: integrin signalling layer, force transduction layer and the actin 
regulatory layer. Adapted with permission from (Kanchanawong et al., 2010).  
Integrins have no enzymatic activity, but the b subunit connects to the signal-
transducing kinase, focal adhesion kinase (FAK), directly or indirectly through 
vinculin or paxillin (Figure 1-10) (Hayashi et al., 2002; Thomas et al., 1999). FAK 
mediates activity of several downstream signalling cascades; including Src 
(nonreceptor tyrosine kinase family), ERK (extracellular signal-regulated kinase) 
and Rho (small GTPase). Rho signalling is a critical regulator of cytoskeletal 
dynamics, contractility and motility – G-protein activation leads to 
phosphorylation of the myosin light chain kinase (MLCK) through Rho-associated 
protein kinase (ROCK), increasing actin-myosin contractility causing integrin 
clustering and cell adhesion formation (Kilian et al., 2010; McBeath et al., 2004).  
Cell mechanosensing responses also occur at the transcriptional level. Both YAP 
(Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding 
motif) are mechanosensitive transcriptional activators with critical roles in 
development (Porazinski et al., 2015), cancer (Moroishi et al., 2015) and organ 
size control (Zhao, Li, Lei and Guan, 2010). YAP/TAZ activity in a cell is controlled 
directly by cell shape and polarity, which is in turn dictated by the cytoskeletal 
structure – in situ the structure and tensional state of the cytoskeleton reflect the 
position of the cell within a tissue – and physical cues such as these are converted 
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by YAP/TAZ into gene expression signatures and coherent, context dependent 
biological responses (Dupont et al., 2011; Totaro et al., 2018). YAP mechanical 
regulation requires the cytoskeleton tension induced by ECM stiffness and cell 
spreading, and recently it was demonstrated that these forces result in nuclear 
flattening, leading to increased nuclear import of YAP due to decreased 
mechanical restriction to molecular transport in nuclear pores (Figure 1-11) 
(Dupont et al., 2011; Elosegui-Artola et al., 2017). These studies highlight how the 
ECM mechanically couples to the nucleus to lead directly to transcription level 
control of cell behaviour.   
 
Figure 1-11 Mechanical coupling of ECM-nucleus translocates YAP to the nucleus. Force 
increases YAP nuclear import by reducing mechanical restriction in nuclear pores. 
Demonstrating molecular mechanical stability as a general regulator of nuclear transport and 
resulting transcriptional activity. From (Elosegui-Artola et al., 2017) with permissions. 
The mechanism of how interactions at the integrin-ligand interface modulate 
cellular response to stiffness has recently emerged. The ‘molecular clutch theory’ 
has long been proposed to explain actin cytoskeleton and cell migration dynamics 
(Mitchison and Kirschner, 1988), but has now been used, somewhat counter-
intuitively, to explain cell adhesion dynamics (Elosegui-Artola et al., 2018). 
Controlled substrate stiffness and ECM ligand (RGD) density were used to show 
that at low stiffness, close to that of softer tissues (>5 kPa), when RGD spacing 
was increased, focal adhesion growth also increased. Remarkably, at higher 
stiffnesses in ranges typical of many body tissues, increased ligand spacing leads 
to focal adhesion collapse. At 30 kPa the rigidity threshold was around 100 nm 
RGD spacing, whereas at 150 kPa focal adhesion collapse was observed at 50 nm 
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spacing. Above this stiffness range, that of tissue culture plastic (TCP), 
conventional rules apply – increased ligand density is required for adhesion 
formation. Whereas for stiffness in the range of physiological interfaces, the 
molecular clutch can be applied, i.e. ligand spacing is not via direct sensing, but 
instead individual integrin-ECM ligands (or cell adhesion molecule-neighbouring 
cell ligand) act as ‘molecular clutches’ and as force load increases more clutches 
are recruited, up to a threshold value. The recruitment of more clutches 
redistributes the force load among them, thus reducing the total force each 
individual clutch is exposed to. When the threshold recruitment is reached at high 
stiffness and increased spacing, no further distribution can occur and the adhesion 
collapses (Donnelly et al., 2018; Elosegui-Artola et al., 2018; Oria et al., 2017).  
As such, mechanotransduction pathways are engaged by the cells’ external 
mechanical environment, enabling the cell to adapt and respond by activating 
internal biochemical signalling pathways in a constant feedback loop. There are 
many signalling pathways implicated in mechanosensitivity, and biomaterial 
strategies have been integral in elucidating these mechanisms by permitting 
nanoscale control of cell receptors at the material interface (Dalby et al., 2018; 
Donnelly et al., 2016).   
1.5.2 Topography 
The architecture (topography) of a cell’s microenvironment contains stimuli 
ranging from the micro to the nanoscale; microscale features are in the range of 
the size of the cell itself and result in whole-cell responses such as alignment of 
cells with topographical features, known as contact guidance (Curtis and Varde, 
1964). However, nanoscale features present a multitude of cues that are several 
orders of magnitude below that of the cell (Figure 1-12) (Dalby et al., 2014). 
Adhesion formation is dynamic, cells use unbundled, actin-driven membrane 
projections, filopodia, to probe the external environment. It has been shown that 
filopodia can follow contact guidance cues down to 10 nm in height (Dalby et al., 
2004). At the sub- 10 nm height nanoscale projections have been detected, 
evidencing the great sensitivity of cellular sensing. Though, it is noteworthy that 
at this sub-10 nm scale, contact guidance was not observed, just feature 
interactions (McNamara et al., 2014).  
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Figure 1-12 Scale of cellular components. Starting from nanometre scale of genetic material 
and single integrin heads, to the micrometre range of focal adhesion complexes and 
mammalian cells. Adapted from (Monteiro A. et al., 2018). This figure was created using 
Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Generic License. 
Material engineering strategies have been employed to gain control over adhesion 
size. Nanopatterned substrates with controlled size, shape, spacing and symmetry 
have been created using lithography in a variety of materials; patterns have 
included nanopits (Dalby et al., 2007b; McMurray et al., 2011) nanopillars (Bucaro 
et al., 2012) and nanogrooves (Watari et al., 2012). Control of these nano-features 
allows control over adhesion size, number and spacing. Large super-mature 
adhesions (>5 µm long) are required for osteogenesis of MSCs (Biggs et al., 2009), 
and on substrates created to promote increased adhesion size, intracellular 
tension is also increased. This conformational change is linked to mechanical 
changes in the cytoskeleton, which can transfer tensile (contractile forces) to the 
nucleus (Elosegui-Artola et al., 2017; Ingber, 2003a, 2003b; Wang et al., 2009), 
and increased intracellular tension is linked to osteogenesis (Biggs et al., 2009). 
These changes in nucleus shape can consequently affect chromosomal 
arrangements; repositioning of chromosomes from euchromatic to 
heterochromatic sites via the nuclear lamina occurs and leads to transcript level 
changes in components of the chromatin remodelling machinery and to lineage 
specific genes. Ultimately leading to impact upon stem cell phenotype (Dalby et 
al., 2007a; McNamara et al., 2012; Tsimbouri et al., 2013). 
Such responses have been well characterised using topographical control over MSC 
fate by our group. Electron beam lithography was used to create well-defined, yet 
remarkably similar, nanopatterns able to direct MSCs to commit to osteogenic 
differentiation or to maintain self-renewal (Figure 1-13). The pattern that permits 
out-of-niche self-renewal is comprised of pits with a diameter of 120 nm, depth 
of 100 nm and centre-centre spacing of 300 nm in a square lattice (SQ) (McMurray 
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et al., 2011). Adding just ± 50 nm offset from the centre position, changing the 
surface to near-square (NSQ) directs MSC fate to osteogenesis (Dalby et al., 
2007b). It was found that this subtle 50 nm offset led to significant differences in 
cell adhesion: MSCs on NSQ form larger, more mature adhesions, increasing 
intracellular tension compared to SQ (Dalby et al., 2007b; McMurray et al., 2011). 
 
Figure 1-13 Topography to control mesenchymal stem cell (MSC) adhesion for self-renewal 
and osteogenesis. Self-renewing MSCs adhere more-weakly than osteo-committed cells, 
leading to lower levels of integrin-mediated signalling through focal adhesion kinase (FAK), 
retaining levels of extracellular signal-regulated kinase (ERK1/2) to support growth but not 
differentiation. B. MSCs undergoing osteogenesis require larger adhesions, increased FAK 
activation elevates ERK1/2 activation to levels required for lineage commitment, increasing 
intracellular tension, activating Runt-related transcription factor 2 (RUNX2), a key regulator 
of osteogenesis, whilst simultaneously inactivating adipogenic regulator peroxisome 
proliferator-activated receptor gamma (PPAR-γ). Fluorescent images show a marked increase 
in adhesion size on near square (NSQ) compared with square (SQ) surfaces. From (Donnelly 
et al., 2018) with permissions.  
Directed differentiation of MSCs has been well investigated by many of these 
material systems; as stated, osteogenesis requires large adhesions that support 
high intracellular tension (Dalby et al., 2007b; Tsimbouri et al., 2012), while 
adipogenesis occurs when adhesion is weak and tension low (Kilian et al., 2010; 
McBeath et al., 2004). Strategies exploiting these requirements have been 
integral in dissecting biochemical mechanisms fundamental to these processes, 
however, less well understood are the mechanisms required for long term self-
renewal of MSCs. For MSCs, self-renewal requires an intermediate adhesion state 
that suppresses differentiation and allows for long term growth in vitro. As such, 
conditions favouring self-renewal sit mid-way between the adhesion requirements 
for osteo- and adipo- commitment. However, these conditions will also favour 
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fibroblast formation, rendering this difficult to harness in culture (Dalby et al., 
2018; Kilian et al., 2010; McBeath et al., 2004). 
Due to the well-defined osteogenic phenotype and commitment profile, many 
studies focus on the generation of osteogenic nanotopographies with orthopaedic 
implants in mind, where incorporation of such nanopatterns to already existing 
implants could help improve implant success. Orthopaedic implants are typically 
made from titanium or titanium alloys, for example, hip replacements that are 
stabilised by titanium stems into the BM of the femoral canal (McCutchen et al., 
1990). When the BM microenvironment is disrupted it loses niche functions and 
resident stem cells differentiate in response to the implant, mainly into soft tissue 
forming fibroblasts or adipocytes. Encapsulation of the implant within soft tissue 
leads to micromotion and ultimately implant failure. As such, nanotopographical 
patterns such as the NSQ developed by our group, have been featured on titania 
(the oxide of titanium) with aims to promote osteogenesis around the implant 
(Sjöström et al., 2013).  
To decouple adhesion requirements for cell spreading topographical substrates 
have been engineered coupled with RGD adhesive sites. As integrins ligate, they 
are coupled to actin cytoskeleton. Actin-myosin contraction through activation of 
G-proteins leads to integrin clustering and the formation of mature adhesions. 
Nanocolloidal particles, with one covalently linked RGD motif per colloid, were 
used to demonstrate that at an RGD spacing of <70 nm integrin clustering occurs, 
forming mature adhesions. Above this density integrins cannot gather (Cavalcanti-
Adam et al., 2008, 2007). Then, using electron beam lithography approaches to 
create groups (dimers to heptamers) of RGD within 70 nm of each other, it was 
demonstrated that smaller clusters were separated beyond gathering distance, 
whereas tetramers of gathered integrins were required for complete cell 
spreading – i.e. functional adhesions (Schvartzman et al., 2011). 
By altering cell adhesion, cytoskeletal organisation and mechanotransduction fate 
changes are likely driven by the topography-protein interface (Donnelly et al., 
2018). When FN, a cell-adhesive protein and major component of the ECM, is 
adsorbed onto nanopit patterned surfaces it is adsorbed within the pit structures, 
and cells have been shown to probe these pits with filopodia. This leads to 
‘nanoimprinting’ of the pits on the cell membrane, an effect that is absent when 
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the nanopattern is not coated with FN (Ngandu Mpoyi et al., 2016). Indicating that 
nanoimprinting is cell-adhesion mediated, with adhesion to topographical features 
leading to mimics of the topography in the basal cell cytoskeleton (Wood et al., 
2008). If the integrins are blocked then nanoimprinting cannot occur (Wood et al., 
2008), indirectly demonstrating the importance of the ECM on cell response to 
shape. This suggests that the topography-driven changes in cell cytoskeleton 
organisation and adhesion are mediated by the protein-adhesive interface and 
cells interact with topography dependant on this interface (Ngandu Mpoyi et al., 
2016). 
Cell adhesion and subsequent spreading governing size and shape influence 
physiological processes such as cell survival, differentiation and growth (Chen et 
al., 1997). Using microcontact printed ECM islands of decreasing size, it was shown 
that cell confinement governs control over growth and death, with small areas 
that restrict spreading leading to apoptosis (Chen et al., 1997). Since then, this 
technique has been employed to confine MSCs in specific morphologies, 
controlling adhesion and intracellular tension (Kilian et al., 2010; McBeath et al., 
2004). On ECM islands/shapes where the MSCs remained rounded, they were 
unable to form mature adhesions, leading to adipogenic lineage commitment. 
Whereas, ECM islands/shapes and sizes that allowed spreading, promoted actin-
myosin contractility and mature adhesion formation support MSC osteogenesis 
(Kilian et al., 2010; McBeath et al., 2004). The actomyosin tension of the 
cytoskeleton contributes to this geometric control, which is biophysically linked 
through adhesion formation governed at the nanoscale by changes in plasma 
membrane. It was also recently demonstrated that modulation of the plasma 
membrane lipid assembly, using similar contact printed shapes, can regulate 
intracellular signalling and thus stem cell fate (von Erlach et al., 2018).   
A similar approach was also used to show how mechanotransductive responses play 
important roles in other cell types, such as macrophages, which regulate distinct 
pathways associated with inflammation. Macrophages are understood to be 
majorly responsive to chemical cues and stimulation such as chemokine signals 
from injury sites, though recent work has suggested that the physical environment 
may also be a critical mediator in macrophage behaviour (McWhorter et al., 2013). 
Like many adherent cell types, surface receptors are likely to be involved in this 
process, however in 2018 Jain and Vogel demonstrated that the cytoskeleton is a 
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critical mediator in macrophage response to the physical environment. By spatially 
confining macrophages on cell adhesive islands they found that changes in actin 
polymerisation leads to modulation of a G-actin bound transcription factor, 
myocardin-related transcription factor A (MRTF-A). When macrophages are 
unconfined and well-spread, actin polymerisation leads to MRTF-A release, upon 
which it translocates to the nucleus, enhancing expression of ‘late’ inflammatory 
response genes. Whereas, preventing actin polymerisation via macrophage 
confinement reduces MRTF-A-mediated transcription and nuclear volume, thereby 
compacting chromatin and leading to changes in epigenetic signatures. Notably 
the same effects are observed if cells are confined in both 3D structures and by 
local cell crowding (Jain and Vogel, 2018).   
1.5.3 Stiffness and mechanics 
The ECM and surrounding cell junctions have major physical influence in 
transmitting forces between cells, ultimately regulating cellular processes and 
behaviours (Vining and Mooney, 2017). Cells can intrinsically generate mechanical 
forces within their environment, for example actin-myosin contractility leading to 
matrix remodelling (Daley et al., 2011, 2009). Equally, mechanical force can come 
from microenvironmental niche factors, extrinsic sources include tensile, 
compressive forces or shear stresses (Vining and Mooney, 2017). Whether 
individually or collectively, these mechanical forces impact and regulate cellular 
behaviour (Donnelly et al., 2018).  
Intrinsic and extrinsic mechanical forces guide embryonic development from as 
early as the blastocyst stage (Vining and Mooney, 2017). Remodelling of cell-cell 
junctions is driven by intrinsic cell forces to relieve tension as the embryo 
transitions through germ-band elongation, where myosin II-dependent spatial 
reorganisation leads to local forces at cell boundaries (Bertet et al., 2004). Later 
in development, organ morphogenesis is regulated by mechanical properties of 
the ECM, where cell layers are organised into defined structures by traction forces 
on the ECM providing the template for organ growth (Vining and Mooney, 2017). 
Such tissue remodelling and development continues into adulthood as tissues 
maintain structure and function. For example, epidermal stem cells use 
biomechanical signalling to regulate and balance stem cell proliferation, 
differentiation rates and coordination of cell fate with position. Local crowding 
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from dividing stem cells deforms cell shape and stress distribution, altering cell-
intrinsic processes and triggering differentiation of the neighbouring cell 
(Miroshnikova et al., 2017). Owing to the complexity of this communication 
between cells and the environmental mechanical milieu, biomaterial strategies 
have played a key role in elucidating how these cues affect stem cell behaviour. 
By deconstructing complex environments and by taking early reductionist 
approaches we are beginning to understand how mechanical force regulates cell 
behaviour (Donnelly et al., 2018). 
Much research on MSCs is carried out on TCP, or on other stiff and planar 
substrates. Many tissues and stem cell niches however, often have low or gradients 
of stiffness and are 3-dimensional (3D) in situ, implicating key mechanical 
properties important for cell behaviour (Figure 1-14). Hydrogel systems are now 
routinely employed, and due to their unique properties, they provide optimal 
systems for understanding cell response on or in substrates with controlled 
stiffness that are more physiological-like. Natural or synthetic polymers can be 
physically or chemically cross-linked in a controlled manner to produce hydrogel 
systems with tuned degradability, hydrophilicity and stiffness. The water that fills 
the space between the macromolecules leads to a degree of flexibility similar to 
that of natural tissues, making them both biocompatible and biomimetic (Ahmed, 
2015; Donnelly et al., 2018).  
 
Figure 1-14 Stiffness of various tissues. Biomechanical properties of various tissues in terms 
of stiffness (elastic modulus) in kilopascals (kPa). Stiffness varies between tissues and 
relates to functions. Mechanically static tissues such as neural exhibit low stiffness, whereas 
tissues exposed to high mechanical loading, such as bone exhibit high elastic moduli with a 
stiffness that is several orders of magnitude greater. This figure was created using Servier 
Medical Art, licensed under a Creative Commons Attribution 3.0 Generic License.  
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Original work from Engler et al, used polyacrylamide (PAM) gels of tuneable matrix 
stiffness to guide stem cell fate through distinct tissue lineages; neural at 0.1-1 
kPa, muscle at 12 kPa and bone at 30 kPa. This simple tuneable system has set 
the pace over the last decade for the unravelling and exploiting of the biological 
mechanisms linked to mechanoregulation of MSCs (Engler et al., 2006).  
Gradients of stiffness are exhibited in vivo at physiological interfaces, such as 
those at tissue junctions or at pathological boundaries, e.g. neuromuscular 
junctions and the tumour boundary (Hadden et al., 2017). Isolated cells are known 
to migrate to regions of different stiffness, ‘durotaxis’, the axis of migration 
depends upon the cell type; with stem cells known to migrate to regions of 
increasing stiffness (Tse and Engler, 2011; Vincent et al., 2013). Cancer cell lines, 
meanwhile, have been shown to have a variable relationship with substrate 
stiffness (Cavo et al., 2016; Reid et al., 2017). Multicellular clusters exhibit 
collective durotaxis, groups of epithelial cells were found to migrate towards 
stiffer regions - cells atop stiffer substrates are able to gain better traction than 
on softer regions through integrin binding, intercellular junctions and the action 
of myosin motors are then able to contract neighbouring cells resulting in 
collective movement to firmer ground (Sunyer et al., 2016). 
These observations highlight a need to think about inherent substrate stiffness and 
the underlying gradient of stiffness. Some polymerisation methods have now been 
developed to allow user control over stiffness gradients in PAM hydrogels. One 
study designed a system ranging from 0.5-8.2 kPa/mm, permitting an in vitro 
model spanning the in vivo physiological and pathological range therefore 
facilitating investigation of a range of mechanical signals on one surface and cell 
population (Hadden et al., 2017). Previous work by our group combined two 
biomaterial strategies with modulated mechanical and topographical properties 
in order to achieve tissue interface-like differentiation of MSCs. An HA hydrogel 
at the stiffness boundary of cartilage, but lower than that of bone, was combined 
with the stiff, topographically patterned substrate, known to promote 
osteogenesis (NSQ). This led to anisotropic commitment of MSCs from a single 
source down chondrogenic and osteogenic lineages, similar to the interface of 
articular cartilage and bone found at the end of long bones (Donnelly et al., 2018, 
2017). 
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Polymeric hydrogels have been used to elucidate fundamental processes involved 
in mechanosensing and how this effects osteogenesis of MSCs. To uncover the role 
of YAP/TAZ in mechanosensing PAM hydrogels of modulated stiffness were used. 
By varying substrate stiffness, it was found that if forces from adhesion and/or 
the cytoskeleton are high enough (above 5k Pa) the cytoskeleton is reinforced by 
stress fibres, mechanically coupling it to the nucleus. Thus, providing a direct link 
from focal adhesion to the nucleus, leading to nuclear flattening, stretching of 
nuclear pores and thereby increasing YAP nuclear import (Figure 1-11) (Elosegui-
Artola et al., 2017). Osteogenesis of MSCs occurs on stiff substrates (above 5 kPa), 
here YAP translocates to the nucleus via this mechanosensitive mechanism and 
consequently activates the master regulator of osteogenesis, transcription factor 
runt-related transcription factor 2 (RUNX2) (Yang et al., 2014). Nuclear 
compartmentalisation of YAP/TAZ is preserved when MSCs are cultured on stiff 
substrates for long culture periods (~10 days), and consequently, the ability to 
respond to softer substrates is lost. These MSCs remain committed to an 
osteogenic differentiation profile, suggesting they possess mechanical memory, 
illustrated in Figure 1-15 (Yang et al., 2014).  
 
Figure 1-15 MSCs have mechanical memory. Cell mechanosensing through integrin-ECM (e.g. 
fibronectin RGD domain) detect changes in matrix stiffness, as stiffness increases so does 
nuclear important of Yes-associated protein (YAP) and its transcriptional co-activator TAZ. 
The YAP/TAZ complex is a master regulator of many downstream effectors, including 
differentiation of MSCs. MSCs will preferentially differentiate into osteoblasts on stiff 
matrices, and soft tissue types (such as adipose tissue) on soft matrices, hence increased 
nuclear import of YAP/TAZ on stiff substrates attenuates osteogenic differentiation of MSCs. 
In MSCs that are preconditioned on a stiff substrate, and then re-plated to a softer substrate, 
YAP/TAZ signalling remains active, and the cells remain committed to an osteogenic 
differentiation profile. Adapted with permissions from (Donnelly et al., 2018).  
Substrate stiffness is perceived by cells through the localisation of receptor-
ligand interactions. Therefore, stiffness correlates to the expression and 
localisation of integrins (cell-matrix) and cadherins, transmembrane receptors 
important in cell junctions (cell-cell). This mechanosensitive mechanism can 
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thus be exploited to modulate cellular signalling (Aragona et al., 2013; Driscoll 
et al., 2015; Dupont et al., 2011). Materials modified to present adhesive 
peptide motifs have been used to modulate fate commitment in MSCs. HA 
hydrogels of tuned stiffness were integrated with peptide motifs mimicking cell-
cell and cell-matrix interactions through co-presentation of the N-cadherin 
adhesive sequence HAVDI (histidine, alanine, valine, aspartic acid, isoleucine), 
and the FN RGD sequence. Co-presentation on stiff 2-dimensional (2D) gels led to 
YAP/TAZ remaining cytosolic, thereby preventing osteogenic commitment. 
However, when the HAVDI motif was removed, exposing MSCs to an environment 
with more ECM-like interactions YAP/TAZ translocated to the nucleus and MSCs 
underwent osteogenic differentiation (Cosgrove et al., 2016). Interestingly, 
differences were observed when the system was transferred to 3D. Incorporation 
of the HAV sequence (the conserved part of the HAVDI sequence) with MSCs 
encapsulated within the gels led to chondrogenic commitment, illustrated in 
Figure 1-16. The MSCs perceived this interface as an increase in cell-cell like 
adhesions, a crucial component for chondrocytes that typically live in pairs (Bian 
et al., 2013).  
Due to studies such as these, the focus on the effects of 3D matrices on stem cell 
differentiation go beyond controlling the bulk mechanical properties, i.e. the 
traditional model proposed by Engler, where bulk stiffness leads to differentiation 
down lineages of similar native stiffness (Engler et al., 2006). For example, MSCs 
encapsulated in alginate gels of varied stiffness (2.5 – 110 kPa) presenting RGD 
motifs at various clustering densities, demonstrated stiff substrates that hindered 
cell spreading but permitted RGD clustering – in a process similar to traction-
mediated unfolding of FN - were still able to permit osteogenic commitment i.e. 
cell fate was not correlated to cell morphology but to integrin-adhesion-ligand 
bonds (Huebsch et al., 2010).  
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Figure 1-16 Cells ‘sense’ matrix stiffness through receptor-adhesion presentations. Materials 
modified to contain specific peptide sequences can modulate mechanosensitive pathways. 
Interactions mimicking cell-cell adhesions (N-cadherin-based interactions) through the HAV 
motif, pathways triggered by soft substrates are activated, reducing the contractile state of 
the cell. Whereas interactions mimicking cell-ECM adhesion (integrin-based interactions) 
through the RGD motif lead to focal adhesion formation, increasing intracellular tension, 
enabling osteogenesis of MSCs. HAV-N-cadherin interactions inhibit Rac-GTP levels, 
decreasing myosin IIA-actin interactions, reducing focal adhesion-related protein recruitment 
to integrins. This reduces the contractile force generation on the cytoskeleton and cells 
behave as though on a softer substrate. In 3D, peptide motif incorporation can tune control 
over osteogenic and chondrogenic differentiation. Chondrocytes typically live in pairs, as 
such, cell-cell interactions are preferable to cell-matrix for chondrogenic commitment – i.e. 
the presence of the HAV motif promotes chondrogenesis. Taken from (Donnelly et al., 2018) 
with permissions. 
A further example incorporated matrix degradable sites into tuneable 3D HA 
hydrogels, presenting a system that either permits or prevents cell-mediated 
degradation (Khetan et al., 2013). This study also demonstrated cell fate was 
morphology-independent when the matrix is nondegradable, but is instead 
directed by cell-mediated traction forces (Khetan et al., 2013). However, by 
incorporating matrix metalloproteinase (MMP)-degradable peptides, encapsulated 
cells were able to reach otherwise unavailable adhesive ligands, rearranging their 
cytoskeletal structure to generate traction forces that potentially led to 
osteogenic commitment, this was irrespective of morphology or bulk matrix 
stiffness (Khetan et al., 2013). These studies support the premise, in 3D, that 
‘sensing’ of matrix stiffness by integrin-adhesion-ligand bonds can act as sensors 
of matrix elasticity and dimensionality, in a morphology-independent manner 
(Huebsch et al., 2010).  
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1.5.4 Chemistry 
Manipulation of chemical properties of substrates has also been investigated. 
Changes in cell adhesion to substrates can be controlled by manipulation of 
material properties such as surface wettability (Celiz et al., 2014; Mei et al., 
2010), control of protein adsorption, such as ECM proteins or GFs (Keselowsky et 
al., 2005, 2004, 2002) and incorporation of different chemical groups has also 
been shown to be sufficient to influence MSC fate (Benoit et al., 2008). The key 
study by Benoit et al, employed poly(ethylene glycol) (PEG) hydrogels 
functionalised with small-molecule functional groups to direct adipogenesis with 
hydrophobic t-butyl groups, and osteogenesis with charged phosphate groups 
(Benoit et al., 2008). Since original studies that alter surface charges and 
functional group presentation such as these, advances in organic chemistry are 
beginning to offer new strategies for biomaterial synthesis and control, for 
example click-chemistry (Deforest et al., 2009; DeForest and Anseth, 2012; Jiang 
et al., 2014) and GF tethering techniques (Alberti et al., 2008; Llopis-hernández 
et al., 2016). With added both spatial and temporal control through in situ 
degradability and delivery, such advances offer a diverse toolbox for precise 
functionalisation of substrates (Donnelly et al., 2018). 
PEG hydrogels are commonly used and can be easily modified to contain 
photodegradable cross linkers, this permits the user post-gelation control over 
substrate properties, such as gel conformation and biochemical composition - with 
stem cells in situ. Degradation of the hydrogel network changes the physical 3D 
environment of encapsulated cells and can lead to migration or lineage 
commitment (Kloxin et al., 2009). Cell adhesive moieties, such as RGD, are often 
incorporated into PEG hydrogels, and one example used pendular RGD motifs that 
could be dynamically cleaved by a light-stimuli, decreasing RGD availability and 
therefore adhesion formation. On-demand temporal control of pendant release 
created spatial changes that could be controlled to direct MSC fate towards 
chondrogenesis (Kloxin et al., 2009). Other click-chemistry strategies incorporate 
a combination of integrin-binding domains, protease-degradable sites and locally 
sequestered GFs into PEG hydrogels; upon cell infiltration cell-secreted MMPs 
degrade networks leading to GF release (Lutolf et al., 2003). This strategy was 
used to deliver recombinant human bone morphogenetic protein-2 (BMP-2) to a 
critical sized defect in rat cranium, where they found bone regeneration was 
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dependent on the ability of cells to infiltrate the matrices through the proteolytic 
sensitive sites (Lutolf et al., 2003).  
GFs are potent biomolecules that have strong influence on cells, such as 
stimulation of proliferation, differentiation and migration. They are instrumental 
during development and play key roles in physiological and pathological processes, 
including tissue homeostasis (e.g. in the BM niche) and tissue repair (e.g. wound 
healing). GFs also have essential roles in directing stem cell phenotype, such as 
BMP-2 to promote osteogenesis, vascular endothelial growth factor (VEGF) to 
promote vascularisation and TGFb to promote chondrogenesis (Salmerón-Sánchez 
and Dalby, 2016).  
Due to this regenerative potential the roles and potential of GFs for tissue 
engineering/regenerative purposes has been widely explored. Typically, GFs used 
in clinic or in vivo are used at supraphysiological doses to enable delivery of 
effective local concentrations, as there will be initial rapid break down and 
propagation from the implant site. The current gold standard for in vivo bone 
repair is a collagen I-based sponge which delivers BMP-2 at a concentration of 1.5 
mg/mL (INFUSE®), however, due to the serious off-target side effects experienced 
in patients the Food and Drug Administration (FDA) released a public health 
notification of life threatening complications associated with this device (Woo, 
2012). Such high GF doses are not only harmful but also extremely costly. Systems 
that bind GFs to surfaces in a solid-phase state, more similar to how the native 
ECM binds and presents GFs in stem cell niches, have been developed - controlled-
release (Lutolf et al., 2003; Mooney et al., 2000) and protein engineered (Martino 
et al., 2011) strategies have aimed to provide a solution for better translation of 
GFs to the clinic by creating matrices that retain GFs, with the hope of decreasing 
off-target effects and cost (Figure 1-17).  
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Figure 1-17 Soluble and matrix bound growth factor delivery. Conventional soluble delivery 
of GFs (right) typically requires high concentrations, which rapidly propagate away from the 
site when applied in vivo. Solid-phase GF delivery, for example by tethering to the ECM (left), 
allows the use of significantly lower concentrations of GFs and more targeted and effective 
delivery. ECM-bound presentation facilitates integrin-GF receptor cross talk due to the close 
proximity of the receptors. From (Donnelly et al., 2018) with permissions.  
Controlled binding of GFs to synthetic materials (‘solid-phase’ delivery) has 
proved difficult. Non-specific crosslinking may compromise bioactivity of the 
molecule, with further concerns over stability, amount and cellular accessibility 
to the ligands. With this in mind, one study developed a poly(ethylene oxide) 
(PEO) based co-polymer to covalently tether epidermal growth factor (EGF) to the 
substrate, a GF associated with tissue repair. By specifically tethering at the N-
terminus, bioactivity was retained but restricted it to the surface. Tethered EGF 
led to signalling through its receptor EGFR (epidermal growth factor receptor), in 
a manner akin to physiological-like matrix-embedded EGF – where EGF is 
stimulated but not internalised (Fan et al., 2007). Using a similar copolymer 
system, immobilised leukaemia inhibitory factor (LIF) was presented, to ESCs. LIF 
is essential for self-renewal in ESCs, and is typically added in ESC feeder-free 
culture conditions. ESCs cultured in this system showed retention of pluripotency 
for up to 2 weeks, in the absence of soluble LIF in the culture media (Alberti et 
al., 2008). 
More recently, substrates were coated with evenly spaced and tuneable arrays of 
gold nanoparticles functionalised with BMP-2. Using block copolymer micellar 
nanolithography, the system permits precise control over the nanoscale 
distribution of BMP-2. One BMP-2 molecule is tethered per nanoparticle, meaning 
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local density and distance between BMP-2 anchor points can be modulated. Here 
it was found that when compared to soluble GF administration, immobilised BMP-
2 increased intracellular Smad-signalling. Even at concentrations as low as 0.2 
ng/cm2 Smad-dependent signalling was observed (Schwab et al., 2015). Tethering 
of BMP-2 in this manner permits sustained local delivery of BMP-2 (or other GFs) 
and allows the user precise ligand control on a platform to investigate effects of 
GF density and spacing on intracellular signalling. 
Other approaches to immobilise GFs exploit the natural affinity of ECM molecules 
for GF binding. FN is a major component of native ECM, it contains the RGD 
integrin-binding domain in its 9th type III repeat, which has been incorporated into 
many materials. FN also contains a highly promiscuous GF binding domain in its 
12th to 14th type III repeats, and is known to sequester GFs from different families 
with high affinity (Martino and Hubbell, 2010). Seminal work by Martino et al, 
exploited this affinity for GF binding by developing recombinant FN fragments that 
incorporate the GF binding region of FN (FNIII12-14) as an approach for GF delivery. 
A fibrin matrix was functionalised with two FN fragments, one containing FNIII9-10, 
the RGD cell adhesion site, another containing the FNIII12-14, the GF binding region. 
Upon functionalisation with platelet-derived growth factor (PDGF)/VEGF or BMP-
2, they demonstrated the system could promote wound repair and bone growth, 
respectively (Martino et al., 2011). 
 
Figure 1-18 FN nanonetwork formation and GF presentation. Atomic force microscopy (AFM) 
images after FN adsorption shows spontaneous formation of FN nanonetworks on PEA, but 
not PMA which results in globular FN aggregates. Sequential adsorption of growth factor 
(here BMP-2, at 25 ng/mL) shows interactions of BMP-2 with FN fibrils on PEA, but not PMA, 
due to an open molecular conformation exposing the key GF binding domain. The proximity 
of the GF binding and integrin binding domain on FN molecules in networks leads to 
synergistic integrin and GF receptor signalling. Adapted from (Donnelly et al., 2018) with 
permissions.  
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This technique illustrated delivery of significantly lower dosages of GFs could be 
effectively used in a clinical setting. The approach, however, relies on complex 
recombinant protein technology. This is due to delivery of whole FN molecules to 
substrates leading to FN adopting a globular conformation, thus concealing these 
key binding domains. However, work by our group has developed a novel strategy 
to drive physiological-like FN network formation. The polymer poly(ethyl acrylate) 
(PEA) causes spontaneous unfolding of FN molecules, leading to assembly into 
nanonetworks, exposing the cell and GF binding domains. Then, by incorporation 
of BMP-2, we demonstrated that due to the close proximity of the integrin- and 
GF-binding domains on open FN molecules, this system drives synergistic signalling 
between integrins and growth factor receptors (GFRs), which attenuates 
intracellular signalling (Figure 1-18). This led to robust osteogenesis of MSCs in 
vitro and bone fracture repair in vivo (Cheng et al., 2018; Llopis-hernández et al., 
2016). This strategy has been incorporated into implanted biomaterials - 
orthopaedic titanium was coated with PEA/FN and BMP-7 tethered to improve 
osteointegration (Al-jarsha et al., 2018), whereas tethering of VEGF has shown 
improved vascularisation of biomaterial scaffolds in vivo (Moulisová et al., 2017). 
This PEA system developed by the Centre for the Cellular Microenvironment is 
used in this thesis, and will be discussed in further detail in Chapter 3.  
1.5.5 Modelling the bone marrow niche 
As in vivo stem cell niches are complex, combinatorial bioengineering techniques 
such as those discussed above, are moving towards allowing deconstruction and 
reconstruction of these multifaceted systems. The use of overly simplified cell 
culture models could be replaced by engineering de novo niche models, these 
models could be built using biomimetic materials with human stem cells to 
replicate tissue complexity (Lee-Thedieck and Spatz, 2012; Müller et al., 2014). 
Such systems could be used to promote in vitro expansion for regenerative 
medicine purposes, e.g. HSCs for HSCT, or to more reliably predict drug 
mechanism, toxicity and efficacy.  
Previous efforts to expand HSCs have mainly focused on identifying cytokines or 
small molecules that target cell signalling to regulate HSC function (Boitano et 
al., 2010; Guo et al., 2018; Hagedorn et al., 2015). Some of these strategies have 
demonstrated extensive cell expansion, but a concomitant loss of long-term in 
Chapter 1 Introduction  47 
vivo function has also been observed (Nakauchi et al., 2006). The absence of 
sustained self-renewal is thought to be a result of complete removal of physical 
and biochemical cues of the native niche when HSCs are placed into standard 
tissue cultureware. As such, HSC expansion or long-term maintenance in culture 
has been notoriously difficult to harness, and approaches such as delivery of small 
molecules - e.g. StemReginin1 (SR1) (Boitano et al., 2010) - that target just one 
parameter of HSC regulation are proving insufficient and completely lack the 
ability to study HSC niche-like behaviour and interactions.  
With this regard, microarray platforms have been developed as multifactorial 
approaches toward deconstructing, and thus elucidating, key stem cell niche 
properties. By modulating and combining biochemical and biophysical niche 
properties to allow screening of key microenvironmental perturbations, 
microarray platforms offer the ability to study single cells in high throughput. 
Using robotic spotting technologies mixtures of protein cues, such as ECM 
components, niche interaction ligands and other signalling proteins can be 
presented and analysed at the single-cell level (Flaim et al., 2005; Gobaa et al., 
2011). 
Recently, one such platform was engineered to systematically analyse early HSC 
fate choices during in vitro culture. First, gene expression signatures and cell-
cycle hallmarks of single HSCs and MPPs were defined. Then, two niche interaction 
ligands were identified that were specifically expressed on the most naïve HSCs, 
and these corresponded to expression of cell-cell adhesion ligands detected in 
populations of stromal niche support cells (such as LepR+ MSPCs). Then, using 
chemically modified hydrogel microwells, these putative ligands were 
incorporated into artificial niches to mimic cell-cell interactions with HSCs. 
Remarkably, single HSCs presented with these ligands demonstrated long term 
maintenance in vitro and the ability to reconstitute the blood system in vivo (Roch 
et al., 2017).  
The above approach is reductionist in nature, however in the endeavour towards 
BM niche recapitulation ex vivo, multiple biomaterial strategies have become a 
central focus in recent years. Many approaches to deconstruct/reconstruct niche 
parameters incorporate one or several niche factors; such as specific cell types, 
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matrix stiffness, fluid flow, or ECM components, and several of these are discussed 
in detail in Table 1-5.  
It should be noted that despite the relative success of some of these systems, the 
complexity of the BM niche must not be underestimated. The BM 
microenvironment itself is multifactorial, with many processes known to regulate 
HSCs directly or indirectly (Pinho and Frenette, 2019). In addition, hormonal and 
neural inputs likely play a fundamental role. The studies that investigate 
combinations of niche factors will ultimately prove significant in elucidating the 
physical and functional properties important in regulating HSC behaviour ex vivo 
and providing insight into fundamental niche behaviours in vivo.  
 
 Table 1-5 Current material strategies to engineer the bone marrow niche 
System  Materials Cell types Remarks Reference 
Co-culture of 
non-adherent 
cells with a 
feeder layer 
None PDGFRa+ CD51+ 
nestin+ MSCs, 
HSCs 
• Identify PDGFRa+ CD51+ MSCs as nestin expressing. 
• Capable of forming HSC supportive mesenspheres in 
vitro and in vivo.  
(Pinho et 
al., 2013) 
Pericytes, HSCs • Pericytes support HSCs ex vivo through cell-cell 
contact and activation of Notch signalling.  
(Corselli et 
al., 2013) 
BM MSCs, HSCs • Enhanced HSC proliferation, especially primitive CD34+ 
CD38- fraction and maintained for several population 
doublings.  
• Knock-down of NCAM and VCAM-1 increased the 
number of slow dividing HSCs.  
• Knock-down of integrin B1 and CD44 impaired 
differentiation.  
(Diehlmann 
et al., 2010) 
Co-culture in 
collagen 
hydrogel 
3D collagen I/III 
gel 
BM-MSCs, UCB-
MSCs, CD34+ 
HSCs 
• UCB-MSCs are unsuitable for HSC maintenance long 
term. 
• Collagen promotes HSC migration and MSCs promote 
CD34+CD38- phenotype.  
• MSC-derived FN may contribute to increased HSC 
migration compared to cell free collagen.  
(Leisten et 
al., 2012) 
3D microcavity 
array 
GAG-PEG hybrid 
hydrogel, 
functionalised 
with RGD, Flt3, 
TPO and SCF. 
 
HSPCs • Defined cavity sizes for single (15 µm) or multiple cells 
(40 µm). Allowing modulation over cell-cell and cell-
matrix interactions. 
• Large cavities (cell-cell contact) led to increased 
expansion rates of HSPCs, single cells more quiescent. 
(Müller et 
al., 2017) 
Perfusion co-
culture 
3D PEG hydrogel 
functionalized 
with RGD and flow  
HSCs, MSCs • Perfusion was as effective as static culture at 
maintaining CD34+ cells.  
• Perfusion increased the number of progenitors and 
enhanced erythroid differentiation.  
(Rödling et 
al., 2017) 
 
Decellularized 
marrow 
Decellularized 
bovine bone 
marrow (DeBM) 
HSCs, BM 
stromal cell line 
• Stromal cells secreted CXCL12 and SCF on DeBM.  
• Supported CD34+ expansion 
(Bianco et 
al., 2019) 
3D scaffold with 
perfusion 
Porous HA scaffold MSCs, HSCs • MSCs deposit matrix, display osteogenic 
differentiation, some maintenance of niche markers 
e.g. nestin 
• HSPC expansion compared to control plain scaffold. 
• Progenitor expansion compared to control plain 
scaffold. 
• HSPCs localise and adhere to MSCs on scaffolds, 
committed cells found in the supernatant. 
(Bourgine et 
al., 2018) 
Endosteal and 
vascular 
spheroid co-
culture  
Collagen I 
hydrogel, 
magnetic 
nanoparticles 
MSC, HSC, 
osteoblasts, 
fibroblasts, 
HUVECs 
• MSCs maintain niche/MSC phenotypic markers, such as 
stro-1 and nestin. 
• Endosteal model supported HSC quiescence. 
• Increased HSC activity in vascular model. 
• HSC differentiation and migration were supported by 
both models.  
(Lewis et 
al., 2016, 
2017; 
Lewis, 
2018) 
3D hydrogel Puramatrix gel MSCs, HSCs • Retained HSCs in the hydrogel. 
• Maintained primitive HSCs and increased number of 
progenitors.  
• LT-HSCs had enhanced engraftment potential that 2D 
cultured controls.  
(Sharma et 
al., 2012) 
Bone marrow-
on-a-chip 
PDMS device, 
central cavity 
containing 
collagen I, 
demineralized 
bone powder, 
BMP-2 and -4 
Populated with 
host cells 
following 
implantation, 
then extracted 
bone with 
central marrow 
compartment  
• Reconstitute complex in vivo niche architecture and 
physiology. 
• HSC culture with perfusion maintained LT-HSCs more 
efficiently than static stromal feeder layers. 
(Torisawa 
et al., 2014) 
Chapter 1 Introduction  51 
1.6 Conclusion  
Stem cell niches are complex and dynamic systems that are fundamental during 
homeostasis, aging and tissue repair. Understanding the stem cell niche is 
evidently important and will help us generate strategies to better harness the full 
clinical potential of stem cells. The BM niche is of significant interest as it harbours 
two sources of clinically relevant stem cells, yet how this microenvironment 
regulates these cells remains to be fully understood. Biomaterial and engineering 
strategies have great potential to recapitulate some of the varied facets described 
in this chapter; such as the supportive cells, 3D architecture, oxygen tension, ECM 
proteins and secreted factors which all contribute to BM niche functionality. 
Development of in vitro platforms such as these will allow better understanding 
of both MSPC and HSC biology within the niche, which ultimately will lead to 
development of better drug screening methods and therapeutic application of 
these cells.  
1.7 Aims and Objectives 
The aim of this thesis is to engineer a biomimetic BM niche model. The model will 
incorporate and compare several important niche factors, including variations in 
ECM proteins and mechanics, GF presentation and local oxygen tensions. First, by 
investigating the response of these factors on a population of MSPCs, pericytes, to 
enable investigation of fundamental mechanisms important in response to niche 
properties. Then investigation into the functional output by co-culturing HSCs 
within the model.  
The model is based on the PEA FN BMP-2 system developed by our group (Cheng 
et al., 2018; Llopis-hernández et al., 2016). Where the addition of FN onto PEA 
causes spontaneous unfolding, allowing the tethering of ultralow GF 
concentrations. Then the addition of a low-stiffness matrix is incorporated using 
a collagen type I hydrogel, and the effects of hypoxia are investigated. The 
collagen type I hydrogel is based on a model previously developed in our group 
(Sweeten, 2019), where a gel of ~1 cm thickness was added on top of cells seeded 
onto PEA substrates, creating a biphasic cell-material interface. This low-stiffness 
component was shown to support a niche-like phenotype of MSCs. Figure 1-19 
represents a schematic of the three niche models used.  
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Figure 1-19 Schematic of in vitro niche models. To investigate the contribution of niche 
components to niche-phenotypes in a population of stromal stem cells (pericytes), a collagen 
type I gel was used to add a low stiffness matrix, and low oxygen tension to investigate 
hypoxic mechanisms.  
With this regard, the aims of this thesis are as follows:  
• Characterisation of the material components of the model. This will include 
verification of FN network formation on PEA, subsequent GF adsorption and 
assessment of elastic properties of the collagen type I gel.  
• Assessment of pericyte phenotype when cultured in the model. This 
includes investigation into the effects of different niche properties in 
supporting a niche-like population of MSPCs, evaluated by expression of 
niche-related markers. 
• Investigation into the effects of hypoxia and matrix mechanics on cellular 
metabolism. A metabolomics approach is used to assess the influence of 
low-stiffness matrices on metabolic mechanisms that may be important in 
niche regulation. 
• Assessment of HSC support in the model. Introduction of HSCs to the model 
and analysis of HSC phenotype after co-culture is evaluated to determine 
if the model can support long-term HSCs in culture.  
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Fibronectin
BMP-2
Pericyte
Hypoxia+Gel-Gel
Collagen 
type I gel
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Chapter 2 General Materials and Methods  
This chapter describes the general materials and methods that were used to carry 
out the experiments in this work. Specific methods, or methods that were 
developed will be detailed in the relevant chapter.  
2.1 Materials and Reagents 
2.1.1 Cell culture reagents 
Reagent Supplier 
10X Modified Eagle’s Medium Sigma-Aldrich, UK 
4- (2-hydroxyethyl)-1-piperazine-ethanesulphonic 
acid (HEPES) 
Thermo Fischer 
Scientific, UK 
Accutaseä Thermo Fischer 
Scientific, UK 
Alpha Minimum Essential Medium Eagle (a-MEM) Sigma-Aldrich, UK 
Bone Morphogenic Protein-2 (BMP-2) Sigma-Aldrich, UK 
Bovine Insulin Transferrin (BIT) Stem Cell Technologies, 
UK 
Bovine Serum Albumin (BSA) Sigma-Aldrich, UK 
Brefeldin A Thermo Fischer 
Scientific, UK 
Collagenase D Sigma-Aldrich, UK 
Dulbecco’s Modified Eagle’s Medium (DMEM) Sigma-Aldrich, UK 
Endothelial Cell Growth Medium 2 (EGM) Lonza, UK 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich, UK 
Fibronectin  Sigma-Aldrich, UK 
Flt3 Ligand Peprotech, UK 
Foetal Bovine Serum (FBS) Sigma-Aldrich, UK 
FungizoneÒ Amphotericin B (250 µg/mL) Gibco by Life 
Technologies, UK 
Gelatin solution, type B Sigma-Aldrich, UK 
Hank’s balanced salt solution (HBSS) Stem Cell Technologies, 
UK 
Human AB Serum (HS) Sigma-Aldrich, UK 
Hydrocortisone Stem Cell Technologies, 
UK 
Iscove’s Modified Dulbecco’s Medium (IMDM) Thermo Fischer 
Scientific, UK 
L-Glutamine (200 nM) Invitrogen, UK 
Methocultä Stem Cell Technologies, 
UK 
Minimum Essential Medium Non-Essential Amino 
Acids (MEM-NEAA) 
Sigma-Aldrich, UK 
MyeloCultä Stem Cell Technologies, 
UK 
Penicillin-Streptomycin (10 mg/mL stock) Sigma-Aldrich, UK 
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Phosphate-Buffered Saline (PBS) Sigma-Aldrich, UK 
Rat tail collagen type I, > 2 mg/mL First Link Ltd., UK 
Sodium hydroxide (0.1 M) Sigma-Aldrich, UK 
Sodium Pyruvate (100 mM) Sigma-Aldrich, UK 
Stem Cell Factor (SCF) Peprotech, UK 
Thrombopoietin (THPO) Peprotech, UK 
TrypLE Thermo Fischer 
Scientific, UK 
Trypsin (10X solution) Sigma-Aldrich, UK 
Type II-S collagenase 1 Sigma-Aldrich, UK 
 
2.1.2 Immunostaining Reagents 
Reagent Supplier 
Biotinylated anti-mouse IgG produced in horse Vector Laboratories, UK 
Biotinylated anti-rabbit IgG produced in horse Vector Laboratories, UK 
Fluorescein Streptavidin Vector Laboratories, UK 
Formaldehyde Thermo Fischer 
Scientific, UK 
Magnesium Chloride Hexahydrate (MgCl2.6H2O) Sigma-Aldrich, UK 
Rhodamine Phalloidin Molecular Probes, Life 
Technologies 
Sodium Chloride  VWR Chemicals 
Sucrose  Thermo Fischer 
Scientific, UK 
Triton X-100 Thermo Fischer 
Scientific, UK 
Tween 20  Sigma-Aldrich, UK 
Vectashield mounting medium with DAPI Vector Laboratories, UK 
 
2.2 Preparation of Cell Culture Solutions 
Reagent Component Amount 
Trypsin/Versene solution NaCl 150 nM 
KCl 5 mM 
glucose 5 mM 
HEPES 10 mM 
Phenol red solution 0.5 % (v/v) 
Trypsin 5 % (v/v) 
HEPES saline solution NaCl 150 nM 
KCl 5 mM 
glucose 5 mM 
HEPES 10 mM 
Phenol red solution 0.5 % (v/v) 
20 % DMEM DMEM 500 mL 
FBS 100 mL 
Penicillin-streptomycin 10 mL 
MEM-NEAA 5 mL 
Sodium pyruvate 5 mL 
2 % DMEM DMEM 500 mL 
Chapter 2 General Materials and Methods 55 
HS 10 mL 
Penicillin-streptomycin 10 mL 
MEM-NEAA 5 mL 
Sodium pyruvate 5 mL 
Fixative solution PBS 90 mL 
Formaldehyde 10 mL 
Sucrose 2 g 
Permeabilisation buffer Sucrose 0.1 % (w/v) 
NaCl 50 mM 
MgCl2.6H2O 3 mM 
HEPES 20 mM 
Triton X-100 0.5 % (v/v) 
Blocking buffer PBS 100 mL 
BSA 1% (w/v) 
ICW blocking buffer PBS 100 mL 
Milk powder 1% (w/v) 
FACS buffer PBS 100 mL 
BSA 0.5 % (w/v) 
EDTA 2 mM 
Human long-term 
culture medium (HLTM) 
MyeloCultä 100 mL 
Hydrocortisone in aMEM 1 x 10-4 M 
 
2.3 General Methods 
2.3.1 Substrate preparation 
2.3.1.1 Spin coating 
Sheets of polymer were obtained by radical polymerization of a solution of either 
MA (methyl acrylate) or EA (ethyl acrylate) (Sigma-Aldrich, UK), using 1 and 0.35 
weight percent benzoin (98% pure; Scharlau) as the photoinitiator. Polymerization 
carried out up to limiting conversion. After polymerization, low molecular mass 
substances extracted by drying under vacuum to constant weight. PMA and PEA 
were dissolved in toluene at a concentration of 6% or 9% and 2.5% or 12% 
dependent on batch. Thin films were then created on glass coverslips using a spin 
coater (Brewer science, USA), 100 µL of polymer was pipetted onto glass coverslips 
that were spun at 2000 rpm for 30 s. Samples dried under vacuum at 60°C for 2 h, 
and sterilised under UV light for 30 min before use.  
2.3.1.2 Fibronectin and growth factor adsorption 
Polymer coated coverslips were placed on parafilm and FN from human plasma 
was adsorbed in solution (20 µg/mL) and incubated at room temperature (RT) for 
1 h. For GF adsorption, substrates were washed twice with PBS, then BMP-2 in PBS 
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(50 ng/mL) was added and incubated at RT for 2 h. After two washes with PBS 
substrates were transferred into 24-well plates in PBS until ready for use. 
2.3.1.3 Collagen gel 
For the relevant conditions (+gel) 1 mL of collagen type-I gel solution was added 
to culture after either 24h (for short term culture) or 72h (for long term culture), 
in 24-well plates. On ice, approximately 6 mL of collagen gel solution was 
generated by addition of 2.5 mL type-I 2.05 mg/mL rat tail collagen in 0.6% acetic 
acid to 0.5 mL human serum (HS), 0.5 mL 10x DMEM, 0.5 mL 2% DMEM, adjusted 
to pH 8.2 using 0.1 M NaOH. Plates were then placed into the incubator for 
gelation to occur for 12-24h, then topped up with 1 mL 2% DMEM. The resulting 
collagen gel is ~1 cm in thickness.  
2.3.2 Pericyte isolation and culture 
2.3.2.1 Pericyte isolation from adipose tissue 
Pericytes were isolated from the adipose tissue of healthy adult donors undergoing 
cosmetic lipectomy procedures with prior written consent, or from patients 
undergoing breast reconstruction procedure, using deep inferior epigastric 
perforators (DIEP), from adult donors. Ethical approval for the collection of tissue 
and subsequent research was granted by the South-East Scotland Research Ethics 
Committee 3 (SESREC03, reference no. 10/S1103/ 45). Incisions were made in the 
adipose tissue using a scalpel to divide the Scarpa’s fascial layer, then tissue was 
mechanically minced using a cheese grater and 150 mL of the resulting tissue 
combined with 100 mL PBS. After 30 s of manual shaking, tissue was centrifuged 
at 445 g for 10 mins at RT, causing phase separation. The 3 phases include the top 
phase (liquid fat/oil), central phase containing the tissue of interest (adipose 
tissue), and the bottom phase (blood/fluid). 25 mL of the middle layer was 
removed and mixed with 25 mL PBS/2% (v/v) FBS and centrifuged at 445 g for 10 
mins. Supernatant was removed leaving the Stromal Vascular Fraction (SVF) 
pellet, which was then enzymatically digested with 25 mL digestion solution (type 
II-S collagenase 1 mg/mL in DMEM/0.5% (v/v) BSA) for 45 mins in a water bath at 
37oC with shaking. After incubation, samples were centrifuged at 445 g for 10 mins 
to obtain the digested SVF. Supernatant was aspirated (containing oil and 
adipocytes) and pellets resuspended in 25 mL PBS/2% (v/v) FBS, manually 
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disrupting or removing large clumps. The tissue solution was then sequentially 
strained through 400 µm, 100 µm and 70 µm cell pluristrainers to remove 
undigested material. Filtered solution centrifuged at 445 g for 10 mins, 
supernatant discarded, and pellets resuspended in 10 mL red blood cell lysis buffer 
and incubated RT for 10 mins. 20 mL PBS/2% (v/v) FBS added and samples 
centrifuged at 400 g for 10 mins. Supernatant aspirated and SVF pellet 
resuspended in Fluorescent Activated Cell Sorting (FACS) buffer and cells counted 
ready for FACS staining. 
2.3.2.2 Fluorescent activated cell sorting of pericytes 
The SVF isolated from adipose tissue was stained with the antibodies in Table 2-1. 
Pericytes were sorted to homogeneity using FACS cell sorter (BD Bioscience) based 
on the following phenotype: CD146+ CD45- CD34- CD31-.  
Table 2-1 Antibodies for fluorescent activated cell-sorting of pericytes from adipose tissue. 
Target Fluorochrome Dilution Manufacturer 
CD146-Alexa647 Ch5 1:100 BC Biosciences 
CD45 APC-cy7 1:200 BD Biosciences 
CD34 FITC 1:100 BD Biosciences 
CD31 PE 1:100 BD Biosciences 
 
2.3.2.3 Primary cell culture 
Immediately after FACS, pericytes were seeded onto 0.1% gelatin-coated wells at 
a density of 2 x 104 cells/cm2 in EGM-2 endothelial growth medium (Lonza) in a 
humidified incubator with 5% CO2 at 37oC. When confluent, cells were detached 
using trypsin/v and split into uncoated wells and cultured in 20% DMEM for all 
subsequent passages. Media changed twice per week and cultured until ready for 
use or until passage 10.  
2.3.2.4 Primary cell culture on polymer substrates 
For cell culture on materials, non-coated glass and polymer coated coverslips were 
transferred to 24 well plates, and cells seeded at 1.5 x103 cells/cm2 in 500 µL 2% 
DMEM. Culture plates were incubated under a humidified atmosphere of 5% CO2 at 
37oC, and 500 µL 2% DMEM added after 24 h. After 3 days for long term 
experiments, or 24h for short term, all culture media was removed and replaced, 
or for the +gel conditions 1 mL collagen gel was added. Hypoxia conditions were 
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moved to hypoxic workstation (Ruskinn) at an oxygen tension of 1%, CO2 5% and 
37oC. Cultures were thereafter fed every 3 days for the remainder of experiment 
time period. Cells were cultured for times indicated in each experiment.  
2.3.3 Flow cytometry  
BD FACS Canto II analyser was used for flow cytometry analysis. Cells were 
prepared from culture models as indicated in Section 2.3.3.1. Unstained control 
cells were used to set the voltage for each of the 6 channels used, and unstained 
cells or isotype controls for each channel were also included with cells as negative 
controls. Allowing for the non-specific background signal to be differentiated from 
the antibody signal.  
2.3.3.1 Preparation of cells from culture models 
For the culture models, the collagen gel was first digested by adding equal volume 
of collagenase D solution (2.5 mg/mL in PBS) into the media and/or gel in each 
well, and incubated at 37oC for 90 min. The solution in each well, containing 
digested collagen gel and media, was then passed through a 70 µm filter. The 
polymer or glass substrates were then washed once with hepes saline and 
incubated with TrpLE for 5-10 min at 37oC. If required, multiple wells for each 
condition were pooled, then centrifuged at 400 g for 4 mins.  
2.3.3.2 Flow cytometer and compensation  
To correct spectral overlap UltraComp eBeadsÔ were used to perform 
fluorescence compensation. 1 drop of beads were added to 8 FACS tubes and 2 µL 
of an antibody corresponding to each of the 8 channels was added. The tubes were 
then stored in the dark at 4oC for 30 mins. 2 mL of flow buffer was then added 
and tubes centrifuged for 4 mins at 600 g. Supernatant was removed and pellets 
resuspended in 200 µL of FACS buffer. Each sample was then run as instructed by 
machine software, and compensation automatically calculated.  
2.3.4 Immunocytochemistry 
After removal of media, samples were washed once with PBS and 10% 
formaldehyde fixation solution (Chapter 2.2) added at 37oC for 15 mins. Fixation 
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solution was then removed, and collagen gels discarded. Cell membranes were 
then permeabilised with 0.5% Triton-X permeabilisation buffer (Chapter 2.2) for 5 
mins at 4oC, and subsequently blocked in 1% BSA blocking buffer (Chapter 2.2) for 
15 min at 37oC. Cells were then incubated overnight at 4oC with the required 
primary antibody diluted in PBS/1% BSA (Table 2-2).Then cells were washed three 
times for 5 min with 0.5% Tween20 in PBS and incubated for one hour at 37oC with 
the corresponding secondary antibody (1:50 in PBS/1% BSA). Cells were then 
washed as before and, if required, incubated 4oC for 30 min with streptavidin 
conjugated FITC, and washed 3 times in PBS/0.5% Tween20 after this incubation. 
Samples were mounted onto glass microscope slides with a drop of vectasheild-
DAPI (a glycerol based mounting medium containing nucleic acid staining). All 
samples were then stored at 4oC in the dark to preserve from photobleaching, 
until ready for microscopic analysis. Secondary antibodies used throughout this 
thesis are well validated in our group and have been demonstrated for specificity 
in many publications (Alakpa et al., 2017b, 2017a; Roberts et al., 2016; Tsimbouri 
et al., 2017, 2012; J. Yang et al., 2014).  
Table 2-2 Primary antibodies used for immunocytochemistry. 
Primary antibody Supplier Dilution  Source 
CXCL12 Abcam, UK 1:200 monoclonal mouse 
HIF1a Abcam, UK 1:300 monoclonal rabbit 
HypoxyprobeÔ HypoxyprobeÔ 1:200 monoclonal mouse 
Nestin Abcam, UK 1:200 monoclonal mouse 
SCF Abcam, UK 1:200 polyclonal rabbit 
Vimentin Sigma-Aldrich, UK 1:300 monoclonal mouse 
  
2.3.5 Microscopy 
Immunostained samples were viewed in 3 channels using an Axiophot microscope 
(FITC, TRITC and DAPI), linked to a camera. Images were obtained using ImagePro 
software and were converted to red green blue (RGB) format using ImageJ 
software (National Institute of Health, USA), subsequent quantification using 
either ImageJ or CellProfiler software will be detailed in later chapters. To 
indicate scale, an image of a 1 mm graticule was taken under the associated 
magnification lens and converted to pixels using ImageJ.  
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2.3.6 In cell western (ICW) 
Following cell culture, cells were fixed and permeabilised as outlined in Chapter 
2.3.4. Samples were then blocked in 1% milk ICW blocking buffer (Chapter 2.2) 
for 1.5 hours. Cells were then incubated overnight at 4oC with the required 
primary antibody (Table 2-3) diluted in ICW blocking buffer (1:100). Then cells 
were washed five times for 5 min with 0.5% Tween20 in PBS and incubated for 
one hour at 37oC with the corresponding IRDye 800CW/700CW secondary anti-
rabbit/mouse antibody (1:800), CellTag 700 stain (1:500) and 0.2% Tween20. 
Secondary antibodies and CellTag 700 stain acquired from Li-Cor. CellTag700 is a 
non-specific cell stain used for normalisation to cell number. After 1h, cells 
were washed five x 5 min with 0.5% Tween20 in PBS. Following the final wash, 
coverslips were transferred to a new 24-well plate and left to air dry before 
imaging.  
Table 2-3 Primary antibodies used for in cell western. 
Primary antibody Supplier Dilution  Source 
Lactate 
dehydrogenase 
Abcam, UK 1:100 Monoclonal 
rabbit 
P5F3 Sant Cruz Biotechnology, UK 1:100 Monoclonal 
mouse 
HFN7.1 Developmental Studies 
Hybridoma Bank, USA 
1:100 Monoclonal 
mouse 
Fibronectin  Sigma Aldrich, UK  1:100 Polyclonal 
rabbit 
 
Samples were then scanned using the Li-Cor Odyssey Sa scanner in the 800 nm 
and 700 nm channels. A grid was then drawn, and measurements of fluorescent 
units taken. Where appropriate the signal of the protein of interest was divided 
by the control (CellTag700) 
2.3.7 RNAseq 
Cells were cultured on substrates as described in 2.3.2.4 for 7 days. They were 
then trypsinised, centrifuged to pellet and lysed using Qiagen RLT lysis buffer.  
Sequencing libraries were then prepared from total RNA using the Illumina TruSeq 
Stranded mRNA Sample Preparation Kit. Libraries were sequenced in 75 base, 
paired end mode on the Illumina NextSeq 500 platform. Raw sequence reads were 
trimmed for contaminating sequence adapters and poor quality bases using the 
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program Cutadapt (Martin, 2011). Bases with an average Phred score lower than 
15 were trimmed. Reads that were trimmed to less than 54 bases were discarded. 
The quality of the reads were checked using the Fastqc program 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) before and after 
trimming. The reads were “pseudo aligned” to the transcriptome using the 
program Kallisto (Bray et al., 2016). The differential expression for the analysis 
groups were assessed using the Bioconductor package DESeq2 (Love et al., 2014). 
This was provided as a service by Glasgow Polyomics Facility. Heatmaps were 
subsequently generated using Cluster 3.0 and Java Treeview 3.0 software, with 
average linkage clustering method.  
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Chapter 3 Characterisation of Materials 
3.1 Introduction 
To engineer increasingly biomimetic materials, current strategies focus on control 
of integrin adhesion receptor-related signalling to direct stem cell behaviour 
(Dalby et al., 2018). These approaches aim recapitulate structures 
topographically, mechanically or chemically similar to native ECM, as discussed in 
Chapter 1. Techniques that present cell adhesive motifs or protease degradable 
cross-links however often fail to reconstitute the network structure and bioactivity 
of native ECM molecules such as FN, this is due to the absence of domains that 
contain complementary or modulatory sequences involved in cellular processes 
(Petrie et al., 2006).  
3.1.1 Fibronectin  
Fibronectin is a ubiquitous ECM glycoprotein that is assembled into fibrillar 
matrices in all tissues. FN forms dimers consisting of two subunits (~220 kDa) 
linked by a disulphide bond near the carboxyl termini (Figure 3-1). Each subunit 
contains domains for mediating interactions with other FN molecules, ECM 
components, and cell surface receptors, contained in three types of repeating 
modules (types I, II and III). FN dimers then multimerise to form fibrillar networks, 
in a process that is normally cell-mediated via an integrin-dependent contractile 
process (Singh et al., 2010).  
 
Figure 3-1 Fibronectin (FN) subunit. FN has three types of repeat, types I (blue), II (yellow) and 
III (red). Domains required to initiate assembly include the cell binding site (RGD in III10 and 
synergy in III9), the N-terminal assembly domain (I1-5), and the intramolecular cysteine dimers 
at the C-terminal. The III1-2 domain contains two FN-binding sites involved in conformational 
changes that promote assembly. The III12-14 domain contains the GF binding site (Singh et al., 
2010). Image adapted from (Donnelly et al., 2018).   
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Cells primarily interact with FN through integrins, and most cells will assemble 
FN-dense matrices, incorporating FN either synthesised by cells or reorganised 
from their surroundings (Singh et al., 2010). Cells mediate FN matrix assembly 
through integrin binding to the RGD cell-binding domain in the type III10 domain, 
the primary receptor for which is integrin α5β1 (Obara et al., 1988). However, a 
synergy sequence is also required to initiate fibril formation, the PSHRN site in 
the type III9 domain enhances the affinity of integrin binding over forty-fold (Aota 
et al., 1994) (Figure 3-1). Further to these cell adhesion sites, FN contains the GF 
binding site in III12-14 previously discussed in Chapter 1.5.4, which has been shown 
to be highly promiscuous in its GF binding. This site, also known as the heparin-
binding domain, binds GFs in several families, including PDGF/VEGF, FGF 
(fibroblast growth factor) and TGFβ (Martino and Hubbell, 2010), through their 
affinity to heparin and heparin sulfate (Kirkpatrick and Selleck, 2007; Pankov and 
Yamada, 2002).  
FN presents a strategy to increase adhesive properties and GF delivery of 
engineered materials. However, upon adsorption to biomaterials FN typically 
adopts a globular conformation, concealing these binding domains and physically 
disrupting the affinity of GF binding to the heparin-binding domain. Only when 
cells adhere are they able to reorganise the FN molecules and mediate 
fibrillogenesis (Singh et al., 2010).  
3.1.1.1 Engineered fibronectin fragments for cell adhesion and growth factor 
delivery 
In approaches to exploit the cell adhesive properties of FN, recombinant 
fragments have been engineered to contain both the RGD and PHSRN synergy site. 
A fragment containing FNIII7-10 was produced that retains the native spacing 
between the adhesive domains, presenting the binding sites in correct structural 
context (Cutler and Garcia, 2003). Surfaces presenting RGD-only, or an 
oligopeptide that failed to control site distances, showed a decrease in cell 
adhesion primarily through integrin α5β1 binding, and reduced FAK activation 
(Petrie et al., 2006). This control over integrin binding using FN fragments was 
found to promote osteoblast differentiation in vitro, and improve osteointegration 
of titanium implants in vivo (Agarwal et al., 2015; Cutler and Garcia, 2003; Petrie 
et al., 2006).  
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The work by Martino et al, discussed in Chapter 1 built on this to further exploit 
FNs integrin- and GF-binding abilities. A recombinant fragment was engineered to 
contain the major cell binding domain (FN III9-10) and the GF binding domain (FN 
III12-14) (Martino et al., 2011). By incorporating PDGF and 2 BMP-2, they found the 
system could promote both wound repair and bone growth (Martino et al., 2011). 
Presentation of the FN III9-10 and FN III12-14 repeats proximally in the same 
polypeptide chain led to potent synergistic signalling through recruitment of 
integrins and GF receptors to adhesion domains.  
These strategies, however, rely on complex recombinant protein technology - the 
FN fragment engineered by Martino et al, relies on addition of extra sequence to 
bind to a fibrin matrix – and intricate engineering that increase cost and 
complexity. Other strategies to deliver GFs, as discussed in detail in Chapter 1, 
typically involve high doses, low efficiency, and lack potential for GFR-integrin 
cross talk. 
3.1.1.2 Material-driven fibronectin assembly 
In efforts to exploit FN molecules for GF delivery without the use of complex 
recombinant technologies, other approaches focus on methods to drive self-
organisation of FN fibrils at the material interface. Material properties are known 
to alter protein adsorption, and seminal work has demonstrated that by carefully 
tuning interface chemistry, FN conformation and subsequent cell adhesion can be 
altered. In these studies, self-assembled monolayers (SAMs) were used to present 
terminal functionalities of differing chemistries (CH3, OH, COOH, NH2), without 
altering other surfaces properties, such as roughness. The effects on adsorbed FN 
conformation were observed through changes in affinity of integrin binding 
(Keselowsky et al., 2002), focal adhesion composition (Keselowsky et al., 2004) 
and cell differentiation (Keselowsky et al., 2005). 
Screening of polymers of different chemistries, with the hypothesis that particular 
surface chemistries would induce exposure of self-assembly domains of FN, 
identified PEA as a potential chemistry to generate FN fibrils (Rico et al., 2009; 
Salmerón-Sánchez et al., 2011). Work by our group has demonstrated the ability 
of PEA, in the absence of cells, to induce the formation of FN networks driven by 
the material interface (Cheng et al., 2018; Llopis-hernández et al., 2016). The 
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formation of these physiological-like networks of FN exposes the cell binding and 
GF binding domains of the molecule. Sequestered GFs can then be presented in 
native synergy with the cell binding domains of FN. Using the GF BMP-2, this simple 
polymer based system that supports spontaneous FN unfolding has been found to 
induce osteogenesis of MSCs in vitro, and implantation of coated constructs lead 
to full union of critical size defects in a mouse model and a non-healing fracture 
in a dog (Cheng et al., 2018; Llopis-hernández et al., 2016).  
3.1.2 BMP-2 
BMPs are potent growth factors, constituting the largest subfamily of the TGFβ 
superfamily (Chen et al., 2004). Originally identified and related to bone 
formation, BMPs have now been shown to be ubiquitously expressed and to play 
essential roles in a wide variety of developmental and cellular processes 
(Obradovic Wagner et al., 2010). Extensive studies in cultured cells, knockout 
mice and humans with naturally occurring mutations in BMP-related genes have 
demonstrated that BMP signalling pathways are indispensable for embryogenesis, 
skeletal formation, neurogenesis and haematopoiesis (Chen et al., 2004).  
BMPs signal through two different types of serine/threonine kinase receptors; 
three type I receptors (BMPR1A, BMPR1B and activin receptor-like kinase 2 
(ALK2)), and three type II receptors (BMPR1, activin receptor 2 (ARTR2) and 
ACTR2B) (Wang et al., 2014). Both receptor types have a short extracellular 
domain, a single transmembrane domain and an intracellular domain with 
serine/threonine kinase activity (Wang et al., 2014). BMPs signal through 
canonical and non-canonical pathways. Canonical pathways are activated by BMP 
binding to a heterotetrameric receptor complex, comprised of two type I and type 
II receptors (Figure 3-2) (Heldin et al., 1997). The mechanism of formation of the 
signalling complex can vary – for example, BMP-2 and BMP-4 preferentially bind 
type I receptors and recruit type II, whereas BMP-6 and BMP-7 interact with type 
II and recruit type I (De Caestecker, 2004). Upon complex formation the type I 
receptor acts as a substrate for the constitutively active type II receptor (De 
Caestecker, 2004; Wang et al., 2014).  
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Figure 3-2 BMP-2 signalling. BMPs, such as BMP-2, signal via the Smad-dependent pathway 
or various non-canonical pathways. In the canonical pathway, BMP-2 initiates the signal 
transduction cascade by binding type I or II serine/threonine kinase receptors to form a 
heterotetrameric complex. Type II receptors are constitutively active, binding 
transphosphorylates the type I receptor. The type I receptor then phosphorylates the R-
Smads (Smad1/5/8). Phosphorylated Smad1/5/8 associates with the co-Smad (Smad-4) and 
the complex translocates to the nucleus where it further associates with co-activators or co-
repressors to regulate gene expression (Wang et al., 2014).  
BMP-activated type I receptors relay the signal to the cytoplasm by 
phosphorylating their immediate downstream targets, Smad1, Smad5 and Smad8, 
which interact with Smad4 and translocate to the nucleus where the complex 
functions as a transcription factor with co-activators and co-repressors regulating 
gene expression (Wang et al., 2014). For osteogenesis, BMP-2 driven Smad 
phosphorylation activates RUNX2, the master regulator of the osteogenic response 
(Phimphilai et al., 2006). Although signalling may occur on multiple levels and 
non-canonical, Smad-independent, signalling pathways have been identified to 
include phosphoinositide 3- kinase (PI3K), Akt, protein kinase C (P/kc), Rho-
GTPases, and the MAPKKK family. Crosstalk with other pathways, such as Wnt 
signalling, and involvement of co-receptors, such as endoglin, add a further layer 
of control and complexity (Derynck and Zhang, 2003).  
The osteoinductive potential of BMP-2 has been demonstrated extensively in many 
in vivo and preclinical models of critical sized defects, and currently it is routinely 
used in the clinic for spinal bone fusions (Sayama et al., 2015). Although, recent 
focus on BMPs roles in processes throughout all organ systems have led to the 
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investigation and application of BMPs in non-bone related pathophysiology, from 
cancer to kidney disease (Bach et al., 2018; Tomita et al., 2013). This versatility 
of functions of BMPs has posed the suggestion the acronym be changed from bone 
to body morphogenetic proteins (Obradovic Wagner et al., 2010).  
3.1.3 Collagen  
Collagen, is a major component of the native ECM, as such, it is the most abundant 
protein in mammals, contributing ~25% of the total protein mass (Alberts et al., 
2008). There are at least 19 different types of collagen, and type I collagen is the 
most prevalent in vivo as it is the principle collagen for bone and skin, accounting 
for 90% of all body collagen (Alberts et al., 2008). Due its abundance, adaptability 
and ease to extract, collagen I has proven popular for tissue engineering 
applications (Antoine et al., 2014).  
The basic primary structure of all collagen is composed of three polypeptide 
chains, which wrap around each other into a rope-like helical structure (Alberts 
et al., 2008). Type I collagen triple-helical proteins are formed of 67 nm 
polypeptide chains (Mw ~ 300 kDa). These fibrils self-assemble at neutral pH into 
bundled fibres (~12 – 120 nm diameter), that crosslink to produce a matrix 
structure, that ultimately forms a hydrogel in the presence of a water-based 
solvent (Antoine et al., 2014; Kadler et al., 2007). Thus collagen fibres and 
scaffolds can be created or engineered and their mechanical properties can be 
accurately tuned by, for example, controlling the rate of polymerisation through 
temperature or pH, introducing crosslinkers, or blending with other polymers 
(Antoine et al., 2014; Drury and Mooney, 2003).  
Early studies that aimed to recapitulate the BM microenvironment such as Dexter 
cultures, pointed to an abundance of collagen I synthesis by the adherent stromal 
cell feeder layers that were isolated from BM aspirates (Bentley, 1982; Dexter et 
al., 1977). As such, collagen based cultures and scaffolds have been employed in 
attempts to mimic both the cell-ECM interactions of the niche and the 3D 
architecture (Dhami et al., 2016; Lai et al., 2013) As discussed in Table 1-5, niche 
mimetic collagen scaffolds have taken the form of microspheres (Wang et al., 
1995), hydrogels (Leisten et al., 2012) and decellularized constructs (Lai et al., 
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2013), and have all shown promise in long-term HSC culture. Consequently, we 
chose to incorporate a collagen type I hydrogel into the niche model.  
3.1.4 Objectives/aims 
This chapter aims to characterise the material properties of the culture model. 
First, the FN adsorption onto polymer surfaces was analysed, then this previously 
developed system was extended for use with a collagen type I hydrogel. Finally, 
assessment of seeding of human adipose tissue derived pericytes into the system 
was carried out. This will be achieved by addressing the following objectives: 
• Assessment of FN conformation on PEA and PMA. 
• Assessment of BMP-2 binding to FN. 
• Assessment of cell numbers on polymer substrates.  
• Measurement of collagen hydrogel stiffness. 
3.2 Materials and Methods 
3.2.1 BCA protein assay 
Pierceä BCA Protein Assay Kit (Thermo Fischer, UK) was used to measure the 
amount of FN adsorbed onto polymer substrates, as per manufacturer’s 
instructions. Polymer substrates were incubated for 1 h at RT with FN solution (20 
µg/mL). Solution was aspirated and collected in Protein LoBind Tubes 
(Eppendorf), if required 10x dilutions of aspirated solution was performed. BSA 
standard (2000 µg/mL – 25 µg/mL) and FN standard (100 µg/mL – 0.5 µg/mL) were 
prepared by serial dilution in PBS. Samples were added in triplicate to a 
microplate with working reagent, incubated at 37oC for 30 mins, cooled to RT and 
absorbance measured at 562 nm on plate reader. Blank replicates (PBS + working 
reagent) measurements were subtracted from measurements of standards and 
replicate samples. Standard curves were generated by plotting blank-corrected 
measurements vs concentration. Unknown sample concentrations were then 
interpolated from the standard curve.  
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3.2.2 BMP-2 ELISA 
For quantification of BMP-2 adsorption, (50 ng/ml) BMP-2 solution was added to 
FN coated polymers and after 2 h incubation the BMP-2 solution was aspirated 
from the samples and collected in Protein LoBind Tubes (Eppendorf). Enzyme-
linked immunosorbent assay (ELISA) was then carried out as per manufacturer’s 
instructions (R&D Systems). Briefly, ELISA plates were coated with capture 
antibody overnight, then blocked for 1 h with BSA. Standards, original solution, 
original solution at 20x dilution and sample aspirates were then added to the 
plate, and bound BMP-2 was detected with biotinylated anti-human BMP-2. 
Streptavidin-HRP was added to plates for 20 min in the dark, followed by substrate 
solution (tetramethylbenzidine and peroxide) for 20 min, the reaction was then 
stopped by adding stop solution. Absorbance measured at 450 nm with wavelength 
correction at 570 nm. The standard curve was calculated using a four-parameter 
logistic curve fit. The amount of BMP-2 was calculated from the standard curve 
based on the BMP-2 standards of known concentration.  
3.2.3 Atomic Force Microscopy 
FN conformation images were produced using atomic force microscopy (AFM) 
Polymers were incubated with FN solution (20 µg/mL) for 10 min, washed twice 
in PBS, once with deionised water and then dried under a stream of nitrogen 
before imaging. A JPK Nanowizard 4 (Zeiss Axio Observer A1; Accurion 
Halcyonics_i4 balance table) was used for imaging in tapping mode, using 
antimony-droped Si cantilevers with a nominal resonant frequency of 75 kHz 
(Bruker). The phase signal was set to 0 at a frequency 5-10% lower than the 
resonant frequency. Height and phase images were acquired from each scan JPK 
Data Processing software version 5 was used for image analysis. 
3.2.4 Rheology 
Rheological measurements were carried out using an Anton Paar Physical MCR301 
rheometer. A parallel plate geometry (25 mm diameter, sandblasted) and 1.0 mm 
gap were used to measure time sweeps. For measuring the frequency and strain 
sweeps, 2 mL collagen gels were prepared as described in Chapter 2.3.1.3 in 6-
well plates and placed in 37 ºC incubator for 12 h for gelation to occur. After 
complete gelation, samples were transferred to the rheometer and the rheological 
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measurements were recorded at 25 ºC. To ensure the measurements were made 
in the viscoelastic range, a strain sweep was carried out. The dynamic modulus of 
the hydrogel was measured as a frequency function, frequency sweeps were 
carried out between 0.1 – 15 Hz, to measure the dynamic shear of the modulus as 
a function of strain. Measurements were repeated 3 times on gels from 3 different 
batches. Storage moduli (G’) values were extracted from the accompanying 
Kinexus software. The Young’s modulus was then determined by taking the G’ and 
multiplying by 3, assuming a Poisson’s ratio of 0.5 in accordance with Hooke’s law.  
3.2.5 Coomassie staining 
After 7 days of culture on surfaces, cells were fixed for 15 min at 37oC with fixative 
solution. After two washes with PBS, 1 mL of filtered Coomassie blue solution was 
added to each well for 2 min at RT. After two more washes with PBS images were 
acquired on a light microscope.  
3.3 Results 
3.3.1 Fibronectin conformation and availability of domains 
To confirm that PEA surfaces promoted FN network formation, we compared it to 
the closely related PMA, which differs to PEA by one methyl group (Figure 3-3) but 
behaves similarly in terms of surface wettability and stiffness (Salmerón-Sánchez 
et al., 2011). AFM examination revealed FN formed interconnected fibrillar 
networks on PEA, but remained in a closed, globular conformation on PMA (Figure 
3-3).  
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Figure 3-3 FN forms networks on PEA surfaces. AFM of FN adsorption onto polymer 
substrates. FN nanonetwork spontaneously assembled on the surface of PEA but not on 
closely related PMA. Chemical structures of polymers are represented. Chemical symbols 
reproduced under the terms of the Creative Commons Attribution NonCommercial License 
4.0 (Llopis-hernández et al., 2016).  
Total FN protein adsorption onto the surface was then quantified using a BCA 
assay, this indicated an increased mass of FN adsorbed on PMA (~775 ng/cm2) 
compared to PEA (~520 ng/cm2) (Figure 3-4A). The concentration of FN solution 
used was based on previous work from our group that demonstrated a minimum 
concentration of 10 µg/mL is needed for full interconnection of networks, and this 
has been optimised to a concentration of 20 µg/mL for more effective network 
formation (Cheng et al., 2018; Llopis-hernández et al., 2016).  
2 µm 1 µm
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Figure 3-4 FN adsorption and domain availability on PEA and PMA. A. Surface density of FN 
on PEA and PMA per cm2 coated from 20 µg/mL solution was determined using BCA assay, 
and indicates more FN adsorbs to PMA. B. In-cell western analysis was used to assess total 
FN availability demonstrated no significant differences; FN domains were tested in C. P5F3 
(GF-binding domain) availability and D. HFN7.1 (RGD integrin-binding domain) availability 
were all increased on PEA substrates. Graphs show mean ± SEM, statistical analysis using 
unpaired two-tailed t-test, *= p<0.05, **= p<0.01, ***= p<0.001, n.s. = non-significant. A n=6, B-
D n=3. 
Although a higher density of FN adsorbed onto PMA, the AFM results depict 
network formation on PEA (Figure 3-4A and Figure 3-3). We therefore wanted to 
confirm FN was forming networks on PEA only, using in-cell western (ICW) 
techniques the availability of total FN was first assessed using a polyclonal 
antibody against total FN (Figure 3-4B), this showed no significant differences 
between PEA and PMA. Then antibodies against the GF binding domain (P5F3) 
(Figure 3-4C) and the integrin binding domain (HFN7.1) (Figure 3-4D) were used. 
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P5F3 is directed against the HepII GF binding domain in the type III12-14 region of 
FN, whereas HFN7.1 is directed to the flexible linker between the 9th and 10th type 
III repeats of FN (Vanterpool et al., 2014). Binding of both antibodies was 
increased on PEA compared to PMA, indicating increased exposure of these two 
domains. As both domains are concealed in globular FN molecules this data 
confirms FN network formation on PEA substrates. 
 
Figure 3-5 Surface density of BMP-2 on PEA FN and PMA FN. A 50 ng/mL BMP-2 solution was 
adsorbed onto PEA FN and PMA FN substrates, and BMP-2 surface density was quantified 
using ELISA. After incubation the amount of BMP-2 in the supernatant was determined using 
a standard curve, and the value was deducted from the concentration of the original solution 
to give the total mass adsorbed. Similar mass of BMP-2 was adsorbed onto both substrates. 
Graph shows mean ± SEM, n = 3, n.s. = non-significant using unpaired two-tailed t-test with 
Mann-Whitney test.  
Exposure of the GF binding domain in FN networks has been previously exploited 
by our group to tether GFs, such as BMP-2 (Cheng et al., 2018; Llopis-hernández 
et al., 2016). To quantify BMP-2 adsorption an ELISA was carried out, although this 
revealed no significant differences in BMP-2 density between the two polymers 
(Figure 3-5). We have however previously demonstrated that only on PEA does 
BMP-2 co-localise to FN molecules, on PMA substrates BMP-2 is randomly dispersed 
and elutes from the substrate faster (Cheng et al., 2018; Llopis-hernández et al., 
2016). The concentration of the BMP-2 solution used was 50 ng/mL, and ELISA 
analysis revealed ~8 ng/cm2 to be adsorbed onto PEA and PMA substrates (Figure 
3-5).  
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3.3.2 Cell adherence 
To assess cell adherence to the polymers Coomassie blue staining was carried out 
after 3 days of culture of pericytes on the polymer substrates. The representative 
images in Figure 3-6A highlight lower levels of adherence and decreased cell-
spreading on polymers containing no protein coating. To confirm this, ICW analysis 
of CellTag 700, a non-specific fluorescent protein stain, was used after 7 days of 
pericyte culture. Fluorescent intensity of each replicate was then measured and 
represented in the graphs in Figure 3-6B as fold change to a control glass coverslip. 
This demonstrated a significant decrease in fluorescence on PEA surfaces 
compared to those +FN and +FN BMP-2. A similar trend was observed for PMA, 
although this was not significant. This suggests cells on polymer substrates coated 
with FN and FN +BMP-2 could be greater in number or more spread, whereas on 
uncoated polymers cells may be less likely to adhere or spread.  
 
Figure 3-6 Cell adherence to PEA and PMA substrates. A. Coomassie blue staining of 
pericytes after 3 days culture on different polymer conditions. Scale bar is 100 μm, n = 3. B. 
ICW scan of CellTag 700 stain after 7 day culture, represented as fold change to glass 
control in graphs. Data suggests FN coating increases cell adhesion or spreading. N=8, data 
are shown as mean ± SEM, **= p<0.01, n.s. = non-significant, by one-way ANOVA followed 
by Kruskal-Wallis with multiple comparisons test. 
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3.3.3 Gel stiffness  
We wanted to add a soft-matrix element to the model, therefore low-stiffness 
collagen type I gels were produced. To measure the stiffness of the gel, 
rheological measurements were carried out to determine the storage modulus (G’) 
which could subsequently be converted into Young’s modulus. To determine the 
Young’s modulus (E) frequency sweeps were carried out between 1 and 10 Hz, and 
the storage modulus (G’) converted using Hooke’s law to Young’s modulus (E = 
3G’).  
 
Figure 3-7 The Young’s modulus of collagen type I gels.  Rheological measurements were 
taken of 3 technical repeats of 3 batches of collagen gels (A-C). Storage modulus (G’) were 
then converted to Young’s modulus (E) using Hooke’s law assuming a Poisson’s ratio of 0.5 
(E=3G’). Graph shows mean ± SEM. No statistical significance was observed, using non-
parametric one-way ANOVA followed by Kruskal-Wallace multiple comparison test. Average 
Young’s modulus is 78.8 Pa. 
Three batches of gels (A-C) were produced, and 3 technical repeats taken for each 
batch, shown in Figure 3-7. The data suggests the mean Young’s modulus of the 
gels to be around ~80 Pa. Some variation was observed between batches, although 
this was not significant, but could be due to inaccuracies in detecting the colour 
change upon adding volumes of NaOH to the gel mixture (Chapter 2.3.1.3). These 
measurements were in agreement with previous results from our group (Sweeten, 
2019), and are slightly lower than that observed for measurements of intact bone 
marrow (Jansen et al., 2015).  
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3.4 Discussion 
This chapter describes the characterisation of the different material components 
employed in the BM niche model used in this thesis.  
3.4.1 PEA drives fibronectin fibrillogenesis  
Using AFM imaging and antibody-based techniques we were able to confirm the 
polymer PEA could drive FN network formation (Figure 3-3 and Figure 3-4). This 
material-driven fibrillogenesis results in exposure of key binding sites on the FN 
molecule, such as the GF binding domain, FN III12-14. Although an increased mass 
of FN was found to be adsorbed to PMA than PEA using BCA protein quantification, 
the AFM images and ICW analysis confirm network formation occurs only on PEA. 
We have previously confirmed 20 µg/mL as the optimum concentration for 
network formation on PEA; increasing the concentration of FN beyond this on PMA 
results only in a higher density of globular molecules, and not spontaneous 
unfolding (Cheng et al., 2018; Llopis-hernández et al., 2016).  
To demonstrate material-driven network formation is driven by PEA, previous 
work employed random copolymer combinations of EA and MA. By modulating the 
EA/MA ratio the ability of adsorbed FN to form networks can be controlled, where 
increasing EA content leads to more interconnected FN networks, and a material 
composition that is >50% MA leads to significant decreases in the degree of 
fibrillogenesis (Mnatsakanyan et al., 2015). This cell-free network formation is 
rapid, it has been demonstrated FN organisation occurs within 1 min of adsorption 
(Gugutkov et al., 2010).  
The increased availability of FNIII9-10 domains on PEA was also correlated with 
increased measurements in cellular protein, as measured by Coomassie blue and 
CellTag protein stains, this suggests that FN adsorption influences cellular 
adherence and/or cell spreading on these surfaces. To quantify cell number more 
effectively DAPI counts could be carried out. Figure 3-6 shows when FN is present, 
there is a significant increase in cell number on PEA after 7 days (p<0.0005). 
Globular FN as presented on PMA follows a similar trend, although this was not 
significant, suggesting the increased availability of the cell binding domain on PEA 
is recognised and beneficial for cell adherence to the substrate.  
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3.4.1.1 Growth factor tethering  
Similar levels of BMP-2 were found to be adsorbed to the PEA and PMA surfaces 
(Figure 3-5). However, our group has previously demonstrated by AFM and 
immunogold labelling that only open FN conformation supported by PEA is able to 
sequester the BMP-2 molecules; BMP-2 molecules were detected using an anti-
BMP-2 antibody with a gold nanoparticle-labelled secondary antibody, depicted 
using height magnitude, then individual FN molecules were observed using phase 
magnitude (Cheng et al., 2018; Llopis-hernández et al., 2016). This revealed 
direct co-localisation of FN and BMP-2 molecules on PEA, whereas on PMA only 
random apposition of FN and BMP-2 molecules was observed, confirming FN 
sequestration of the GF on PEA. Very low release profiles have been demonstrated 
for both polymers over 14 days (>10% loss) (Cheng et al., 2018; Llopis-hernández 
et al., 2016). The results presented here, demonstrate BMP-2 can be adsorbed 
onto the polymer surfaces, however based on previous characterisation we show 
adsorption of FN onto PEA, but not PMA, allows controlled binding and 
presentation of the GF BMP-2 on the FN networks. 
When considering the system for clinical application, the ability to deliver ultra-
low doses of GFs is highly desirable, as discussed in Chapter 1.5.4. The controlled 
GF binding of the PEA system allows for GF delivery at nano-concentrations; 50 
ng/mL BMP-2 coating was demonstrated to be sufficient to support osteogenesis 
both in vitro and in vivo (Cheng et al., 2018). We chose to employ BMP-2 at 50 
ng/mL in this thesis based on these results, with the rationale of taking a system 
we had previously demonstrated to promote osteogenesis and bone formation, 
and manipulate different properties to more closely mimic aspects of the bone 
marrow microenvironment.  
Bioinspired materials that focus on the interaction of GFs with the ECM have 
utilised GF sequestration in FN (Martino et al., 2011), vitronectin (Martino et al., 
2014), tenascin c (De Laporte et al., 2013) and fibrinogen (Martino et al., 2013), 
and these have been applied to bone regeneration, wound healing and 
angiogenesis (Martino et al., 2011). Although collagen I is commonly used 
(typically in hydrogel format) as a vehicle for GF delivery, no GF binding site has 
yet been reported. In attempts to exploit these GF-ECM interactions, one study 
engineered GFs with supper-affinity to ECM binding sites (Martino et al., 2014). 
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Placental growth factor-2 (PlGF2) was found to most strongly bind to several ECM 
proteins through a heparin binding domain near its C-terminus, protein 
engineering techniques were then used to incorporate this domain onto clinically 
relevant GFs, such as BMP-2, VEGFA and PDGF-BB. Faster wound closure and tissue 
granulation was observed when these super-affinity GFs were applied to wound 
healing models at doses 40 – 250-fold lower (~200 ng) than that previously reported 
(Martino et al., 2014). This work underlines the importance and ability of efficient 
GF presentation to augment efficacy, although in this study delivery was without 
the use of a biomaterial carrier, engineering of the GFs to bind host ECM would 
be required to achieve potency in the clinical context.  
3.4.1.2 Fibronectin networks present integrin- and growth factor- binding 
domains in close proximity 
The coexistence of binding sites for integrin adhesion and high affinity GF binding 
in many ECM proteins allows for local concentrations of GFs near the cell surface. 
The data presented in Figure 3-4C-D indicates an increased availability of these 
two key binding sites on FN adsorbed onto PEA substrates. This arrangement leads 
to close localisation of integrin-mechanoreceptors and GFRs, stimulating integrin 
and GFR signalling in a confined space resulting in synergistic signalling, or 
integrin-GFR crosstalk (Figure 3-8) (Cheng et al., 2018; Llopis-hernández et al., 
2016). For over a decade, the importance of integrin-GFR crosstalk has been 
investigated - cell adhesion is necessary to facilitate activation of GFRs, and GFs 
are necessary to stimulate cell adhesion, migration and integrin-dependent signals 
(Comoglio et al., 2003). 
The work previously discussed by Martino et al (2011), was a landmark study for 
highlighting the potency of integrin-GFR crosstalk. Using the FN fragments 
incorporated into fibrin matrices to show that only when FN fragments FNIII9-
10/FNIII12-14 were co-delivered was GF signalling significantly enhanced, integrin 
activation alone was not enough to activate proliferation or migration. Increased 
phosphorylation of GFRs and downstream signalling pathways (such as ERK1/2 - 
phosphoERK1/2) was observed for prolonged time periods (up to 40 minutes) post-
stimulation with the FNIII9-10/ FNIII12-14  fragment, but not solubilised delivery 
FNIII9-10 and FNIII12-14 (not linked) or FNIII9-10 alone. Suggesting the synergistic 
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effects of integrin-GFR crosstalk require co-localisation in the same nanoscale 
cluster (Martino et al., 2011). 
Integrin and GFR synergistic signalling has been demonstrated to augment several 
biological processes, such as blood vessel formation, wound healing and bone 
regeneration (Table 3-1). Our previous work with MSCs in the PEA system 
demonstrated co-localisation of the BMPR1A receptor to focal adhesion plaques 
(Cheng et al., 2018), and coimmunoprecipitation confirmed specific interactions 
between BMPR1A and integrin b1, part of a5b1 FN receptor (Llopis-hernández et 
al., 2016). To confirm the colocalization in pericytes on PEA FN BMP-2 substrates, 
a proximity ligation assay (PLA) should be carried out. Low cell numbers are used 
in this system which would pose limitations for coimmunoprecipitation assays, 
whereas PLA allows for sensitive in situ detection of protein interactions that can 
be detected using fluorescent microscopy. 
The colocalization of BMPR1A and integrin b1 enables crosstalk, and our previous 
works shows this had significant effects on subsequent cell signalling; significant 
increases in Smad and integrin-associated FAK phosphorylation was observed with 
PEA conditions promoting simultaneous binding of integrins and GFRs compared to 
soluble BMP-2 administration. Blocking of the GF-binding region of FN lead to 
reversal to basal levels of phosphorylation. That these synergy promoting surfaces 
showed enhanced osteogenic effects in vitro and in vivo signifies how 
GFR/integrin cooperation may be exploited for accelerated regeneration (Cheng 
et al., 2018; Llopis-hernández et al., 2016).  
To better understand the interplay between integrin-led mechanotransduction 
and GFR signalling, Crouzier et al, developed films made from poly(L-lysine) and 
HA with modulated stiffness and the ability to immobilise BMP-2 - enabling the 
ability to uncouple biochemical and matrix mechanical signals (Crouzier et al., 
2011). They found C2C12 myoblast cells were able to respond to both soluble and 
matrix-bound BMP-2 on stiff substrates, but on softer substrates matrix-bound 
BMP-2 showed only migratory/adhesive responses, however with soluble BMP-2 
poor spreading and cell rounding was observed. This study proposed bound BMP-2 
encourages close localisation of adhesion receptors to GFRs, enabling cross-talk 
that may induce cytoskeletal remodelling and cell spreading (Crouzier et al., 
2011). The group then used the same stiffness-modulated films to show matrix-
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bound BMP-2 was sufficient to induce C2C12 cell spreading in a b3 integrin-
dependent manner, even on soft substrates. They found that BMP-2 stimulation 
activated Smad signalling through integrin avb5 (but not a5b1), and that the 
colocalization of the receptors was driven by cell secreted FN which enabled the 
close localisation of FN adhesion sites with the matrix-bound BMP-2 (Fourel et al., 
2016). 
 
Figure 3-8 Integrin-GF receptor crosstalk.  When FN is adsorbed onto the polymer PEA it 
causes spontaneous unfolding, simultaneously exposing integrin-binging (FNIII9-10) and GF-
binding (FNIII12-14) domains. GFs can then be tethered to the FN molecules, promoting GFR 
and integrin colocalization, activating synergistic signalling pathways.   
Table 3-1 Integrin and growth factor receptor synergistic signalling and biological effects.  
Growth Factor Integrin Synergistic effect Reference 
BMP-2 a5b1 Osteogenesis and bone 
regeneration   
(Cheng et al., 
2018; Llopis-
hernández et al., 
2016) 
VEGF/PDGF a5b1 Wound healing  (Martino et al., 
2014, 2011) 
BMP-2/PDGF a5b1 Bone regeneration (Martino et al., 
2014, 2011) 
VEGF avb3 Increased cell adhesion and 
spreading in vitro, limited 
angiogenic response in vivo 
(Traub et al., 
2013) 
BMP-2 avb3 Osteogenesis (Fourel et al., 
2016) 
VEGF av Vasculogenesis (Moulisová et al., 
2017) 
 
Together these studies and with those summarised in Table 3-1 provide further 
evidence for the cooperative effects of GFR and integrin signalling in biological 
contexts. However, they also demonstrate contradictions over which receptors 
are involved in synergy signalling. This is further complicated by studies 
demonstrating that removing the integrin binding domain enhanced wound healing 
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in a VEGF based system (Martino et al., 2013), and by evidence for activation of 
GFRs via integrin juxtaposition even in the absence of GFs (Veevers-Lowe et al., 
2011). This suggests the need for well-defined model systems coupling mechanical 
and biochemical properties to understand the subtleties of the synergies between 
integrins and GFRs.   
3.4.2 Low stiffness collagen gels in the range of bone marrow 
The design of this system and the decision to add a collagen hydrogel was 
motivated by two observations: (I) the effects of matrix mechanics on MSPC 
phenotype, where soft/low-stiffness microenvironments have been demonstrated 
to maintain self-renewing, or niche-like phenotypes (Engler et al., 2006; Sweeten, 
2019); and (II) that the BM is composed of discrete regions of heterogeneous 
physical and compositional properties (Jansen et al., 2015). Near to the bone 
surface, osteoid and collagenous bone are thought to define a stiffer 
microenvironment shown to be enriched with FN, whereas softer perivascular 
microenvironments have been shown as laminin-rich, with collagens I and IV found 
to be more generally distributed throughout the marrow cavity (Nilsson et al., 
1998). The rationale behind the thickness of the gel was influenced by our previous 
work, where ~1 cm thick gels were demonstrated to have a niche-supporting 
effect on MSCs (Sweeten, 2019), but also with the aim of culturing gels that will 
remain at the cell-material interface for long-term culture. Work in our group has 
demonstrated lower volumes of gel are more readily contracted by cells leading 
to dissociation of gels from the well-plates and resulting in floating gels 
(Orapiriyakul, 2020).  
These subtle gradations in matrix stiffness have proved difficult to measure 
accurately in an in vivo-like context. Although porcine models have shown the 
intact marrow is viscoelastic, with mechanical properties reported to range from 
0.25 – 24.7 kPa (Young’s modulus) (Jansen et al., 2015), the study was unable to 
correlate the heterogeneity in stiffness to specific endosteal/central marrow 
locations. The rheological data presented in Figure 3-7 shows collagen type I 
hydrogels used in this thesis display a mean Young’s modulus of ~80 Pa, falling 
just outside the lower scale of the range measured for intact marrow, but similar 
to that of low stiffness systems previously reported to promote MSPC phenotype 
maintenance (Engler et al., 2006; Sweeten, 2019). However, future work would 
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aim to tune the stiffness of these gels to fall more accurately within the measured 
stiffness range of intact BM, this could be done by changes to cross-linking which 
may also affect the alignment of the collagen fibrils, or by investigation into the 
use of different concentrations of collagen. 2.05 mg/mL collagen I was used in 
this work as it is a concentration we have characterised and employed in previous 
studies (Lewis et al., 2017; Sweeten, 2019; Tsimbouri et al., 2017). In previous 
work in our group, we found that increasing the collagen concentration to 5 
mg/mL did not significantly effect hydrogel stiffness compared to the 2.05 mg/mL 
hydrogels (Orapiriyakul, 2020). As such, other more readily tuneable materials 
have been considered for future work, such as synthetic PEG matrices, which is 
discussed further in Chapter 7.2. 
It is of note that the Jansen et al, 2015 study is currently the only study to measure 
intact marrow, whilst this is important, it must also be considered that these 
measurements are carried out with cells in situ, which will contribute to 
rheological properties. Thus, perhaps the stiffness measured is not directly 
comparable to the cell free collagen matrices we employ here. However, 
measurements of decellularized marrow also prove difficult, as post-processing 
(such as chemical and temperature changes, length of post-mortem time) has 
been demonstrated to dramatically affect the elastic modulus of bone marrow 
other tissues (Davis and Praveen, 2006; Jansen et al., 2015; Rashid et al., 2013). 
These studies demonstrate that to truly measure the exact elastic and viscoelastic 
components of the BM microenvironment that cells interact with is difficult and 
will undoubtedly require synchronisation of several techniques. 
Further to the impact of gel stiffness on cellular phenotype and behaviour, the 
fibrillar microstructure of collagen has been demonstrated to impact cell 
response. One study demonstrated short fibre length and high fibre stiffness 
limited the transfer of cellular traction forces to nearby fibres, thus reducing focal 
adhesion formation and cellular spreading and leading to preference for MSCs to 
undergo adipogenesis. Whilst cell migration, proliferation, spreading and thus 
osteogenesis, was associated with the ability to recruit fibres and produce long-
range deformations in the matrix (Xie et al., 2017). As such, fibre microstructure 
is an important consideration, and could be further investigated in future work - 
by crosslinking collagen gels at different temperatures, inducing different 
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arrangements of collagen fibrils, the impact on cellular behaviour (e.g. on 
proliferation and expansion of MSPCs) could be explored.  
3.4.2.1 HSC response to niche stiffness 
Although the impact of matrix elasticity is well understood in stromal stem cells, 
comparatively less understood is the impact of biophysical signals on 
haematopoiesis. Similarly to MSCs, myosin-II plays a key role in generating 
actomyosin forces in adhesion and sensing the stiffness of the environment; where 
G-CFS stimulated BM osteoblast stiffening leads to HSC mobilisation, and soft or 
highly elastic matrices have been shown to drive expansion of HSC/HSPCs (Engler 
et al., 2006; Holst et al., 2010). Myosin-IIA (MIIA) and myosin-IIB (MIIB), contractile 
motor molecules, serve as matrix stiffness sensors in HSCs and influence HSC fate 
through regulation of asymmetric cell division (Shin et al., 2014). Stiff endosteum-
like matrix activates MIIA increasing more symmetric divisions that lead to 
differentiation, whereas soft-matrices reduce MIIA activation leading to polarised 
MIIB expression in dividing cells, resulting in asymmetric self-renewing divisions 
(Shin et al., 2014). MIIB is known to interact directly with cell surface markers, 
and hence MIIBhigh cells could correlate with an increase in putative HSC markers, 
such as CD34 (Clark et al., 2006; Shin et al., 2013).  
Gradients of cellular and ECM protein composition across the niche impact the 
biophysical environment to which HSCs are exposed. The study by Choi and Harley 
(2017) engineered marrow-inspired ECM ligand-coated PA substrates with 
tuneable stiffness and used these to demonstrate how different combinations of 
stiffness/ligand can influence HSC fate decisions. Here, they reported increased 
primitive myeloid proliferation in the substrates resembling endosteal niches (high 
FN content, stiff microenvironment ~40 kPa), whereas those resembling vascular 
zones (high laminin content) favoured erythroid lineages, although 
microenvironment stiffness displayed an undetermined role in combination with 
laminin. The effect was abrogated through inhibition of myosin-II or adhesion to 
FN via integrins a5b1 and avb3, suggesting intracellular tension as a key regulator 
of HSC lineage specification (Choi and Harley, 2017). HSCs engage matrix 
components via integrins, and several integrins have been found to be enriched in 
specific sub-populations of HSCs, as discussed in Chapter 1.3.3. The study by Choi 
and Harley (2017) provides functional output on niche biophysical effects on HSC 
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fate decisions, and alongside the evidence suggesting HSC-ECM ligand interactions 
may be critical during different stages of haematopoiesis, further supports a direct 
link of the heterogeneity of BM niche matrix ligand composition and mechanical 
properties to the differential regulation of HSCs.  
3.4.3 Summary 
The results discussed in this chapter provide evidence and reason for using each 
material component in the development of a BM niche model. The initial rationale 
to employ the PEA system is based on previous results obtained from our group in 
using this system to (I) efficiently present GFs in synergy with integrins and (II) its 
ability to promote osteogenesis. The concept for this thesis was to take an 
environment that could promote bone formation, then add key niche factors such 
as low-stiffness ECM (in the form of the collagen type I hydrogel) to create a 
system that could promote, and allow us to investigate, BM-like regulation of 
stromal cells and HSCs.  
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Chapter 4 Characterising a Bone Marrow Niche 
MSPC Phenotype 
4.1 Introduction 
Chapter 3 described the materials used in this thesis to engineer model BM niche 
systems. This chapter characterises the phenotypic properties of the stromal 
cellular component of the model, with a view to introducing HSCs in co-culture.  
As described in Chapter 1, MSPCs are tightly regulated by their niche 
microenvironment, and in turn also act as crucial support to HSCs in the BM where 
they co-reside. A growing understanding of the heterogeneity of niche cell types 
(Table 1-3) and their interactions, both cell-cell and cell-microenvironmental 
cues, are proving fundamental to harnessing stem cell potential ex vivo (Pinho and 
Frenette, 2019). Signalling molecules, such as GFs and cytokines, are released 
from nestin+ MSPCs and are central to homing, maintenance and retention of HSCs 
in the BM (Asada et al., 2017; Kunisaki et al., 2013; Nakahara et al., 2019; Pinho 
et al., 2013). The inclusion of nestin+ MSPCs is therefore highly favourable for an 
HSC niche model.  
4.1.1 Nestin  
Nestin is a type VI intermediate filament (IF) protein that, unlike most other IF 
proteins, cannot self-polymerise and instead relies on its interaction with its 
copolymerisation partner vimentin to form networks. The inability of nestin to 
form networks is presumably due to a very short N-terminal head domain, that in 
other IF proteins is essential for filament assembly (Park et al., 2010). Nestin was 
first identified as a neuroepithelial progenitor marker in the central nervous 
system (CNS) (Lendahl et al., 1990), as such, it was commonly used as a marker 
to identify neuronal precursor cells and as a marker of neurogenesis in other stem 
cell types, despite this its specific functions remain largely undetermined.  
As highlighted in Chapter 1, more recently nestin+ stromal cells have been 
characterised as important BM niche cells. They are found close to vasculature 
and in tight association with adrenergic nerve fibres and HSCs in vivo, and are 
enriched for MSPC activity ex vivo (Méndez-Ferrer et al., 2010). Selective ablation 
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of nestin+ cells (Méndez-Ferrer et al., 2010) or CAR cells (Omatsu et al., 2010) led 
to significant aberrant effects on HSC and progenitor cell maintenance in mouse 
BM. However, the intracellular location of nestin limits its use as a potential 
marker to isolate naïve cells directly from live BM. As such, surface markers 
specific to nestin+ cells have been identified. A subset of nestin+ cells positively 
expressing CD51 (integrin aV) and PDGFRa have been demonstrated by the 
Frenette group to be enriched for MSPC and HSC niche activity in vivo and in vitro. 
Cultured CD51+PDGFRa+ cells are self-renewing and able to express high levels of 
niche-related genes and maintain populations of haematopoietic progenitors in 
vitro (Pinho et al., 2013). This suggests that these markers could be evaluated as 
markers for identifying and isolating key niche MSPCs.  
Seminal work from the Discher group used gels of varying stiffnesses to promote 
differentiation of MSCs down distinct tissue lineages, correlating gel stiffness to 
in vivo tissue stiffness and resulting cell phenotype. Here it was reported that soft 
(0.1 - 1 kPa) gels promote neurogenesis of MSCs, using increased nestin expression 
as a marker of neural commitment (Engler et al., 2006). However MSC capacity to 
undergo neural differentiation has remained somewhat contentious over the years 
(Lattanzi et al., 2015), and now it is suggested that the low stiffness previously 
correlated to neural environments, for MSCs is somewhat representative of BM 
stiffness (Jansen et al., 2015). In this regard, in this thesis we chose to add a low-
stiffness gel component to the culture system, with the aim to mimic BM 
mechanics and increase nestin expression to promote a BM niche-like phenotype 
in a population of MSPCs. Hypothesising that a nestin+ stromal population would 
be enriched for BM niche activity, such as an elevated expression of HSC 
maintenance factors, allowing us to harness this for HSC support in co-culture and 
to investigate the mechanisms fundamental to this phenotype.  
4.1.2 HSC maintenance cytokines 
As described in (Table 1-4) soluble factors contribute to HSC maintenance within 
the BM niche. Known to direct chemotaxis of HSCs, CXCL12 signalling also 
contributes to maintaining HSCs in a slowly proliferative state and supports their 
retention in the BM (Ara et al., 2003; Nie et al., 2008; Sugiyama et al., 2006). 
CXCL12 is synthesized by several niche cell types, including CAR cells, endothelial 
cells and perivascular nestin+ cells (Table 1-4). Nestin+ MSPCs are tightly 
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associated with nerves and HSCs, and their CXCL12-expression is regulated in 
response to adrenergic signals from the sympathetic nervous system (SNS) in a 
circadian manner (Katayama et al., 2006; Lucas et al., 2008; Méndez-Ferrer et 
al., 2008). Nestin+ MSPCs and endothelial cells also express high levels of SCF, 
which can be both soluble and membrane-bound, and is required throughout BM 
development and for HSC maintenance in the adult BM (Ding et al., 2012; Pinho 
et al., 2013). 
Gold standard conditions used for in vitro HSC culture require the addition of such 
soluble maintenance factors, primarily SCF at concentrations ranging from 10 to 
150 ng/mL, TPO at 6 to 50 ng/mL and Flt3 at 5 to 25 ng/mL (Lewis, 2018). 
Therefore, we hypothesised that engineering a niche model that promotes and 
supports a population of stromal cells that are phenotypically similar to nestin+ 
MSPCs, this may lead to increased expression of HSC maintenance factors, and 
would ultimately be favourable for, and reduce the need for additional cytokine 
input, in HSC co-culture.  
4.1.3 Aims and objectives 
This chapter aims to recapitulate key aspects of the BM niche microenvironment 
and investigate support of defined niche phenotypes in a population of MSPCs. 
CD146+ pericytes were seeded onto glass or polymer coated substrates, with the 
addition of ECM factors (FN, BMP-2), factors that mimic BM stiffness (collagen I 
hydrogels) and the addition of an oxygen gradient (hypoxia, 1% O2) to mimic the 
hypoxic niche, for up to 14 days (represented in Figure 4-1). Assessment of 
phenotypic changes were then carried out using RNA-seq, flow cytometry and 
immunofluorescence analysis. The aims of this chapter were as such: 
• Assess support or changes in key niche phenotypic markers.  
• Investigate if low-stiffness gels can be used to increase nestin expression.  
• Assess if increased nestin expression correlates to HSC-support activities, 
such as maintenance factor production. 
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Figure 4-1 Timeline of model culture.  Cells are seeded onto polymer or glass substrates, on 
day 3 collagen gels are added or samples added into hypoxia (1% oxygen). Models are then 
cultured for the desired time period (usually 7-14 days), media changed every 3 days.  
4.2 Materials and Methods 
4.2.1 Phenotyping of pericytes by flow cytometry  
Pericytes were seeded in desired niche models, and gels/hypoxia added and 
cultured for 14 days, as per Figure 4-1. To obtain high numbers of cells for analysis 
12 technical replicates were combined, and this was repeated for 3 biological 
replicates. 
4.2.1.1 Flow cytometry staining 
Cells were prepared for flow cytometry analysis as per Chapter 2.3.3. To assess 
expression of surface markers associated with niche phenotypes, two panels of 
antibodies were used and are shown in Table 4-1. 
Table 4-1 Antibodies used for flow cytometry assessment of pericyte phenotype. 
Fluorophore Panel 1 Panel 2 
APC LepR CD51 
APC-Cy7 CD90  CD31 
FITC CD29   
eFluor 450  CD105  
PE NG2 CD140a  
Cy7  CD140b  
Cy5 CD146 CD166  
 
4.2.1.2 Gating strategy  
FlowJoÔ software was used to analyse flow cytometry data after acquisition. A 
gate was added to the forward scatter area (FSC-A) versus side scatter area (SSC-
A) plot to identify viable pericyte populations, shown in Figure 4-2. A significant 
proportion of dead cells were observed due to collagenase digest. At least 5 x 103 
Cells seeded
HypoxiaCollagen gel
LOW O2 TENSION
Add gel/hypoxia
Day 1 Day 3 Day 7 Day 14
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viable cells were analysed per condition. Unstained cells were used as a negative 
control. Figure 4-2 shows representative histograms for one biological replicate 
for panel A and panel B (Table 4-1).  
 
Figure 4-2 Gating strategy and representative histograms for analysis of pericyte phenotype. 
Sample data from one patient for flow cytometry of pericytes cultured in niche systems for 14 
days. A. Representative gating strategy for pericytes from PEA FN BMP-2 -gel, which was 
then analysed for each marker in antibody panel A (B i-v) and panel B (C i-vi) represented by 
histograms. Unstained cells were used as the negative control (red). Dotted line is a visual 
representation of positive marker expression. Count A and Count B shown in the legend 
indicate numbers of cells analysed for panel A and panel B respectively.  
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Sample Name Subset Count A Count B
PEA FN BMP-2 -Gel Pericytes 10463 11301
PMA FN BMP-2 -Gel Pericytes 10618 10694
PMA FN BMP-2 +Gel Pericytes 7654 6391
PMA FN +Gel Pericytes 10648 10616
PEA FN BMP-2 +Gel Pericytes 5976 5264
PEA FN +Gel Pericytes 11418 11526
PEA FN BMP-2 Hypoxia Pericytes 5650 5664
Glass Hypoxia Pericytes 6431 9260
Glass Pericytes 10943 10919
Glass +sol. BMP-2 Pericytes 11055 11049
Negative control Pericytes 6127
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4.2.1.3 Analysis 
The median fluorescent intensity (MFI) values for each channel were recorded for 
analysis, the value for the negative control was subtracted from each sample. 
Values were then represented as fold change over pericytes cultured on glass, and 
3 patients displayed as a heatmap using Cluster 3.0 and Java TreeView software.  
4.2.2 Brefeldin A treatment 
Cells were cultured in model systems for 14 days, for the last 24 h of culture the 
media was removed and fresh 2% media was added supplemented with 5 µg/mL 
of Brefeldin A. Brefeldin A inhibits protein transport, enhancing detection of 
intracellular cytokines. After 24h incubation with brefeldin A, samples were fixed, 
stained for immunofluorescent analysis of cytokines CXCL12 and SCF and visualised 
on the microscope as described in Chapter 2.3.4 and 2.3.5. Cytokine output was 
then quantified using ImageJ software, where a global threshold was applied and 
measurements of integrated intensity taken, this was then divided by the number 
of nuclei per image to give an average intensity. At least 10 representative images 
were analysed per replicate, n=3. Statistical analysis was carried out using 
GraphPad Prism 6 software.  
4.3 Results 
4.3.1 Support of a niche phenotype in MSPCs 
4.3.1.1 Transcriptomics day 7 
Global RNA-seq profiling was carried out on pericytes in each niche system at day 
7 to gain a snapshot into changes in transcript levels of key phenotypic genes 
(Figure 4-3). Based on literature searches a list of 84 genes was generated 
including:  
1. Osteogenesis markers (e.g. BGLAP, SPP1 and RUNX2) 
2. Stem cell and stem cell maintenance markers (e.g. MCAM, THY1 and 
ALCAM) 
3. Defined niche markers (e.g. LEPR, NES, THPO and KITL) 
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The RNA-seq analysis revealed only subtle changes between experimental 
conditions at day 7, as changes were no greater than ±3 fold when compared to 
the glass control. However, in PEA FN BMP-2 -gel some early osteogenic markers 
were elevated, such as RUNX2, or equal to expression on the glass control, such 
as SPARC (encoding the protein osteonectin, ON). Later osteogenic markers BGLAP 
(encoding the protein osteocalcin, OCN) and ALPP (alkaline phosphatase) were 
down regulated or unchanged in this condition, although this is expected as 
expression of these usually increases around days 14 - 21 during osteogenic 
differentiation of MSCs (Yang et al., 2014). Hypoxia induced an increase in several 
early and late osteogenic markers in cells on glass and PEA FN BMP-2, including 
SP7 (encoding the protein osterix, OSX), ALPP and BGLAP. The hypoxic conditions 
also had elevated levels of transcription factors and marker proteins related to 
other lineages. For example ADIPOQ (adiponectin) related to adipogenesis 
(Amable et al., 2014), and several genes typically implicated in neuronal 
phenotypes but with broad roles, such as NGF, NGFR and NCAM1 (Engler et al., 
2006). Interestingly, BMP2 was strongly upregulated in all condition except PEA 
FN BMP-2 +gel and glass +sol. BMP-2 where it was only slightly elevated, and glass 
hypoxia where it was down-regulated. These results are represented as a heatmap 
in Figure 4-3 and broadly agree with previous work with MSCs that solid-phase 
BMP-2 presentation can promote osteogenesis. 
Transcripts with increased expression in conditions with low-stiffness gels (+gel), 
were mostly related to stem cell maintenance or stem cell niches (Figure 4-3). 
Pericyte markers were either increased, e.g. MCAM (CD146) or maintained e.g. 
CSPG4 (NG2) and PDGFRA (PDGFRa), with the addition of a gel. Niche genes, 
including NES (nestin), CDH2 (N-Cadherin) and ITGB1 (integrin b1, CD29) showed 
increased expression with gels. Expression of HSC maintenance cytokine THPO 
(TPO) levels were observed for all glass and PEA conditions, but not by PMA-based 
conditions, however down-regulation of CXCL12 and KITLG (SCF) was observed for 
all conditions, which was unexpected (Figure 4-3).  
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Figure 4-3 RNA-seq profiling of niche-related and differentiation markers at day 7. Change in 
transcript levels after 7 days culture in each niche system, compared to glass control. Genes 
are clustered through average linkage. Genes related to 1. Osteogenesis, 2. Stem cell 
markers/maintenance and 3. Niche markers are indicated. N = 2 for PEA FN BMP-2 hypoxia, n 
= 3 for all other conditions. 
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4.3.1.2 Surface marker expression day 14 
The RNA-seq data gave us an overview into cell phenotypic response to the 
different niche models at day 7. To further characterise the phenotype and 
validate to changes observed at the transcript level, analysis of surface markers 
implicated in MSPC BM niche phenotypes was carried out using flow cytometry and 
is shown in Figure 4-4. This was carried out at day 14, as previous work in our 
group suggested a period of ‘priming’ of the stromal population is beneficial 
(Sweeten 2019). This provides cells time to respond to the microenvironmental 
cues presented by each system and allows for assessment of longer-term 
maintenance of phenotypic markers. Flow cytometry allowed us to assess several 
surface markers in the same population of cells (Table 4-1), and this data is 
displayed as a heatmap in Figure 4-4, represented as fold change to the glass 
control.  
Analysis of each marker, and its relevance in the BM niche, is described in 
Table 4-2. Taken together the data suggests that addition of low-stiffness gels to 
both PEA- and PMA-based systems supported expression of the markers studied, 
three of which have been implicated in HSC-regulating MSPCs in in situ mouse BM 
– NG2, CD146 and CD51 (Kunisaki et al., 2013; Pinho et al., 2013).  
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Figure 4-4 Assessment of pericyte phenotype after 14 day culture in niche models.  A. 
Heatmap shows fold change over glass of median fluorescent values obtained by flow 
cytometry from 3 independent experiments with ≥5 x 103 cells from 3 biological replicates. 
Values are represented as fold change to pericytes seeded on glass controls. Markers are 
clustered by average linkage. B. Representative histograms of 4 markers from one patient for 
glass (cyan) PEA FN BMP-2 -gel (blue), PEA FN BMP-2 +gel (red) and PEA FN BMP-2 Hypoxia 
(grey) conditions. Unstained cells were used as the negative control (black line). i. CD146 is 
better retained by +gel and hypoxia; ii. All conditions retain CD51 expression; iii. +gel displays 
2 populations, one of which are NG2+; iv. LepR expression is largely positive in hypoxia. 
Dotted line is a visual representation of positive marker expression. N = 3 biological repeats, 
at least 5x103 cells analysed per condition. 
 
Sample Name Subset Count
PEA FN BMP-2 -Gel Pericytes 10463
PEA FN BMP-2 +Gel Pericytes 5976
PEA FN BMP-2 Hypoxia Pericytes 5650
Glass Pericytes 10943
Negative control Pericytes 6127
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Table 4-2 Summary of changes in expression of surface markers assessed by flow 
cytometry at day 14. PECAM-1; platelet and endothelial adhesion molecule-1. ALCAM; 
activated leukocyte cell adhesion molecule. 
Marker Result Relevance in the BM 
niche 
Reference 
CD90 Expression supported in PEA 
FN BMP-2 +gel, PMA FN +gel 
and PMA FN BMP-2 +gel. 
Suggests low-stiffness gels 
reduce differentiation. 
Thy-1, required 
expression for defined 
MSCs. Loss of 
expression indicates 
differentiation. 
(Dominici et 
al., 2006) 
NG2 Expression supported with 
the addition of low-stiffness 
gel and hypoxia. 
Expressed by rare 
subset of pericytes 
implicated in 
maintaining LT-HSCs 
(Kunisaki et 
al., 2013) 
CD146 Expression supported with 
addition of low-stiffness gel, 
hypoxia and soluble BMP-2 
administration. 
CD146+ nestin+ cells 
are enriched for HSC-
support activity. 
(Pinho et 
al., 2013) 
CD51 Expression supported with 
addition of low-stiffness gel 
and soluble BMP-2 
administration. Decreased 
with -gel.  
Integrin av, surrogate 
marker for nestin+ 
MSPCs. 
(Pinho et 
al., 2013) 
LEPR Expression supported in 
hypoxia. No change observed 
with gel addition. 
Expressed by 
perisinusoidal MSPCs. 
Support HSC activation. 
(Kunisaki et 
al., 2013) 
CD140a Increased expression 
supported in hypoxia, 
decreased in PEA FN BMP-2 
and PMA FN BMP-2 -gel. No 
change +gel. 
PDGFRa, surrogate 
marker for nestin+ 
MSPCs, expressed by 
perivascular cells. 
(Pinho et 
al., 2013) 
CD31 No change.  PECAM-1, endothelial 
marker. 
(Crisan et 
al., 2008) 
CD29 No change. Integrin b1, commonly 
expressed by MSPCs, 
used for isolation from 
tissues. 
(Guimaraes-
Camboa et 
al., 2017) 
CD105 Slight decrease observed in 
PEA FN +gel and PEA FN 
BMP-2 +gel, whereas support 
observed with soluble BMP-2 
administration. 
Endoglin, expressed by 
subset of MSPCs shown 
to produce ectopic 
haematopoietic 
marrow.  
(Chan et 
al., 2009) 
CD166 Slight decrease observed in 
PEA FN +gel and PEA FN 
BMP-2 +gel, whereas subtle 
support observed with 
soluble BMP-2 
administration. 
ALCAM, commonly used 
to mark stromal cell 
multipotency. 
(Boxall and 
Jones, 
2012; 
Tsimbouri 
et al., 2014) 
CD140b Decreased in PEA FN +gel 
and PEA FN BMP-2 +gel, low 
level support in glass 
hypoxia. 
PDGFRb, commonly 
used to isolate MSPCs 
from tissues. 
(Crisan et 
al., 2008; 
Guimaraes-
Camboa et 
al., 2017) 
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At day 14, for the markers tested, the contribution of the low-stiffness gel or 
hypoxia is greater than that of FN network and BMP-2 availability, as no notable 
differences were observed between these conditions (Figure 4-4 and  
Table 4-2). However, it suggests that low-stiffness gels are able to support a 
population of MSPCs that express similar markers to those described in the 
literature to act as HSC support cells, that is NG2+ CD51+ CD146+ pericytes (Pinho 
et al., 2013).  
4.3.2 Intermediate filament expression 
Nestin expression was observed to be increased in the RNA-seq screen at day 7 
(Figure 4-3). One of the surrogate markers shown to correlate with nestin+ MSPCs 
in the BM, CD51 (Pinho et al., 2013), was found to be elevated in the flow 
cytometry analysis at day 14 (Figure 4-4) in cells exposed to gels (2 -fold PEA FN 
BMP-2 +gel). To confirm this finding, protein level analysis of nestin expression 
was carried out at both 7 and 14 days using immunofluorescence microscopy 
(Figure 4-5). The highest nestin expression levels were observed in PEA FN +gel 
and PEA FN BMP-2 +gel conditions at 7 days. A small increase was observed in the 
PMA FN +gel conditions, but this was not significant compared to similar polymer 
conditions in the absence of a gel. Nestin expression in cells on PEA FN +gel and 
PEA FN BMP-2 +gel systems were 9.6- and 8.5-fold greater, respectively, than 
MSPCs grown on identical polymer conditions in the absence of a gel at day 7 
(Figure 4-5A). 
By day 14, both PEA and PMA +gel-based systems exhibited similar levels of nestin 
expression that increased significantly compared to hypoxic and -gel systems 
(Figure 4-5A). Data from the two timepoints reveals that exposure to a preformed 
FN network (PEA) in combination with low-stiffness gels drives increased MSPCs 
nestin expression earlier than when FN is presented in globular conformation 
(PMA). However, by day 14 this effect is indistinguishable. The presence of BMP-2 
tethered to FN networks did not produce any discernible differences to nestin 
expression. Figure 4-5B shows representative images at 14 days, where nestin 
network formation can be observed in the PEA FN BMP-2 +gel system.  
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Figure 4-5 Nestin expression at 7 and 14 days. A. Analysis of nestin by immunofluorescence 
shows that the addition of low-stiffness gels to the model drives increased expression. This 
was more pronounced in PEA substrates than PMA at 7 days, and increased significantly on 
PEA and PMA substrates +gel by day 14. B. Representative images of nestin expression at 
day 7, scale bar is 100 μm, red = nestin, blue = DAPI. Graphs show mean integrated intensity 
of nestin ± SD (n=3 technical repeats), -gel = blue, +gel = red, hypoxia = grey, each point 
represents 1ximage field/number nuclei. One-way ANOVA followed by Kruskal-Wallis test 
with multiple comparisons, *= p<0.05, **= p<0.01, ***= p<0.001, ****= p<0.0001. 
Nestin polymerisation and network formation requires its copolymerisation with 
vimentin, although vimentin network formation is not reliant on nestin (Park et 
al., 2010). Previous reports in NSCs indicate that changes in nestin levels have no 
significant effect on vimentin levels (Park et al., 2010). To investigate whether 
the increase in nestin observed in Figure 4-5 was specific to nestin, or to a general 
increase in IF proteins, vimentin levels were assessed. Immunofluorescence 
staining was carried out on PEA FN BMP-2 samples in the presence or absence of a 
gel, or in hypoxic conditions at day 7. Figure 4-6 indicates pericytes in all 
conditions express vimentin networks, with no significant changes in vimentin 
levels observed between the different conditions. Demonstrating that the increase 
in nestin expression observed with gel addition, is specific to nestin filaments and 
does not rely on changes in vimentin dynamics.  
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Figure 4-6 Vimentin expression on PEA FN BMP-2 at 7 days. A. Analysis of vimentin by 
immunofluorescence shows no significant increase with the addition of collagen gels or 
hypoxia. B. Representative images of vimentin expression, scale bar is 100 μm. Graphs show 
mean integrated intensity of nestin ± SD (n=3 technical repeats), each point represents 
1ximage field/number nuclei. One-way ANOVA followed by Kruskal-Wallis test with multiple 
comparisons, n.s.= non-significant.  
4.3.3 HSC maintenance factor expression 
Nestin+ MSPCs have been shown to be enriched for HSC-supporting activity, with 
an increased expression of HSC maintenance cytokines (Kunisaki et al., 2013; 
Pinho et al., 2013). As such, we sought to determine if the 
nestin+NG2+CD51+CD146+ MSPCs supported by the +gel systems were able to 
produce the critical HSC maintenance factors SCF and CXCL12. Cells were cultured 
for 14 days total, and brefeldin A was added for the final 24h of culture. Brefeldin 
A inhibits intracellular protein transport by blocking transport to the Golgi 
complex, leading to accumulation of proteins in the endoplasmic reticulum, and 
is commonly used to study cytokine production. Previous work had indicated 24h 
as appropriate incubation time, allowing for significant cytokine build up without 
causing significant effects on cell viability (Sweeten, 2019). 
Cells were then stained with anti- CXCL12 and SCF for immunofluorescence 
analysis (Figure 4-7). Figure 4-7A-C shows representative images for CXCL12 
expression in PEA FN BMP-2 conditions (-gel, +gel, +hypoxia), and quantification 
(Figure 4-7D) revealed a significant increase in CXCL12 expression in PEA FN +gel 
and PEA FN BMP-2 +gel, compared to PEA FN BMP-2 -gel (3-fold), PEA FN BMP-2 
hypoxia (2-fold), PMA +gel based conditions (>10-fold), and PMA FN BMP-2 -gel 
(5.5-fold). Glass hypoxia also had significantly increased expression compared to 
PMA, PEA FN BMP-2 hypoxia, glass and glass +sol. BMP-2.  
Figure 4-7E-G show representative images for SCF expression in PEA FN BMP-2 
conditions (-gel, +gel, +hypoxia). Quantification of SCF expression (Figure 4-7H) 
revealed SCF levels increased exclusively in PEA FN +gel and PEA FN BMP-2 +gel, 
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0
5000
10000
15000
20000
In
te
gr
at
ed
 in
te
ns
it
y 
(a
.u
.)
n.s. n.s.
n.s.
Vimentin 7 days
PEA FN BMP-2
-Gel +Gel Hypoxia
Vimentin
DAPI
A B
Chapter 4 Characterising a Bone Marrow Niche MSPC Phenotype 99 
ranging from 8- to 25-fold increases. This was significant to all conditions, 
although no difference was observed ±BMP-2 in the PEA +gel conditions. This data 
demonstrates that the nestin+ NG2+ CD51+ CD146+ MSPCs maintained in the PEA 
FN/PEA FN BMP-2 +gel systems contain HSC-support activities. Interestingly, in 
contrast to the surface marker and nestin level analysis, CXCL12 and SCF 
expression was supported only when the cells were presented with FN networks 
and low-stiffness gels.  
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Figure 4-7 CXCL12 and SCF production in niche models.  Cells were cultured in niche systems 
for 14 days with brefeldin A treatment (5 µg/mL in culture media) added for the final 24h to 
inhibit intracellular protein transport. Quantification of immunofluorescence staining with 
CXCL12 (A-D) and SCF (E-H) revealed significantly increased production of both cytokines in 
PEA FN +gel and PEA FN BMP-2 +gel, and in glass hypoxia for CXCL12. Scale bar = 100 μm, 
(A-C) red = CXCL12, blue = DAPI, (E-G) red = SCF, blue = DAPI. D & H show mean integrated 
intensity of CXCL12 and SCF ±SD (n=3 technical replicates), -gel = blue, +gel = red, hypoxia 
= grey, each point represents 1ximage field/number nuclei. One-way ANOVA followed by 
Kruskal-Wallis test with multiple comparisons, *= p<0.05, **= p<0.01, ***= p<0.001, ****= 
p<0.0001. 
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4.4 Discussion 
The aim of this chapter was to assess the phenotype of pericytes seeded into our 
niche systems after up to 14 days culture. We wanted to assess the contribution 
of different niche properties, such as low-stiffness gels or hypoxia, on the ability 
to promote/maintain a niche-like MSPC phenotype in vitro.  
4.4.1 Low-stiffness gels support expression of phenotypic niche 
markers 
Transcriptomics performed at day 7 gave a snapshot of gene changes at an early 
time point in the MSPC niche model (Figure 4-3). The PEA FN BMP-2 -gel condition 
was predicted to show preference to osteo-commitment, and the data supports 
this hypothesis with an increase of the early osteogenic marker RUNX2 observed. 
RUNX2 is a key transcription factor which plays a central role in the regulation of 
bone matrix proteins (Hassan et al., 2006). A second important transcription 
factor that is required for bone matrix proteins is SP7 (also called osterix; OSX), 
whose activation can be RUNX2 dependent or independent. As such SP7 activation 
is usually observed after RUNX2 activity peaks (Yang et al., 2014). The RNA-seq 
data from this model (Figure 4-3) reveals in some conditions SP7 levels increase 
in hypoxia, whilst PEA FN BMP-2 hypoxia also increased RUNX2. This reflects 
several reports where hypoxia can promote osteogenesis of MSPCs in vitro 
(Ejtehadifar et al., 2015; Hung et al., 2012). Other osteogenic markers such as 
OCN and ALPP were not observed to have increased. This was expected at day 7 
as these are typically late osteogenic markers, indicative of a mature mineralised 
matrix, more typically elevated around day 16 – 28 in MSCs (Yang et al., 2014).  
The results from the RNA-seq analysis provide an overview of cell phenotype, and 
are useful to direct further investigation, however changes in transcript 
abundance were only small, as such the regulation of these osteogenic transcripts 
would need to be confirmed by qPCR. Further to this, pericytes isolated from 
adipose tissue, as used in this thesis, and adipose-derived MSCs/MSPCs have been 
shown to display less potent osteogenic commitment in vitro than BM equivalents 
(Herrmann et al., 2016; Im et al., 2005). As such, the temporal gene expression 
of differentiation markers may be different between the published, characterised 
MSC time points and adipose-derived pericytes, and this may explain the only weak 
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up-regulation of these genes. A qPCR experiment at several time points would be 
required to elucidate peak RUNX2 activity in this system.  
The list of genes produced for Figure 4-3 also included many genes implicated in 
stem cell maintenance and in the BM niche, such as surface markers MCAM, NES, 
CSPG4, several of which appeared to show increased expression in the presence 
of low-stiffness gels. We therefore chose to assess and confirm these trends by 
analysing protein levels. Other studies have demonstrated that a ‘priming’ period 
is beneficial when introducing HSCs into co-culture systems (Leisten et al., 2012; 
Sweeten, 2019). Therefore, we chose to carry out these assessments at the later 
time point of 14 days, in order to allow time for cells to establish responses to the 
different niche cues.  
Flow cytometry was used to assess a panel of markers associated with MSPC and 
BM niche phenotypes. As for the RNA-seq analysis, mostly subtle changes were 
observed, with no fold change greater than ±3. Although this is perhaps expected 
in cultured stromal cell populations, for which no defined set of surface markers 
has been identified to robustly confirm phenotypes, and with further subsets of 
MSPCs being described in the literature (Dominici et al., 2006; Mo et al., 2016; 
Pinho et al., 2013).  
The analysis demonstrated retention of CD90 in cells in systems containing gels, 
loss of which is associated with differentiation. Increased expression of the 
pericyte marker CD146 (MCAM) in systems containing gels was confirmed, and 
interestingly, these systems also demonstrated increase of the pericyte marker 
NG2 (CSPG4) which has been implicated as a marker of MSPCs that reside in 
periarteriolar locations and promote HSC quiescence (Figure 4-8) (Kunisaki et al., 
2013). The expression of CD51 was also observed to increase in +gel conditions; 
CD51 has been implicated as a surrogate marker along with PDGFRa for a subset 
of MSPCs that are nestin+ and CD146+ (Pinho et al., 2013), although the cells 
lacked expression of PDGFRa. Interestingly, LepR expression was supported in 
hypoxic conditions, and LepR+ MSPCs have been shown to preferentially reside in 
the most hypoxic sinusoidal regions of mouse BM, suggesting low oxygen tensions 
may be adequate to support this phenotype (Figure 4-8) (Kunisaki et al., 2013).  
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The flow cytometry data confirmed expression of markers identified in the RNA-
seq screen, and several of these markers suggested that the phenotype supported 
by the systems containing low-stiffness gels may be similar to nestin+ MSPCs in the 
BM.  
However, for better comparison the cells should have been subject to the same 
flow cytometry analysis on the day of seeding, so changes from this phenotype 
could be assessed. Further, it should be noted that the percentage of recovery of 
cells from the niche systems to perform flow cytometry was low. Several 
replicates needed to be pooled to achieve statistically relevant numbers of cells 
to analyse. This was in part due to difficulties detaching cells from PEA surfaces 
using flow cytometry suitable detachment solutions (e.g. TrpLE or accuatse), and 
due to the time period required to digest the collagen gels (~90 minutes), which 
led to some cell death and cell debris. This could of course lead to bias in the 
population of cells retrieved and analysed. Therefore techniques that rely on 
fixation, isolation of cell RNA, or protein extraction, of cells directly on the 
materials may provide information more representative of the entire cell 
population. This also restricted the use of this data to assess changes in cell 
expansion and proliferation between the different systems, something likely 
effected by the different components of the system, and as such, is something 
that should be investigated in future work. 
4.4.2 Low-stiffness gels promote nestin expression 
We found that addition of a soft collagen hydrogel (~80 Pa) on top of pericytes 
seeded on polymer substrates led to increased nestin expression (Figure 4-5). 
Elevated expression was only observed at 7 days when pericytes were seeded onto 
substrates containing unfolded FN networks, where PEA FN +gel and PEA FN BMP-
2 +gel increased nestin expression 9.6- and 8.5-fold respectively, when compared 
to cultures in the absence of low-stiffness gels. However, by day 14 increased 
expression was observed in these conditions and also in PMA FN +gel and PMA FN 
BMP-2 +gel (Figure 4-5). This suggests the addition of low-stiffness gels is able to 
drive nestin expression, but that the addition of FN networks drives expression 
earlier only when presented in a non-globular conformation on the PEA polymer. 
Suggesting that in order to promote a nestin+ niche-like phenotype of stromal cells 
in low-stiffness environments, early ECM attachment is required by the cells. 
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Nestin-expressing cells are frequently found in areas of regeneration, where they 
may function as a reservoir of stem/progenitor cells capable of proliferation and 
differentiation (Park et al., 2010). Nestin expression is observed during myogenic 
differentiation, in progenitor cells of the CNS and in highly proliferative tissues 
such as during neoplastic transformation e.g. glioma and neuroblastoma (Matsuda 
et al., 2015; Pallari et al., 2011; Sahlgren et al., 2003). As an IF, nestin function 
is often linked to its involvement in the cytoskeleton, however it has been shown 
in NSCs that nestin supports expansion of the stem cell pool by preventing 
apoptosis. This function was shown to be independent of nestin involvement in 
the cytoskeleton, as when vimentin was knocked down, preventing nestin from 
polymerising, no negative effects were observed. Whereas, nestin knock-down in 
NSCs significantly increased early apoptosis and in vivo nestin deficiency is known 
to be embryonically lethal (Park et al., 2010). This study suggests that nestin 
incorporation into the cytoskeleton enhances its function, and that nestin has 
roles that go beyond its structural function. Studies have implicated a role in the 
disassembly of vimentin during mitosis (Chou et al., 2003), and as a selective 
scaffolding protein for cyclin-dependent kinase 5 (Cdk5), a crucial signalling 
determinant during development and myogenic differentiation in neuronal and 
myogenic precursors (Pallari et al., 2011; Sahlgren et al., 2006, 2003).  
Here, we observed a similar effect where nestin was significantly increased with 
gel addition, yet no significant changes in vimentin where observed (Figure 4-6). 
This perhaps supports the idea that the role of nestin in stem cells is independent 
of its involvement in the cytoskeleton. However, vimentin networks have physical 
properties likely to contribute to cell mechanics, for example they are 
characterised by a high degree of strain stiffening and ability to withstand large 
strains without breakage, in contrast to microtubules and microfilaments that 
rupture at more moderate strains (Janmey et al., 1991; Murray et al., 2014; Qin 
et al., 2009). Previous studies demonstrate that whilst substrate stiffness has been 
shown to alter many aspects of cell behaviour, changes in vimentin organisation 
were not reported. However, one more recent study investigating  regulation of 
vimentin in response to substrate stiffness in MSCs, found that although the 
amount of total vimentin protein remains constant, the amount of protein that 
becomes soluble significantly increases with decreasing stiffness (Murray et al., 
2014). This could explain the results observed in Figure 4-6, and suggests 
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investigation into the fraction of soluble vimentin rather than total protein could 
be investigated in future work.  
The functional role of nestin expression in the BM remains to be elucidated. The 
2013 study by Pinho et al, suggests that cell surface markers CD51 and PDGFRa 
can be used to identify Nestin+ MSPCs (Pinho et al., 2013). Interestingly, the 
expression of nestin at day 14 observed in the immunofluorescence analysis 
(Figure 4-5) correlated with increased expression of CD51 obtained from flow 
cytometry, but not PDGFRa (Figure 4-4). Nestin+ CD51+ PDGFRa+ cells isolated 
from human BM were also found to homogeneously express CD146. This correlates 
to nestin expression driven by low-stiffness gels (Figure 4-3, Figure 4-4, Figure 
4-5). The nestin+ CD51+ PDGFRa+ cells isolated by Pinho et al, were enriched for 
HSC supporting niche activity and contained colony forming units-fibroblast (CFU-
F) activity compared to nestin- CD51- PDGFRa- cells. However, only a small 
proportion of CD146+ cells expressed all 3 markers, suggesting further 
heterogeneities in the stromal population in human marrow. It is of note, that 
most studies demonstrating PDGFRa+ as a marker for MSPCs, use it as a method 
for isolation from tissues, whether PDGFRa expression is supported upon in vitro 
culture is unclear (Sá da Bandeira et al., 2016). This data suggests the phenotype 
of pericytes seeded in the +gel systems is similar to that of HSC-maintaining 
periarteriolar MSPCs identified in the BM, illustrated in Figure 4-8. 
In context of the in vivo murine BM, distinct nestin+ MSPC distribution has been 
demonstrated. Based on cell fluorescence intensity and morphology, two distinct 
types of Nes-GFP+ cells (Nes-GFPbright and Nes-GFPdim) have been identified and 
characterised (Kunisaki et al., 2013). Both populations displayed mesenchymal 
progenitor (CFU-F) activities in vitro, but Nes-GFPbright cells contained most CFU-
F activity and increased expression of genes associated with HSC maintenance. 
However, Nes-GFPbright cells are much fewer in number (~0.002% of total BM). The 
two nestin+ populations revealed physiological differences in localisation, with 
Nes-GFPbright exclusively associating along arterioles, while Nes-GFPdim were 
associated with sinusoids. Interestingly, Nes-GFPdim cells were enriched for genes 
associated with DNA replication and cell cycle. Proliferation analysis revealed a 
significant decrease in Nes-GFPbright cells, suggesting these cells are largely 
quiescent within the niche (Kunisaki et al., 2013). This is perhaps in contrast to 
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evidence in other cell types that proposes roles for nestin in supporting cell 
proliferation, and further highlights the discrepancies in function associated to 
nestin expression in different cell types. In future work, it would be of interest to 
characterise the proliferation of the pericytes in the BM niche model used in this 
thesis, to further characterise the phenotypic state of the stromal cells.    
 
Figure 4-8 MSPC phenotypes in the BM niche.  Nestin+ NG2+ CD146+ MSPCs are reside on 
arterioles near the endosteal surface, they express high levels of HSC-maintenance cytokines 
SCF and CXCL12 and are in close association with sympathetic nerve fibres. LepR+ MSPCs 
reside on more hypoxic sinusoids. MSPC; mesenchymal stromal and perivascular cells. OB; 
osteoblast. EC; endothelial cell.  
4.4.3 Fibronectin +gel driven nestin expression correlates with 
HSC maintenance cytokine production 
We hypothesised that by promoting a nestin+ MSPC phenotype we would also see 
elevated expression in HSC maintenance cytokines, primarily CXCL12 and SCF. 
Although Figure 4-3 suggests that transcription levels for both cytokines were low 
at day 7 we sought to investigate this at the protein level, to examine if cytokine 
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production was detectable in culture media ELISAs were initially carried out. 
However, inconsistencies with repeatability led us to believe the gel may have 
been capturing significant levels of cytokines, resulting in unreliable readings. 
Instead we chose to investigate cytokine expression by blocking protein transport 
for the final 24h of culture during the ‘priming’ period of 14 days.  
Figure 4-7 shows CXCL12 production was most significantly elevated in PEA FN 
BMP-2 +gel, PEA FN +gel and also glass hypoxia. SCF was significantly elevated in 
PEA FN BMP-2 +gel and PEA FN +gel only. Firstly, this suggests that the combination 
of FN networks and low-stiffness gels are proficient to stimulate cytokine 
expression, and that the addition of BMP-2 is not required. Secondly, this 
increased HSC-maintenance factor phenotype is concomitant with the nestin+ 
CD51+ CD146+ MSPC phenotype we observed in these conditions. Nestin+ MSPCs 
are known to demonstrate enhanced HSC support activity (Table 1-3). Therefore, 
this data supports our hypothesis that using specific microenvironmental cues we 
can direct pericyte physiology towards a niche-like phenotype (Figure 4-8).  
Surprisingly, although similar phenotypes were maintained on the PEA- and PMA-
based +gel systems in all previous analysis, this did not correlate to increased 
cytokine production on PMA substrates (Figure 4-7). This could correlate with the 
delayed onset of nestin expression on PMA substrates observed in Figure 4-5, and 
suggests a longer priming period would be required for cytokine production in 
these conditions.   
Interestingly, TPO, another important maintenance cytokine, displayed elevated 
transcript levels in the RNA-seq analysis (Figure 4-3). TPO production was similarly 
tested by ELISA at day 7 and 14, levels of the cytokine were undetectable in all 
conditions at both time points (Appendix Figure 7-3). TPO production in the niche 
is primarily from osteoblasts and osteoprogenitors, although it is believed systemic 
production from hepatocytes also has a major contribution to levels in vivo (Qian 
et al., 2007; Yoshihara et al., 2007). As the stromal phenotype supported by the 
niche model appears to be suggestive of nestin+ MSPCs, which do not produce 
significant TPO (Pinho and Frenette, 2019), this was not pursued further. 
However, in future, similar investigations using brefeldin A should be carried out, 
as the PEA FN BMP-2 -gel condition which has been previously demonstrated with 
MSCs to promote osteogenesis (Cheng et al., 2018; Llopis-hernández et al., 2016; 
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Sweeten, 2019), may promote TPO production at a later time point when a mature 
osteogenic state is reached. 
4.5 Summary 
This chapter describes the analysis of cell phenotype in response to engineered 
niche systems. We wanted to assess which microenvironmental cues presented to 
cells were able to support specific phenotypes of MSPCs, with the aim to identify 
those that enhance BM niche properties and drive an HSC supporting phenotype. 
The results in this chapter demonstrate:  
• The addition of low-stiffness collagen gels directs pericyte phenotype 
towards that of periarteriolar MSPCs described in the BM niche. This 
phenotype is nestin+ NG2+ CD51+ CD146+. 
• When in contact with preformed FN networks on PEA FN +gel and PEA FN 
BMP-2 +gel this MSCP population produces cytokines CXCL12 and SCF. 
Suggesting these systems may drive an HSC-supportive MSPC phenotype. 
• FN networks drive earlier nestin expression, suggesting ECM interactions 
are important for nestin regulation. 
• Nestin expression can be driven by the addition of low-stiffness matrices, 
suggesting this is a mechanosensitive response. 
• The addition of the GF BMP-2 had no significant effect on the PEA FN +gel-
based systems. 
In the next chapter, these models are used further to investigate how the different 
microenvironmental cues influence stem cell metabolism, and how this relates to 
the phenotypes observed in this chapter.  
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Chapter 5 Hypoxia and Metabolism 
5.1 Introduction 
Low oxygen tension (hypoxia) is a key niche characteristic in maintaining 
quiescent or self-renewing states of embryonic, haematopoietic, mesenchymal, 
neural and cancer stem cells (Mohyeldin et al., 2010). This low oxygen 
environment is tolerated by stem cells, and appears to be essential for their 
function. It is thought that the ‘hypoxic niche’ offers an adaptive advantage to 
the stem cell, as in hypoxia anaerobic metabolism is utilised, avoiding 
mitochondrial OXPHOS and the resulting generation of ROS that can be damaging 
to DNA. The energy demand of self-renewing stem cells is less than that of cells 
undergoing differentiation, and it has been shown that MSCs in standard culture 
are more glycolytic, a phenomenon also known as the Warburg effect (Pattappa 
et al., 2011; Warburg, 1925). Then as differentiating cells begin to migrate out of 
the niche, metabolism shifts to OXPHOS to meet increased energy demands (Figure 
5-1) (Mohyeldin et al., 2010; Pattappa et al., 2011; Simsek et al., 2010; Suda et 
al., 2011). Thus, hypoxic niches are thought to have an important role in 
regulating stem cell differentiation and self-renewal, thereby avoiding exhaustion 
of the stem cell pool (Yoon-Young and Sharkis, 2007).  
It has been well studied that hypoxia is a hallmark of the BM niche, with studies 
identifying genetic and metabolic profiles that reflect adaption to low oxygen 
environments in HSCs (Simsek et al., 2010; Takubo et al., 2013, 2010). As discussed 
in Chapter 1.4.4, although the BM is a highly vascularized tissue, direct 
measurements of oxygen tension in vivo have found the absolute pO2 of the cavity 
to be quite low (ranging from 1.5 - 4.2% oxygen). The most hypoxic zones have 
been revealed to be the deep sinusoidal regions, with the highly vascularised 
endosteal region displaying a slightly higher pO2 (Figure 5-2) (Spencer et al., 2014).  
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Figure 5-1 Stem cells reside in and adapt to hypoxic niches.  In hypoxic environments, such 
as stem cell niches, stem cells switch their metabolism to anaerobic glycolysis. This is 
controlled by the master transcriptional regulator of the hypoxic response HIF1a, which in 
hypoxia translocates to the nucleus and activates target genes. Several of these genes are 
glycolytic enzymes, such as LDH (lactate dehydrogenase) and PDK1 (pyruvate 
dehydrogenase kinase 1). This metabolises pyruvate to lactate, preventing it from entering 
the mitochondria, and ATP is generated from glycolysis. As cells move out of hypoxic niches 
they lose quiescence and begin to differentiate. HIF1a is no longer active and pyruvate is able 
to enter the mitochondria via PDH (pyruvate dehydrogenase), where it moves through the 
citric acid cycle (TCA) and electron transport chain (ETC) to generate a greater ATP output 
than glycolysis alone.  
Isolation and in vitro culture of stem cells along with biomaterials strategies have 
greatly accelerated our understanding of fundamental niche mechanisms and 
behaviours. Initially little attention was paid to the metabolic milieu of native 
niches, and as for all other established cell lines, culture was typically at normoxic 
pO2 levels on tissue culture plastic. However, as culture at low oxygen of stem 
cells began to be investigated, active hypoxia-related signalling pathways were 
shown to be important for retaining naive phenotypes (Pattappa et al., 2011). 
Coupled with direct measurements of pO2 levels of native niches, the importance 
of the low oxygen environment and its impact on cellular metabolism is now being 
widely investigated.  
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Figure 5-2 Oxygen gradient in the bone marrow niche. More hypoxic sinusoidal regions house 
LepR+ MSPCs that regulate active HSCs. The endosteal region is highly populated with 
arterioles, which house Nestin+ CD146+ NG2+ MSPCs that regulate quiescent HSCs. 
5.1.1 HIF1a 
Response to low oxygen tensions is mediated by the transcriptional complex 
hypoxia-inducible factor (HIF) proteins at the cellular level (Wang and Semenza, 
1995). HIF is a heterodimeric DNA-binding complex composed of two basic-helix-
loop-helix proteins of the PAS family (PER, AHR, ARNT and SIM family) (Semenza 
et al., 1997). The HIFb subunits are non-oxygen responsive nuclear proteins and 
levels are stably maintained in cells, whereas the HIFa subunits (HIF1a and HIF2a) 
are constitutively turned over in the cytoplasm and are highly oxygen responsive 
(Weidemann and Johnson, 2008). Under hypoxia the a/b heterodimer binds to 
hypoxia response elements (HRE) of target genes via a core pentanucleotide 
sequence (RCGTG; arginine, cysteine, glycine, threonine, glycine). HIF related 
activity is key in regulating a broad range of responses to hypoxia both cellular 
and systemically, and is known to directly or indirectly regulate over 100 genes. 
HIF-mediated pathways influence genes that are themselves non-oxygen 
responsive, but that also influence metabolic adaption, angiogenesis, cell growth, 
differentiation, survival and apoptosis (Weidemann and Johnson, 2008).  
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HIF1a subunits have a short half-life under normoxia (Salceda and Caro, 1997). 
The continually produced a-subunits are degraded through oxygen-dependent 
hydroxylation of two prolyl residues in their oxygen-dependent degradation 
domains (ODDD), by HIF prolyl hydroxylases (PHDs) (Ivan et al., 2001; Jaakkola et 
al., 2001). PHD enzymes are 2-oxoglutarate dependent, non-heme FE(II)-
dioxygenases, and hence split molecular oxygen - one atom is inserted into the 
HIF1a peptide at the prolyl residue, the other reacts with 2-oxoglutarate, 
producing CO2 and succinate as by products. PHDs remain unmodified under low 
oxygen, and hence the effects of hypoxia are often simulated in culture by iron 
chelation, most commonly cobalt chloride (CoCl) (Bruick and McKnight, 2001).  
 
Figure 5-3 HIF1a regulation by oxygen tension. HIF1a contains hydroxylation sites on two 
prolyl residues in the oxygen-dependent degradation domain (ODDD). In the presence of 
oxygen, prolyl hydroxylation is catalysed by the Fe(II)-, oxygen- and 2-oxoglutarate-
dependent PHDs. The hydroxylated prolyl residues allow capture of HIF1a by the von Hippel-
Lindau protein (VHL), an E3 ubiquitin ligase. Ubiquitination leads to subsequent proteasomal 
degradation. In the absence of hydroxylation, i.e. in low oxygen or PHD inhibition, HIF1a 
translocates to the nucleus, heterodimerizes with HIF1b and binds to hypoxia-response 
elements (HREs) in the regulatory regions of target genes.  
In normoxia, the hydroxylated ODDD is recognised by the E3 ubiquitin ligase von 
Hippel-Lindau (VHL), which facilitates polyubiquitination and subsequent 
proteasomal degradation of HIF1a. Consequently, in hypoxic conditions 
hydroxylation is supressed and HIF1a protein can accumulate. Subsequently, 
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HIF1a subunits translocate to the nucleus where they can dimerise with HIF1β 
(Staller et al., 2003), the heterodimeric protein complex then binds the HREs on 
promoter or enhancer sequences on target genes that facilitate adaption to 
hypoxia (Figure 5-3) (Weidemann and Johnson, 2008).  
The role of HIF1a as a regulator of metabolic adaption is important for many 
cellular processes. It has been shown to play an important role in both MSCs and 
HSCs in their niches, where the balance between self-renewal and differentiation 
requires distinct metabolic programs to meet the changing energy demands 
(Guarnerio et al., 2014; Morikawa and Takubo, 2016; Pattappa et al., 2011; Simsek 
et al., 2010; Takubo et al., 2010), which will be discussed and investigated in this 
chapter.  
5.1.1.1 HIF2a and HIF3a 
HIF1a was the first hypoxia-inducible factor described, it is believed to be the 
master regulator of the hypoxic response and initial characterisation was focussed 
on this subunit. However, there are two other oxygen-dependent HIFa subunits, 
HIF2a (also known as EPAS1) and HIF3a, that remain to be fully characterised (Ivan 
et al., 2001; Masson et al., 2001). The three HIFa isoforms are encoded by distinct 
gene loci but retain some similarities; all possess the ODDD and HIFb-dimerising 
domain. HIF1a is ubiquitously expressed, whereas HIF2a and HIF3a are found in a 
subset of tissues. HIF2a also binds to HRE and upregulates gene expression but its 
expression is more limited and appears to be tissue or cell type-specific and 
limited to e.g. endothelium (Tian et al., 1997), kidney (Wiesener et al., 2002), 
lungs (Ema et al., 1997) and small intestine (Wiesener et al., 2002). HIF1a and 
HIF2a show some functional overlap, but have also been shown to regulate unique 
genes and physiological functions (Covello et al., 2006). HIF1a uniquely activates 
glycolytic enzyme genes, while HIF2a preferentially activates VEGF (Hu et al., 
2003), Oct4 (Covello et al., 2006) and Cyclin D1 (Baba et al., 2003). 
HIF2a is known to be an upstream regulator of POU5F1 (OCT4) in mouse ESCs 
suggesting an important role in maintenance of ESC pluripotency (Covello et al., 
2006). OCT4 expression, along with other ESC markers (NANOG, SOX2), is lost upon 
culture at 20% oxygen (Chen et al., 2010). One study investigated the levels of the 
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three HIFa subunits in ESCs and found transient HIF1a expression at low oxygen, 
whereas the HIF2a and HIF3a subunits although initially low, were significantly 
upregulated and localised to the nucleus in long-term exposure to hypoxia. 
Silencing of HIF2a lead to a loss of ESC pluripotency genes and proliferation, 
whereas HIF3a knockdown decreased HIF2a expression, but promoted HIF1a 
levels (Forristal et al., 2010). This demonstrates complex interactions between 
the 3 subunits is necessary to maintain ESC pluripotency under hypoxic culture, 
where HIF3a regulates expression of both HIF2a and HIF1a, but HIF2a is required 
for proliferation and pluripotency regulation.  
HIF3a is less closely related to HIF1a, it lacks the C-terminal activation domain 
required for co-activator binding, meaning it is unable to recruit the basal 
transcriptional machinery to target genes. Little is known is about which genes 
HIF3a regulates, although it has also been shown to act as a dominant negative 
regulator of HIF1a in the corneal epithelium of the eye (Makino et al., 2001). For 
MSPCs, one recent study illustrated HIF3a pro-inflammatory activation that is 
oxygen-independent (Cuomo et al., 2018), and another implicated it as a regulator 
of chondrogenesis (Markway et al., 2015). As such, the role of the less well studied 
HIF3a subunit remains unclear.  
5.1.2 MSPCs and hypoxia 
Hypoxia has been indicated as a key caveat in all stem cell niches, requiring tight 
metabolic regulation to maintain long-term quiescence and self-renewal of stem 
cell populations (Mohyeldin et al., 2010). As such, MSPC response and regulation 
in hypoxia has been of great focus, with the aim of maintaining niche-like 
phenotypes that would allow for longer term culture and ultimately use for tissue 
engineering or immune suppressive purposes (Ejtehadifar et al., 2015).  
There exists conflict in reports of the effects of hypoxia and hypoxia-relating 
signalling on MSPC differentiation capacity in vitro. For example some studies 
demonstrate BM-derived MSCs showed decreased osteogenic commitment in 
hypoxic culture (D’Ippolito et al., 2006; Fehrer et al., 2007), with one study 
highlighting even after long-term culture no osteoblastic markers or 
mineralisation could be observed compared to actively differentiating normoxic 
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counterparts, instead upregulation of naïve markers could be observed, such as 
OCT-4, telomerase reverse transcriptase and HIF1a (D’Ippolito et al., 2006). 
Another report shows culture for short periods in hypoxia can significantly 
augment beneficial therapeutic characteristics of MSCs, increased modulation of 
key genes and self-renewal capacity has been observed with hypoxic exposure for 
just 48h (Antebi et al., 2018) 
Contrastingly, there have been reports of hypoxic culture of BM MSCs promoting 
chondrogenic, osteogenic and adipogenic differentiation capacity (Müller et al., 
2011; Tsai et al., 2011; Wagegg et al., 2012). Reports on MSCs from other sources 
have corroborated these findings, where one study evidenced an increase of 
oxygen from just 1% to 3% was shown to restore the osteogenic potential of MSPCs 
from various tissues (Holzwarth et al., 2010), and ‘hypoxic priming’ has been 
shown to increase chondrogenic potential of adipose-derived MSPCs (Mohyeldin et 
al., 2010). Bone formation during fracture healing operates in a hypoxic 
environment due to disruption of vasculature (Dimitriou et al., 2005), and a recent 
study demonstrated both HIF1a and HIF2a are highly expressed in osteoblasts 
(Merceron et al., 2019). The study by Merceron et al, indicated HIF1a was a 
positive regulator of osteogenesis, whereas HIF2a was found to inhibit osteoblast 
formation through upregulation of chondrogenic marker SOX9 (Merceron et al., 
2019).  
Reports on the effect of hypoxia specifically on BM pericytes are fewer, however, 
the in situ localisation of CD146+ pericytes predominantly to arteriolar walls 
suggests preference for the less hypoxic regions of the BM. This was confirmed in 
a study that correlated CD146 expression to perivascular cells surrounding vessel 
endothelium. Upon isolation and hypoxic in vitro culture CD146 expression was 
markedly decreased in these cells after 2 weeks, although the loss was reversible 
when cells were reintroduced into normoxic culture for a further 2 weeks (Tormin 
et al., 2011).  
Stem cell expansion and lifespan has been shown to increase in cultures at low 
oxygen tensions; the glycolytic phenotype, driven primarily by HIF1a, limits 
oxidative stress, DNA damage and chromosomal aberrations, which compromise 
the safety and viability of long-term cultures. Despite faster growth, studies have 
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shown MSPCs can be passaged up to 10x more under hypoxic conditions. It is 
thought that hypoxia reduces the rate of telomere shortening per cell division, 
suggesting these oxidative stress protection mechanisms help maintain an 
increased lifespan (Estrada et al., 2012; Fehrer et al., 2007).  
Overall, the effects of hypoxic culture on MSPCs remains unclear, this could be 
due to i. ill-defined isolation profiles of MSPCs leading to heterogeneities in the 
cell types used, and ii. ill-defined methods of hypoxic culture, some studies use 
ion-chelators, others hypoxic incubators at varying oxygen concentrations. With 
recent reports suggesting differences in pO2 gradients sensed by cells will differ 
even with uneven media heights, means making comparisons between studies can 
perhaps be inconsistent (Wenger et al., 2015).  
5.1.3 HSCs and hypoxia 
HSCs are thought to be localised to the hypoxic regions of the BM niche, and indeed 
hypoxic ex vivo culture of primitive haematopoietic progenitors or HSCs has been 
shown to maintain cell cycle quiescence (Hermitte et al., 2006), and stemness 
(Danet et al., 2003). How HSCs adapt to this environment has been well studied, 
and was revealed in two landmark studies from 2010, that used complementary 
approaches to provide important insights into the role of hypoxia and HIF1a 
signalling in regulating HSC function (Simsek et al., 2010; Takubo et al., 2010).  
Simsek et al, demonstrated HSCs adapt to and utilise chronic hypoxia through 
stabilisation of HIF1a, activating transcription of target genes that are involved in 
adaption to glycolysis as the main source of energy. They showed HSCs exhibit 
elevated levels of HIF1a, increased rates of glucose consumption and lactate 
production, with correspondingly decreased rates of mitochondrial OXPHOS when 
compared to mature cells (Simsek et al., 2010). Takubo et al (2010), corroborated 
these findings, presenting conditional deletion of HIF1a in HSCs led to loss of 
quiescence and of long-term repopulation capacity in serial transplantation 
assays. Then, by conditionally deleting VHL this landmark study revealed that 
monoallelic deletion of the E3 ubiquitin ligase leads to HIF1a stabilisation, 
increasing the population of LT-HSCs. However, complete ablation of VHL appears 
to lead to over stabilisation of HIF1a, leading to a loss of HSC activity in 
transplantation assays (Takubo et al., 2010). Collectively these two studies 
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provide genetic evidence that HIF1a is an essential regulator for HSC long-term 
maintenance, and that tight regulation of HIF1a levels are essential for 
maintaining this function.  
Takubo et al, went on to further investigate the metabolic implications of HIF1a 
regulation in HSCs using metabolomic analysis (Takubo et al., 2013). High flux 
through the glycolytic pathway was characterised through accumulation of 
fructose-1,6-bisphosphate (F1,6BP), a product of the rate-limiting step of 
glycolysis, reflecting irreversible commitment to the pathway. Elevated levels of 
pyruvate corresponded with low levels of phosphoenolpyruvate, the by-product 
and substrate for the final ATP-generating step in the glycolytic pathway. 
Alongside this, high glycolytic enzyme expression and activity, such as pyruvate 
kinase, in LT-HSCs confirmed a reliance on anaerobic metabolism for energy 
production. Presenting striking differences in metabolic wiring of LT-HSCs 
compared to their committed progeny. Engagement with the citric acid (TCA) 
cycle, and therefore OXPHOS, is prevented in these HSCs through HIF1a driven 
expression of pyruvate dehydrogenase kinase (PDK) 2 and 4, which suppresses 
pyruvate dehydrogenase (PDH) activity, preventing the conversion of pyruvate to 
acetyl-CoA (Takubo et al., 2013).  
Reliance on tight regulation of distinct metabolic profiles in HSCs is not only 
essential for maintenance of quiescence, but a timely shift is required for 
activation and differentiation to committed progeny, which was highlighted in a 
further complementary study by Yu et al, in 2013. Here they showed disruption of 
mitochondrial OXPHOS was achieved through depletion of a PTEN-like 
phosphatase, PTPMT1 which is located on the inner membrane of mitochondria, 
and was found to completely block HSC differentiation. The decrease in 
differentiation observed was not due to loss of the HSC compartment, but to the 
inability of Ptpmt1-deficient HSCs to undergo differentiation-associated divisions 
both in vitro and in vivo, leading to rapid haematopoietic failure in a mouse model 
(Yu et al., 2013).  
However, the hypoxic state of HSCs has been demonstrated to be not entirely due 
to a hypoxic niche, but also regulated through cell-autonomous mechanisms. one 
recent study demonstrated that HSC hypoxic status is independent of location 
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within the BM cavity (Nombela-Arrieta et al., 2013). Here they demonstrated that 
HIF1a was stably expressed, and hypoxic probe pimonidazole was stably 
incorporated in HSCs isolated from throughout distinct BM regions, and this profile 
was retained in human circulating HSCs. Indicating the hypoxic phenotype of HSCs 
is cell-specific rather than location dependent. The importance of HIF1a stability 
in HSCs is further demonstrated by non-cell-autonomous niche 
microenvironmental factors able to drive its stabilisation. Both SCF (Pedersen et 
al., 2008) and TPO (Kirito et al., 2005) have been shown to drive HIF1a 
stabilisation and hypoxic response profile in HSCs cultured in normoxia. In 
addition, MSPCs exhibiting elevated HIFs and a hypoxic profile have been shown 
to inhibit HSC expansion and differentiation in vitro (Guarnerio et al., 2014).  
Collectively, this landmark series of studies implicate the importance in tight 
regulation of HIF1a levels in HSCs, and how this supports a metabolic phenotype 
that is required for self-renewing HSCs and functional haematopoiesis. HIF1a 
drives expression of key genes that allow adaption to hypoxia through utilisation 
of anaerobic glycolysis, and by preventing entry into OXPHOS. However, this 
program may rapidly switch to utilise mitochondrial OXPHOS to facilitate the 
increased energy demands associated with differentiation. Current in vitro culture 
of HSCs is limited by loss of self-renewing ability after only a few days, highlighting 
the importance of signals provided by the native niche. Studies such as these 
explain the importance of building culture systems that more accurately mimic 
stem cell native microenvironments to successfully expand populations in vitro.  
5.1.4 Investigating cellular metabolism with metabolomics 
Measurable shifts in energy demand and metabolic activities occur as cells respond 
to their physical and chemical microenvironment. Metabolites are small molecules 
that are transformed during these metabolic processes, as such, they can provide 
a functional readout of cellular biochemistry. Genes and protein functions are 
subject to epigenetic regulation and post-translational modifications, whereas 
metabolites serve as direct signatures of biochemical activity, offering 
mechanistic insights for understanding, and interrogating, how cellular 
biochemistry correlates to phenotype (Patti et al., 2012). Progression in mass 
spectrometry (MS) technologies now offers tools for global metabolite profiling, 
known as untargeted metabolomics. This can be performed using either nuclear 
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magnetic resonance (NMR), or liquid chromatography followed by mass 
spectrometry (LC/MS) which has become the technique of choice for global 
profiling. LC/MS provides higher sensitivity and enables the detection of thousands 
of peaks measured from minimal amount of biological material, requiring minimal 
sample preparation (for example, <25 mg of tissue, several thousands of cells, or 
~50 µL of biofluids) (Buscher et al., 2009; Jonsson et al., 2005; Patti et al., 2012).  
MS distinguishes metabolites based on the mass-to-charge ratios (m/z) of the 
intact metabolite and their fragmentation patterns. Coupling this with 
chromatography provides an additional dimension of identification, whereby 
metabolites can be differentiated by their retention times. LC/MS has been widely 
used in metabolite profiling studies of human urine, or other biofluids, for 
biomarker discovery. Metabolic signatures have been assigned that correlate with 
insulin resistance (Newgard et al., 2009), increased risk of cardiovascular disease 
(Shah et al., 2012) and non-alcoholic fatty liver disease (Luukkonen et al., 2016).  
There has also been recent focus on global profiling of stem cells permitting 
systems-level analysis to uncover biochemical effectors of cellular behaviours. For 
example, metabolic profiling was carried out on pericytes and MSCs as 
differentiation was directed down distinct lineages, or their stemness maintained 
(Alakpa et al., 2017a, 2016; McMurray et al., 2011; Tsimbouri et al., 2012). By 
using material-based platforms to direct cellular behaviour, such as gels ranging 
in stiffness, or nanotopographies to direct self-renewal or osteogenesis, rather 
than biochemical components (such as GFs or defined medias) our group has 
identified metabolites involved in these processes. By feeding these bioactive 
molecules into stem cell cultures, differentiation could be induced (Alakpa et al., 
2016). This approach highlights critical biochemical pathways for investigation, 
and a method for identifying individual metabolites of therapeutic significance 
using reproducible biomaterial strategies.  
5.1.5 Objectives and aims 
Metabolic adaption is a requirement of stem cells in their niches. We aimed to 
investigate if we could mimic aspects of this metabolic phenotype in our BM model 
systems using low-stiffness gels. The aims of this chapter were to investigate 
cellular metabolism as such: 
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• Investigate changes in HIF1a levels and activation in hypoxia and with low-
stiffness gel addition.  
• Assess the effects on downstream targets of HIF1a, such as glycolytic 
enzymes and GFs.  
• Use metabolomics to identify differences/similarities between the niche 
model systems at the biochemical pathway level.  
5.2 Materials and Methods 
5.2.1 HIF1a co-localisation analysis 
To assess levels of active HIF1a in cell nuclei, cultures of 3 days were initiated 
(gel added after 24h), then fixed and stained with rabbit anti-HIF1a followed by 
secondary anti-rabbit fluorescent probes, nuclei stained with DAPI and samples 
mounted and visualised on a fluorescent microscope (Chapter 2.3.5). The images 
captured were uploaded to CellProfiler software (version 2.1.1), using a custom 
developed pipeline. Using the DAPI image, a mask was drawn around the nucleus, 
then imposed onto the corresponding raw HIF1a image and the integrated 
intensity measured, demonstrated in Figure 5-4. The value for each nucleus 
measured was then plotted as an individual point and subject to statistical analysis 
using GraphPad Prism 6 software.  
 
Figure 5-4 HIF1a analysis using CellProfiler script. The DAPI image was used to create a 
mask, which was overlaid to the HIF1a image and integrated intensity of this area measured. 
This ensures activated HIF1a that was co-localised with the nucleus was measured. Images 
from PEA FN BMP-2 Hypoxia. Scale bar is 20 µm. 
5.2.2 HypoxyprobeÔ  
After 6 days culture in the model, medium was changed to a fresh medium 
containing 200 µM pimonidazole (Chen et al., 2010; Genetos et al., 2010; Raheja 
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et al., 2008), and cultured for a further 24 h. Cells were then fixed, blocked and 
stained with mouse anti-pimonidazole as in Chapter 2.3.4. Secondary Texas Red 
anti-mouse was added, and samples visualised on the fluorescent microscope. 
Integrated intensity was measured using imageJ software and subject to statistical 
analysis using GraphPad Prism 6 software. 
5.2.3 Metabolomics analysis 
Whole cell metabolomic analysis was performed on cell lysates isolated from 
pericytes cultured in niche systems for 7 or 14 days. Substrates were washed with 
ice-cold PBS, and cells lysed in extraction buffer (PBS/methanol/chloroform at 
1:3:1 ratio) for 60 mins at 4°C with constant agitation. Lysates were then 
transferred to cold Eppendorfs and spun at 13000 g at 4°C for 5 mins to remove 
debris, and stored at -80°C. Cleared extracts were used for hydrophilic interaction 
LC/MS analysis (UltiMate 3000 RSLC, (ThermoFisher), with a 6 150 x 4.6 mm ZIC-
pHILIC column running at 300 µl/min-1 and Orbitrap Exactive). A standard 
pipeline, consisting of XCMS (peak picking), MzMatch (filtering and grouping) and 
IDEOM (further filtering, post-processing and identification) was used to process 
the raw mass spectrometry data. Identified core metabolites were validated 
against a panel of unambiguous standards by mass and predicted retention time. 
Further putative identifications were generated by mass and predicted retention 
times. Heatmaps of selected metabolites and principle component analysis (PCA) 
plots were generated using MetaboAnalyst software (version 4.0). 
5.2.4 13C6-Glucose metabolomic tracing 
Pericytes were seeded onto PEA FN BMP-2 niche systems and allowed to grow for 
72 h. Cells were then washed and media was changed to basal media comprising 
25% normal glucose and 75% 13C6-Glucose (Cambridge Isotopes Ltd), for +gel 
conditions collagen gels were generated as in Chapter 2.3.1.3, where 0.5 mL 2% 
DMEM was substituted with 0.5 mL 13C6-Glucose containing 2% DMEM, hypoxic 
samples were added to hypoxic workstation. After 3 days incubation extractions 
were performed as in section 5.2.3 and LC-MS was performed. The LC-MS platform 
consisted of an Accela 600 HPLC system combined with an Exactive (Orbitrap) 
mass spectrometer (ThermoFisher). Two complementary columns were used; the 
zwitterionic ZICpHILLIC column (150 mm x 4.6 mm; 3.5 µm, Merck) and the 
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reversed phase ACE C18-AR column (150 mm x 4.6 mm; 3.5 µm Hichrom) and in 
both cases sample volume was 10 µl at a flow rate of 0.3 ml/min. Eluted samples 
were then analysed by mass spectrometry. Raw data from LC-MS of 13C-labelled 
extracts was processed to generate a combined PeakML file (Westrop et al., 2017). 
Further analysis using mzMatch-ISO in R (Chokkathukalam et al., 2013) generated 
a PDF file containing chromatograms used to check peak-shape and retention 
time, and a tabdelineated file detailing peak height for each isopotologue, which 
was used to calculate percentage labelling. Cell number measurements were 
taken by ICW CellTag700 staining of duplicate samples and used to standardise 
samples. Total 13C6-Glucose incorporation was calculated by totalling 
incorporation excluding up to C2 to eliminate natural incorporation.  
5.3 Results 
5.3.1 Analysis of HIF1α levels and its downstream targets 
Using RNA-seq, a list of genes involved in hypoxic adaption was generated (Figure 
5-5). This list includes regulators of hypoxic response HIFs (HIF1a and HIF3a), and 
downstream targets such as growth factors (VEGFA, VEGFB), and glycolytic or 
mitochondrial OXPHOS enzymes (PDK1, PTPMT1, PDK2, PDK3, PDK4). An increase 
in HIF1a expression was observed in all polymer +gel conditions compared to 
polymers or glass -gel or +hypoxia, whereas HIF3a appeared to increase in hypoxia 
and in PEA FN +gel and PEA FN BMP-2 +gel specifically.  
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Figure 5-5 RNA-Seq profiling of pericyte transcripts relating to hypoxic adaption after 7 days. 
Results are shown as fold change to glass control. The hypoxic systems show up regulation 
of most genes, except HIF1A which is increased in +gel conditions only. Genes are clustered 
by average linkage. N = 2 for PEA FN BMP-2 hypoxia, n = 3 for all other conditions. 
To confirm this effect of HIF1a, immunofluorescence microscopy was carried out. 
As HIF1a is constitutively produced and degraded in the cytoplasm, only active 
levels were measured, that is, HIF1a protein co-localised with the nucleus (Figure 
5-4). Measurements of the integrated intensity of a masked area corresponding to 
the nucleus were compared (Figure 5-6). For the protein level analysis glass +gel 
condition was included. The increase in HIF1a observed with gel addition in Figure 
5-5 was corroborated in PEA FN BMP-2 +gel at the protein level (Figure 5-6). 
Although a similar trend was observed with PMA FN BMP-2 +gel, it was not 
significant. To confirm this effect, the same experiment was carried out using 
Stro1+ MSCs, where a significant increase in HIF1a with gel addition was observed 
(Appendix Figure 7-2). These results suggest the addition of the low-stiffness gel 
increases stimulation, or accumulation, of active HIF1a to levels higher than those 
required for steady state or chronic hypoxia. Figure 5-6B shows representative 
images for each PEA FN BMP-2 condition, where increased HIF1a localised to the 
nucleus in gel conditions.   
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Figure 5-6 Nuclear HIF1a levels increase with low-stiffness gels. HIF1a is active when 
localised to the nucleus. Immunofluorescence analysis was carried out after 3 days, and the 
integrated intensity of HIF1a in cell nuclei measured. A. Shows increased HIF1a levels were 
observed on PEA FN BMP-2 substrates, and that addition of a low-stiffness gel increases 
HIF1a levels in glass and PEA FN BMP-2. B. Representative images of HIF1a, red = HIF1a, 
white = nuclear outline. Scale is 20 µm. Graph shows mean integrated intensity of nuclear 
HIF1a ± SD (n=3), each point represents 1 nuclei. One-way ANOVA followed by Kruskal-Wallis 
test with multiple comparisons, n.s. = non-significant, *= p<0.05, **= p<0.01, ***= p<0.001, ****= 
p<0.0001. 
To further investigate the observed increase in HIF1a levels, analysis of 
downstream targets was carried out. Lactate dehydrogenase (LDH) is a glycolytic 
enzyme catalysing the conversation of pyruvate to lactate. LDH levels were 
investigated using ICW. A significant increase of LDH levels was observed in the 
PEA FN BMP-2 hypoxia condition compared to glass and glass +sol. BMP-2, with a 
trend towards increasing levels in glass hypoxia, although this was not significant 
(Figure 5-7A). This was consistent with the increase observed in LDHA expression 
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in the RNA-seq analysis in Figure 5-5. Glass +gel was excluded from analysis as 
cells migrated into the gel, making techniques such as ICW unreliable. 
 
Figure 5-7 Analysis of HIF1a downstream targets LDH and VEGF.  A. LDH levels assessed 
after 7 days culture by in cell western analysis (n=4) . B. Cell supernatant was collected at day 
7 and 14 and VEGF levels assessed using ELISA (n=3). Data reported as means ± SD. One-
way ANOVA followed by Kruskal-Wallis test with multiple comparisons, *p<0.05, **p<0.001, 
****p<0.0001. Data suggests both LDH and VEGF are increased in hypoxia, but no significant 
changes are observed in the -/+gel conditions.  
A further downstream HIF1a target is VEGF, to assess changes in levels an ELISA 
was carried out on cell supernatant collected at both 7 and 14 days (Figure 5-7B). 
As expected, a significant increase in VEGF was observed in PEA FN BMP-2 hypoxia, 
where VEGF levels were increased ~30-fold compared to PEA FN BMP-2 –gel. VEGF 
levels in –gel, +gel and glass conditions were comparably low, ranging from ~5 – 
26 ng/mL.  
5.3.2 Hypoxia gradient analysis  
To distinguish whether the increasing HIF1a levels observed in the conditions with 
low-stiffness gels was due to a potential oxygen gradient at the interface, 
Hypoxyprobeä was used. Hypoxyprobeä (pimonidazole hydrochloride) indirectly 
measures cellular hypoxia, by forming thiol adducts with proteins. The probe can 
only bind at pO2 < 10 mmHg (1.4% oxygen), these adducts can then be detected 
using an anti-pimonidazole antibody (Genetos et al., 2010).  
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Figure 5-8 Hypoxia gradient analysis. Hypoxyprobeä forms antibody-detectable adducts in 
cellular proteins at 1.4% oxygen, positive detection was observed only in hypoxia, not with 
low-stiffness gel addition (+Gel). Red is Hypoxyprobeä, blue is DAPI, scale bar is 100 µm. 
Integrated intensity of Hypoxyprobeä for immunofluorescence images shown on graph, bar 
is mean ±SD, each point represents 1ximage field/number nuclei, n=4. **** p< 0.0001, n.s. = 
non-significant; by one-way ANOVA followed by Kruskal-Wallis test with multiple 
comparisons.  
Immunofluorescence analysis revealed positive staining in the conditions in 
hypoxia (PEA FN BMP-2 and glass, p<0.0001), with no positive detection of the 
probe in PEA FN BMP-2 or glass +/- gels (Figure 5-8). Indicating the polymer/gel 
interface does not generate a local hypoxia gradient.  
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5.3.3 Analysis of the cell metabolome in response to material 
mechanics and hypoxia 
To gain further insight into the effects of the HIF1a regulation exhibited in the 
different niche models, analysis of the entire cell metabolome was carried out by 
LC-MS. The abundance of each metabolite detected (peak intensities) was then 
subject to PCA (Figure 5-9). In Figure 5-9, differences in the entire metabolome 
for each condition (n = 3 or 4, where one replicate of PEA FN BMP-2 +gel 7d was 
excluded from analysis due to inconsistent ion chromatograms) are represented in 
a two-dimensional space composed of the principle component (PC) vectors PC1 
and PC2. Figure 5-9A represents analysis at 7 days, and Figure 5-9B at 14 days, in 
which PC1 represents 40.7% and 20.5%, and PC2 represents 15.1% and 17.8% of the 
observed variance between conditions, respectively. The projection of substrate 
conditions onto PC1 and PC2 separates their metabolic signatures into distinct 
clusters. Clustering at both time points is relatively similar, with conditions with 
low-stiffness gels (+gel) forming a distinctly similar clustering pattern, regardless 
of underlying polymer or presence of GFs. Whereas, the glass, glass +sol.BMP-2 
and PEA FN BMP-2 conditions -/+ hypoxia show similar clustering in PC1, but can 
be distinguished in PC2 at both time points. +gel conditions are distinct at both 
time points in PC1, but in PC2 they cluster at the intersection between the -/+ 
hypoxia conditions, suggesting metabolic properties that are both distinct to the 
presence of the gel, but also share some similarities with both normoxic and 
hypoxic signatures.  
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Figure 5-9 Principle component analysis (PCA) of entire metabolome in all niche systems. 
Pericytes were cultured in niche systems for 7 and 14 days, and all detectable metabolites 
were subject to PCA. Each point represented 1 replicate (n=4 or 3 where 1 failed sample was 
removed), ellipses represent the spatial borders associated with each condition with a 95% 
confidence interval. Data shows similar clustering at both time points, with all +gel conditions 
clustering, and hypoxia and -gel clustering closely in PC1.  
To better consider these effects, PEA FN BMP-2 -/+gel/hypoxia conditions were 
subject to PCA. Analysis of the entire cell metabolome at each time point, this 
time including a third PC (PC3), presented a similar trend. Where +gel conditions 
exhibited more similarities to hypoxic counterparts in PC1 and PC3, and to –gel in 
PC2 (Figure 5-10A).  
The identified metabolites were then filtered based on pathway. As HIF1a 
primarily regulates adaption to anaerobic respiration, metabolites involved in 
glycolysis and OXPHOS were analysed. Figure 5-10B shows the PCA of these filtered 
results, where +gel clustering appears more similar to hypoxia in PC1 (50.3%), and 
intermediate of hypoxia/normoxia in PC2 (26.7%) and PC3 (10.8%). 
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Figure 5-10 PCA of PEA FN BMP-2 conditions. Pericytes were cultured in PEA FN BMP-2 -
gel/+gel/hypoxia niche systems for 7 and 14 days. A. All detectable metabolites and B. 
identified metabolites involved in energy metabolism were subject to PCA. Each point 
represented 1 replicate (n=4 or 3 where 1 failed sample was removed). Both plots show 
distinct clustering based on system and time point, PC1 separates both time points, whereas 
PC2 separates system condition. In both A and B, hypoxia and +gel show similar clustering 
in PC1.  
To observe what these similarities/differences in energy metabolism were at the 
pathway level, a heatmap of individual metabolite abundance was generated from 
the filtered list. In Figure 5-11 assessment of individual metabolite abundance 
revealed an increase in metabolites associated with glycolysis in hypoxic samples, 
and an increase in the TCA cycle metabolites in–gel conditions. The PEA FN BMP-
2 +gel conditions showed a similarly low regulation of glycolytic metabolites to –
gel, however there was also down regulation of TCA cycle metabolites - similar to 
the regulatory pattern observed in hypoxia. This suggests that the addition of the 
low-stiffness gel promotes a degree of glycolytic adaption, where glycolysis is not 
up regulated, but the TCA cycle appears to be down regulated. 
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Figure 5-11 Glycolytic and TCA cycle metabolite profile in PEA FN BMP-2 -gel/+gel/hypoxia. 
Heatmap shows group averages of log transformed peak intensities of each replicate at 7 and 
14 days. Hypoxia related metabolites show increased abundance (red) in PEA FN BMP-2 
hypoxia 7 and 14 days, whereas TCA cycle metabolites are increased in PEA FN BMP-2 -gel 
7 and 14 days. PEA FN BMP-2 +gel conditions show no increase in hypoxia, but similar down 
regulation of TCA cycle associated metabolites as for hypoxic samples. N =3 for +gel 7 d, n=4 
for all other samples. Clustered through average linkage. 
5.3.4 Flux of heavy glucose in glycolysis 
To further investigate changes in cellular metabolism in pericytes in response to 
different niche systems, we used MS to follow the conversion of 13C-labelled 
glucose. To investigate differences between the effects of gels and hypoxia we 
assessed only PEA FN BMP-2 -gel/+gel/hypoxia samples. Cells were cultured in 
standard 2% DMEM for 3 days followed by 3 days incubation with 13C-glucose 
containing media. As illustrated in Figure 5-12 pericytes cultured in hypoxia and 
+gel significantly increased glucose uptake compared to -gel. As expected, 
hypoxia then led to significant increases in lactate and pyruvate production to -
gel, although, interestingly a similar trend was not observed in +gel for these 
downstream metabolites. This is interesting and indicates that while there is 
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increased glucose uptake, it agrees with trends in Figure 5-11 where glycolysis 
does not appear to be enhanced but, importantly, neither does TCA (no TCA 
intermediates were labelled). It is tempting to suggest that respiration is just 
slowed as cells become more quiescent, and in slowing, the cells accumulate more 
glucose but don’t use it.  
 
Figure 5-12 13C6-Glucose metabolomic tracing. Pericytes were seeded for 7 days in PEA FN 
BMP-2 niche systems in the presence of 13C6-glucose for 72h. LC-MS was then used to 
measure the conversion and abundance of 13C6-labelled metabolites in the glycolysis 
pathway. Graphs show a fold change relative to 13C6-labelled metabolites in pericytes cultured 
in the PEA FN BMP-gel system. Graphs show means ± SD, n=4. One-way ANOVA followed by 
Kruskal-Wallis test with multiple comparisons to -gel control, *p< 0.05, **p<0.001.  
5.4 Discussion 
The aim of this chapter was to investigate whether the maintenance of pericyte 
phenotype by low-stiffness gels was due to similarities in metabolic programmes 
utilised in hypoxia. The in vivo BM niche exhibits low oxygen tensions, to which 
stromal and haematopoietic stem cells adapt through a specific response primarily 
controlled by HIFs.  
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5.4.1 HIF1a increases with gel addition 
Hypoxia is known to affect MSPC self-renewal capacity. Basal HIF1a levels are 
upregulated in MSCs in normoxia compared to established tissue-specific cell lines 
(Palomäki et al., 2013). However, this effect will dissipate with long term culture 
as self-renewal capacity is lost in standard normoxic cell culture conditions (~20% 
O2). 
In the BM niche, hypoxia is thought to maintain enhanced glycolysis in MSPCs and 
HSCs via HIF1a (Ejtehadifar et al., 2015; Mohyeldin et al., 2010). HIF1a promotes 
the expression of glycolytic enzymes such as pyruvate dehydrogenase kinase 
(PDK1, 2 and 4), which prevents pyruvate from entering the TCA cycle and thereby 
inhibiting OXPHOS (Weidemann and Johnson, 2008). In Figure 5-5 we show that 
HIF1a transcript levels are increased at 7 days in all PEA/PMA conditions that are 
cultured with low-stiffness gels, this suggests the soft environment supports the 
stem cell-like phenotype characterised by stabilisation of the protein. 
Interestingly, in conditions cultured in hypoxia HIF1a expression was observed to 
be down regulated, however PDK1 was increased in hypoxia and small increases 
were observed in PEA/PMA +gel conditions, but not -gel.  
During periods of prolonged exposure to hypoxia, transient HIF1a activation has 
been observed (Forristal et al., 2010); HIF1a activates an auto-negative feedback 
loop to avert over accumulation, in which PHD2 and 3 expression is induced by 
HIF1a, leading to stabilisation of its levels (Marxsen et al., 2004), and PHD2 
(EGLN1) transcript levels were observed to be increased in Figure 5-5. Factor 
inhibiting HIF (FIH, HIFA1N) is a further factor regulating HIF1a post-
translationally, however no changes in transcript levels were observed (Figure 
5-5). HIF1a is also subject to other post-translational modifications, such as 
oxygen independent pathways, as such, transcript level analysis of HIF1a can often 
be an unreliable marker for assessing its activity (Dengler et al., 2014). 
Consequently, we then investigated HIF1a protein levels in Figure 5-6, where a 
similar trend was observed to the RNA-seq data. A significant increase in active 
HIF1a in the conditions with a gel was observed. We confirmed this effect is non-
pericyte specific, as the same trend was observed in MSCs (Appendix Figure 7-2). 
Chapter 5 Hypoxia and Metabolism  133 
Hypoxyprobeä staining revealed this effect is not due to an oxygen gradient 
presented at the gel/material interface (Figure 5-8), suggesting this response 
could be related to matrix mechanics sensing, where soft-ECM leads to increased 
stem cell niche-like HIF1a activation.  
Analysis of downstream targets such as HIF1a-controlled VEGF production and 
glycolytic enzyme LDH levels showed up-regulation at both transcript (Figure 5-5) 
and protein levels only in hypoxia (Figure 5-7). LDH mRNA expression was 
increased in PEA FN BMP-2 hypoxia and glass hypoxia conditions, though at the 
protein level this trend was only significant in PEA FN BMP-2 hypoxia to glass and 
glass +sol.BMP-2 (p<0.005, p<0.05) (Figure 5-7). This could be due to a low level 
of maintenance of stem cell metabolic phenotype in the other conditions at 7 days 
and hence maintenance of increased LDH protein, as regardless of the substrate 
there was a slight trend towards higher levels in conditions with gels. However, in 
the future, a more suitable method to investigate this would be an LDH enzyme 
activity assay, rather than gene or protein level analysis, as protein levels may 
remain similar whilst enzyme activity regulated or increased.  
That HIF1a mRNA and protein levels are not elevated in hypoxia, but the response 
programme it initiates is still active (Figure 5-7 and Figure 5-11). This suggests its 
regulation in response to prolonged/chronic hypoxia. As illustrated in both 
untargeted and targeted metabolomic analysis, the up regulation of metabolites 
involved in the glycolytic pathway, such as lactate and pyruvate, in the hypoxic 
conditions also confirms the hypoxic anaerobic glycolysis response was active 
(Figure 5-11 and Figure 5-12). It is likely no significant increase in active HIF1a 
levels were observed at the protein level in hypoxia due to this negative feedback 
loop leading to HIF1a-levels cycling.  
The elevated HIF1a phenotype is important for stem cell maintenance as it drives 
the glycolytic metabolic profile associated with self-renewing stem cells in the BM 
niche. In MSCs, HIF1a translocation to the nucleus is mediated by a motor adaptor 
protein, Bicaudal D homolog 1 (BICD1). BICD1 interaction with HIF1a is regulated 
through the Akt/GSK3b pathway, in which hypoxia-inactivation of GSK3b is 
induced by Akt, resulting in increased interaction between BICD1 and HIF1a 
(Beitner-Johnson et al., 2001; Deguchi et al., 2009; Lee et al., 2018). 
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Interestingly, Akt activation has been linked to increased nestin expression in 
several types of cancer stem cells (Z. Chen et al., 2014; Hambardzumyan et al., 
2008; Matsuda et al., 2017), taken together with results from Chapter 4 this 
pathway could be investigated as a potential mechanism for supporting this niche-
like metabolic phenotype with low-stiffness gels. 
5.4.2 Gel addition down regulates TCA cycle 
Our group has previously studied the effects of physical microenvironment 
properties, such as matrix stiffness and nanotopography, on cellular metabolism 
(Alakpa et al., 2017a, 2016; Tsimbouri et al., 2012). In these studies it was shown 
that pericytes grown on top of gels of varying stiffness showed distinct metabolic 
signatures, with high percentages of variance observed in carbohydrate, amino 
acid and lipid metabolism pathways (Alakpa, 2014). Similarly, here the global 
analysis of the cellular metabolome for all conditions revealed distinct clustering 
patterns, with most apparent differences observed between the presence of low-
stiffness gels or hypoxia, rather than the chemistry of the underlying substrate 
(PEA/PMA/glass) or availability of GFs (Figure 5-9), suggesting the significance of 
the mechanical environment.  
To assess if the HIF1a regulation we observed with the addition of gels was 
promoting a hypoxic-like metabolic profile, a list of metabolites involved in 
glycolysis and the TCA cycle was generated. PCA presented a similar pattern of 
clustering for this metabolic pathway as had been observed in PCA of the entire 
metabolome, with +gel clustering midway of hypoxia and –gel conditions (Figure 
5-10B). Here we chose to focus analysis on only PEA FN BMP-2 -gel/+gel/hypoxia 
samples, in order to direct the comparison of hypoxic and low-stiffness 
environments. Analysis of individual metabolite abundance illustrated where 
similarities in metabolism lay. Figure 5-11 highlights the pericytes in +gel 
conditions do not appear to up regulate glycolysis but instead suggests repression 
of mitochondrial OXPHOS in a way that is similar to those in hypoxic conditions. 
This metabolic signature closely resembles the Warburg effect. First identified in 
cancer cells, it describes a method of energy production in which glycolysis is 
induced and mitochondrial OXPHOS repressed in normoxic conditions (Warburg, 
1925), often referred to as oxidative glycolysis. It is suggested this enables more 
efficient conversion of glucose into biomass rather than ATP, supporting the 
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characteristic rapid proliferation of cancer cells. This shift is perhaps 
counterintuitive in fast-growing cancer cells, as oxidative glycolysis is less 
efficient than OXPHOS in terms of ATP production (the main source of cellular 
energy), however, this is predominantly problematic when glucose is deficient, 
whereas in the body or cell culture, glucose is in ready supply (Vander Heiden et 
al., 2009). It is thought that the Warburg effect is exhibited in MSPCs, and other 
stem cells, in order to preserve the beneficial effects of a predominantly 
glycolytic metabolic programme on maintenance of stem cell phenotypes (Ross et 
al., 2019).  
To investigate this in more detail, we carried out heavy labelled glucose tracing. 
Interestingly, we found that the pericytes cultured in +gel conditions significantly 
increased their glucose uptake compared to -gel (Figure 5-12). However, this 
elevated consumption did not result in increased pyruvate and lactate production, 
as is characteristic of anaerobic glycolysis and as was predictably observed in the 
hypoxic samples. Increased glucose uptake is a hallmark of the hypoxic response, 
where the inhibition of OXPHOS results from hypoxic exposure and leads to a 
stimulation of glucose transport (Zhang et al., 1999). Increased glucose uptake is 
primarily through stimulation of transcription of glucose transporters (Glut) Glut1, 
Glut3 and Glut 4, which is activated through i. HIF1a activation leading to 
enhanced transcription, and ii. enhanced Glut transcription secondary to 
inhibition of OXPHOS (Zhang et al., 1999). Our RNA-Seq data suggested increased 
transcript levels of Glut1 (SLC2A1) in hypoxic samples, whereas Glut 3 and 4 were 
elevated in +gel conditions (Figure 5-5). Glut1 is the only Glut that retains 
enhanced transcription in response to chronic hypoxia, whereas 3 and 4 are 
initially expressed upon OXPHOS inhibition. This would need to be confirmed in 
future work by qPCR analysis, however may be suggestive of a hypoxic response 
similar to early hypoxic exposure in the gel samples, whereas those cultured in 
prolonged hypoxia show a response signature to chronic hypoxic exposure.  
The heavy labelled glucose metabolomic analysis would have benefited from 
analysis of more glycolysis intermediates and TCA cycle intermediates; this would 
have provided deeper insight into the flux of glucose in the systems. However, 
these metabolites were unreliably detected, and hence future work would use 
more defined standards in LC-MS in order to better detect their abundance.  
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Overall, the metabolomic data presented the expected increased glycolytic 
response in the hypoxic niche system, -gel also presented expected increased 
OXPHOS more similar to the profile of actively differentiating cells. The +gel 
system appears to inhibit OXPHOS and increase glucose uptake, however we did 
not observe a similar increase in all glycolytic metabolites as observed for the 
hypoxic system. Hypoxic systems were exposed to chronic low pO2 which presents 
a defined metabolic phenotype, the inhibition of OXPHOS in +gel conditions is 
suggestive of an oxidative glycolytic phenotype which presents some overlap with 
the response to chronic hypoxia, but may be more similar to early hypoxic 
exposure.  
5.4.3 Summary 
Taken together, the data presented in this chapter highlights a system where low-
stiffness gels that maintain BM niche like MSPC phenotypes constitutively activate 
HIF1a, in a way that is dissimilar to exposure to chronic hypoxia (Figure 5-6). In 
response to hypoxia, elevation of glycolytic effectors, such as Glut1, is second to 
inhibition of OXPHOS, and our metabolomic data suggests pericytes cultured in 
+gel systems inhibit flux through the TCA cycle (Figure 5-11 and Figure 5-12). This 
could suggest a mechanism where the elevated levels of HIF1a in +gel niche 
systems are constitutively active in order to inhibit OXPHOS. This response is 
different to chronic hypoxic exposure, and may explain why hallmark downstream 
effectors, such as VEGF and LDH, are not elevated in the same way (Figure 5-7). 
Suggesting the +gel systems promote a ‘pseudo-hypoxia/hypoxia-like’ response in 
order to inhibit OXPHOS, which is beneficial for protecting self-renewing stem 
cells against DNA-damaging ROS produced as by-products from the TCA cycle. Or 
indeed, the pericytes in this system may be in a more quiescent state, and hence 
they do not need to meet the high energy demand produced via OXPHOS. To 
investigate this further a cell proliferation experiment should be carried out.  
Further to this, to investigate in more detail how this pseudo-hypoxia is regulated 
at the pathway level, functional assays would be useful to distinguish activity 
levels of certain glycolytic and OXPHOS enzymes, as this will give a more accurate 
overview of metabolic activity than transcript or protein level analysis of the 
enzymes. Also of interest for future work would be investigation of the protein 
level and potential activity of the HIF3a subunit, as increased transcript levels 
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were observed in hypoxia and PEA +gel conditions (Figure 5-5). HIF3a has been 
shown to directly regulate HIF1a activity in ESCs, yet other studies have shown 
differing cell-type specific responses. Currently little evidence exists of the role 
of HIF3a in MSPCs, or the stem cell niche.  
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6.1 Introduction 
HSCs are the best-characterised population of ASCs, where individual stages of 
lineage commitment and differentiation have been characterised by surface 
marker expression (Seita and Weissman, 2010), illustrated in Figure 6-1. Their 
differentiation potential is hierarchal in structure, where lineage commitment 
leads to progressive loss of multipotency (Figure 1-6 and Figure 6-1) (Chao et al., 
2008). The mammalian blood system contains more than 10 distinct mature cell 
types all derived from a common progenitor cell i.e. HSCs; including red blood 
cells (erythrocyte), megakaryocytes/platelets, myeloid cells 
(monocyte/macrophage and granulocytes), mast cells, T- and B-lymphocytes, 
natural killer (NK) cells and dendritic cells (Eaves, 2015; Zhang et al., 2018). 
However, despite the term self-renewal being prevalent in HSC literature, this 
process remains to be fully defined on a molecular level (Zon, 2008).  
6.1.1 The HSC phenotype  
HSCs were originally isolated from mice in 1988 by FACS using combinations of 
monoclonal antibodies to cell surface markers (Spangrude et al., 1988). Since 
then, a wealth of knowledge has formed through the use of functional readout 
assays and investigations of multiple combinations of cell surface markers, leading 
to the development of a well-characterised HSC hierarchy in humans (Figure 6-1) 
(Chao et al., 2008; Notta et al., 2011).  
The first positive marker used to identify human HSCs was CD34, which is also 
expressed in non-haematopoietic endothelial cells (Krause et al., 1996). CD34+ 
cells constitute 0.5 – 5% of the total bone marrow and are the only cells to possess 
in vitro self-renewal capacity (Murray et al., 1995). However, the CD34+ cell 
population is itself heterogeneous, with 90 - 99% co-expressing CD38; these 
CD34+CD38+ cells are able to generate myeloid and lymphoid progeny but have 
lost clonogenic capacity (Hao et al., 1995). Whereas, CD34+CD38- cells show long-
term repopulating potential and this phenotype has been employed routinely for 
several decades to identify HSC populations (Chao et al., 2008). Loss of CD34 
expression is associated with uni-lineage differentiation (Civin et al., 1984; 
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DiGiusto et al., 1994). As the field has developed, further markers have been 
elucidated to characterise the different stages of haematopoiesis, the most 
common marker panels used to differentiate between HSCs and progenitor cells 
are shown in Figure 6-1.  
 
Figure 6-1 Surface markers associated with human haematopoietic stem cell (HSC) 
differentiation into lineage progenitors.  Self-renewing HSCs differentiate producing 
multipotent progenitors (MPP), that will further commit to common myeloid progenitors 
(CMP) and common lymphoid progenitors (CLP) (Chao et al., 2008; Notta et al., 2011). This 
figure was created using Servier Medical Art, licensed under a Creative Commons Attribution 
3.0 Generic License 
It should be noted that although murine haematopoiesis reflects human 
haematopoiesis in many ways, the immunophenotypic markers of human HSCs 
(CD34+ CD38-) differ from functionally similar mouse counterparts (Larochelle et 
al., 2011). Mouse HSCs use a different set of markers to define HSC subsets. They 
use Lineage- (Lin-), Sca-1+ and c-Kit+ to identify the naïve HSC heterogenous 
population, followed by a combination of signalling lymphocyte activation 
molecule (SLAM) family receptors (CD150+ CD244– CD48–) markers to define the 
subsets, which have previously been associated with lymphocyte activation and 
proliferation (Kiel et al., 2005; Yilmaz et al., 2006). Whereas for human HSCs SLAM 
markers alone can be used to identify HSCs (Mikkola and Orkin, 2006).  
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6.1.2 HSC ex vivo culture 
As discussed in Chapter 1.3.3.1 HSCs have been employed clinically for over 50 
years (Aljurf et al., 2019). HSCTs are the gold standard treatment for many 
haematological disorders and have shown further promise in clinical trials for the 
treatment of autoimmune diseases (Radaelli et al., 2014). The multilineage 
differentiation capacity and ability to repopulate the entire blood system in 
recipients means the clinical relevance of these cells is enormous. Although, 
whilst HSCTs are currently routinely used for therapy the demand for donor HSCTs 
cannot currently be met. HSCTs require hosts to be heavily immunosuppressed, 
donor cells have to be closely immunologically matched to prevent graft-versus-
host disease (Park and Seo, 2012) and the relative inability to expand naïve 
pluripotent HSCs in the laboratory (Kumar et al., 2017) means their true clinical 
potential remains to be fully realised.  
HSCTs are life-saving, however insufficient numbers of HSCs in the graft is a 
common problem, leading to graft failure (Brunstein et al., 2010). This is a critical 
problem for both autologous and matched allogeneic HSCTs. Some clinical studies 
have attempted to increase success rates using grafts from multiple donors and 
have shown that even a 2- to 3-fold expansion would have great clinical impact 
(Boitano et al., 2010; Brunstein et al., 2010). As such, research has focussed on 
methods of ex vivo expansion of HSCs for clinical use, which itself has proved 
difficult. For ex vivo expansion, symmetric cell division is required, thus avoiding 
robust proliferation which ultimately leads to differentiation and apoptosis 
(Morrison and Kimble, 2006).  
HSCs lose their self-renewal capacity when they are removed from their native 
niche (Jones and Wagers, 2008; Morrison and Scadden, 2014; Pinho and Frenette, 
2019). The current gold standard culture conditions for HSC expansion use 
complex media formulations, the most common being serum-free supplemented 
with TPO, SCF, Flt3 ligand, G-CSF and IL-6 (interleukin-6) (Kumar and Geiger, 
2017). This media is expensive and ineffective for long term maintenance; 
typically only leading to 2- to 4-fold expansions before differentiation and 
exhaustion of the stem cell pool, meaning inability to increase cell yield to 
clinically relevant levels (Patterson and Pelus, 2018). Thus, efforts have focussed 
on HSC expansion using other strategies such as genetic manipulation (Wang and 
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Rivière, 2017), small molecules (Zon, 2008) and to recapitulate aspects of the 
native niche using material engineering (Bello et al., 2018; Lee-Thedieck and 
Spatz, 2012). Methods such as these aim to produce clinically relevant yields of 
HSCs, and also allow investigation into functional mechanisms involved in 
important niche cellular processes.  
6.1.3 Aims and objectives 
The aim of this chapter is to investigate the potential of the developed BM niche 
systems for HSCs regulation. Analysis of surface marker expression using flow 
cytometry will be used to assess the ability of each model to support the HSC 
population, in terms of maintenance, expansion and differentiation.  
Pericytes were seeded into the models and cultured for 14 days to allow robust 
response to the model components, or ‘priming’ time. At day 14, HSCs were added 
in three different media formulations; 100 % – full concentration of cytokines, 
considered gold standard HSC culture conditions, 10% – 10x dilution of cytokines 
and 0% – culture media containing no cytokines (detailed in Table 6-1). For the 
+gel conditions HSCs were seeded on top of the gel. After 5 days of co-culture the 
HSCs are removed for analysis by flow cytometry.  
Then, to examine the impact of the different niche systems ability to maintain 
the long-term repopulating progenitors and potential impact on direct lineage 
specification, HSCs were sorted into long term culture initiating cell (LTC-IC) 
assays for 6 weeks (Liu et al., 2013), harvested and plated into colony-forming 
unit (CFU) assays for 5 days and resulting colonies counted. A schematic of the 
cell culture timeline is shown in Figure 6-2.  
The LTC system assesses the ability of CD34+ cells capacity to initiate and sustain 
proliferation for long periods in vitro as a surrogate definition of self-renewing 
long-term repopulating cells (Sutherland et al., 1990). The assay provides the 
appropriate feeder layer, medium, supplements and culture conditions to support 
this. Already committed progenitors in the test sample will proliferate and die out 
due to clonal expansion. The resulting cells capable of long-term culture share 
functional and phenotypic properties with in vivo LT-HSCs, and are referred to as 
LTC-ICs. LTC-ICs are then added to methylcellulose semi-solid culture media to 
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assess their differentiation potential using a colony forming assay. This media 
contains all the necessary factors to allow progenitors to differentiate into all 
mature progenitor types which BM LT-HSCs can differentiate into. Therefore, 
using this assay we can quantify both the number of CFUs from the LTC-ICs and 
reveal any lineage bias in the expanded cells (Lemieux et al., 1995; Sutherland et 
al., 1990). 
 
Figure 6-2 Schematic of HSC co-culture in niche systems.  Pericytes were seeded for a 14 day 
priming period in niche systems. On day 14 HSCs were added and co-culture and maintained 
for 5 days. At day 5 cells were either subject to phenotypic analysis by flow cytometry, or 
CD34+ cells were sorted and seeded into long term culture-initiating cell (LTC-IC) assay, 
which were maintained for 6 weeks. LTC-ICs were then seeded into colony forming unit (CFU) 
assays and after 5 days colonies were counted.  
6.2 Materials and Methods 
6.2.1 HSC culture 
BM HSCs were obtained from CalTag MedSystems, UK and stored in liquid nitrogen 
until required. To thaw cells, they were immediately placed in a 37oC water bath, 
transferred to a 15 mL falcon tube. 10 mL of pre-warmed IMDM+BIT media was 
added drop wise for the first 5 mL. The cell suspension was centrifuged for 10 
mins at 400 g, and the cell pellet re-suspended in 1 mL. Cell counts were 
performed and the cell suspension was seeded into one well of a 24-well plate at 
5x105 cells/mL, and left to rest overnight in an incubator at 37oC and 5% CO2 in 
100% cytokine media (Table 6-1).  
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After overnight incubation, cells were recounted and seeded into the niche models 
outlined in Chapter 4, where a population of MSPCs had been cultured for 14 days. 
HSCs were seeded into the 24-well plated models at 5 x 104 cells/mL at 0.5 
mL/well, in the appropriate media type (Table 6-1). For conditions containing gels 
the HSCs were seeded on top of the gel. Separate control wells with 5 x 104 
cells/well in media only were also setup (cells only control). Seeded cells were 
then cultured for 5 days. At least 1 x 103 cells were transferred to an Eppendorf 
and subsequently phenotyped at day 0 using flow cytometry. 
Table 6-1 HSC media formulations. 
Media type SCF (ng/mL) TPO (ng/mL) Flt3 (ng/mL) 
100% cytokine 100 50 100 
10% cytokine 10 5 10 
0% cytokine  0 0 0 
 
6.2.2 HSC phenotyping by flow cytometry 
6.2.2.1 HSC flow cytometry staining 
HSCs were harvested from niche systems after 5 days culture. Collagen gels were 
digested as in Chapter 2.3.1.3 and collagenase solution was added to all other 
conditions. Supernatants were passed through 70 µm filters and collected in 50 
mL falcon tubes. Accutaseä was then added for 5-10 mins to detach cells and 
pooled into the same 50 mL falcon tube. Cells were centrifuged for 5 mins at 400 
g and transferred to 96 well plates for staining. The antibodies used for staining 
are detailed in Table 6-2.  
Table 6-2 Antibodies used for flow cytometry assessment of HSC phenotype 
Fluorophore Marker Supplier 
Am Cyan CD45 BD Biosciences 
PE CD34 BD Biosciences 
Cy7 CD38 BD Biosciences 
 
6.2.2.2 Gating strategy and data analysis 
Flow cytometry analysis of stained HSC phenotype was then carried out using BD 
FACS Canto II analyser. The gating strategy used for analysis is shown in Figure 
6-3.  
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Figure 6-3 Gating strategy for analysis of HSC identification.  Sample data taken from glass 
control. A. Forward scatter area (FSC-A) versus side scatter area (SSC-A) plot used to identify 
viable cells; B. FSC-A versus FSC width (FSC-W) plot used to identify single cells; C. A gate 
was added on CD45+ cells to remove any pericytes and D. 3 gates used to identify CD34+CD38 
-, CD34+CD38- and CD34-CD38+. The CD34+CD38- population represents both LT- and ST-
HSCs, whereas CD34+CD38+ and CD34-CD38+ populations represent HSPCs and committed 
progenitors. 
6.2.3 LTC-IC 
LTC-ICs were carried out on CD34+ HSC harvested from niche systems after 5 days. 
Engineered stromal fibroblast feeder layers were first established. M2-10B4 
(overexpressing IL-3 and G-CSF) was maintained in RPMI containing 10% FBS, and 
Sl/Sl (overexpressing IL-3 and SCF) in DMEM containing 10% FBS, and were passaged 
at ~90% confluence. Cells were grown for 2 weeks prior to use in selection agents 
to select stromal cells expressing long-term cell maintenance factors (M2-10B4, 
0.4mg/ml G418 and 0.06mg/ml Hygromycin B; Sl/Sl, 0.8mg/ml G418 and 
0.15mg/ml Hygromycin B). On the final passage, cells at ~80% confluence were 
irradiated with 8000 cGy, trypsinised and counted. M2-10B4 and Sl/Sl were mixed 
at 1:1 ratio at a final concentration of 1.5x106/ml. Cells were then seeded into 
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C
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collagen coated 24-well plates (Stem Cell Technologies, UK) for 24 hours before 
adding CD34+ cells. 
6.2.3.1 Cell sorting from niche systems 
Collagen gels were digested as in Chapter 2.3.1.3, surfaces treated with 
accutaseä and cells collected from all niche systems after 5 days of pericyte-HSC 
co-culture. Populations were then stained with the antibodies detailed in Table 
6-3.  
Table 6-3 Antibodies used for cell sorting to LTC-IC. 
Fluorophore Marker Supplier 
PE CD34 BD Biosciences 
FITC Lin- BD Biosciences 
Am Cyan CD45 BD Biosciences 
PE-Cy7 CD38 BD Biosciences 
 
 
Figure 6-4 Gating strategy used for cell sorting for LTC-IC. Sample data taken from PEA FN 
BMP-2 -gel, patient 1. A. FSC-A versus SSC-A plot used to identify viable cells; B. Gate added 
on CD45+ cells to remove any pericytes; C. Lin- gate used to remove any committed 
progenitors and D. Gate added on CD34+ population, and these cells were collected and used 
in the LTC-IC assay.  
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BD FACSAria cell sorter (BD Biosciences) was used to sort single CD34+ cells by 
FACS. Lin- was used to remove any committed progenitors, CD45 to remove any 
pericytes and cells were selected based on CD34+ expression, the gating strategy 
used is represented in Figure 6-4. CD34+ cells were sorted into suspension and 
were resuspended at 5 x 104 cells/mL in HLTM+10-6M Hydrocortisone (HC). Media 
was removed from feeder layers, and 5 x 104 CD34+ cells were seeded/well. 
Duplicates were seeded for each condition; when enough cells were unable to be 
collected in certain conditions, only single replicates were used. Cultures were 
then incubated at 37oC in 5% CO2 for 6 weeks. 0.5 mL HLTM was removed and 0.5 
mL fresh HLTM+10-6M HC added weekly.  
6.2.4 CFU assay 
To harvest cells from LTC-IC cultures after 6 weeks, HLTM was removed containing 
any non-adherent cells and added to a 5 mL sterile tube. Each well was then 
washed with 0.1 mL HBSS, then trypsin added for 5 mins at 37oC in 5% CO2. Once 
adherent layer had started to detach cells were resuspended and added to the 5 
mL tubes. Wells were subsequently washed once with IMDM containing 2 % FBS and 
added to the appropriate tubes. Tubes were filled with IMDM with 2% FBS and 
centrifuged at 300 g for 8 mins. Supernatant was removed without disturbing the 
cell pellet, leaving 0.1 mL of medium. Cells were then counted, and 2.4 x 105 cells 
added to bijou tubes containing 2.5 mL of MethocultÔ. Bijoux tubes were briefly 
vortexed and left at RT for 5 mins to allow bubbles to dissipate. 1.1 mL from each 
tube was then plated into duplicate 35 mm culture dishes using a 3 mL syringe 
with a blunt needle. The 2 replicate dishes were placed within a 100 mm Petri 
dish containing a third 35 mm dish (without lid) containing 3 mL of sterile water. 
Cultures were incubated at 37oC in 5% CO2 for 5 days. 
After 7 days total colonies were counted using a light microscope. Scores were 
taken for detection of classes of colonies, summarised in Table 6-4. Each CFU 
assay was counted by two independent researchers and an average taken. 
Averages were then plotted in graphs using GraphPad Prism 6.0 software.  
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6.3 Results 
Flow cytometry analysis was used to determine whether our engineered niche 
systems could support LT-HSCs in culture. In brief, HSCs were added into ‘primed’ 
niche systems and co-culture was maintained for 5 days in the 3 different media 
types outlined in Table 6-1. CD34+ cells in 100% media on TCP were used as the 
control (cells only). At day 5 cells were harvested for phenotypic analysis, or 
further experimentation in the LTC-IC functional assays (Figure 6-2).  
6.3.1 Low-stiffness gels reduce HSC/HSPC proliferation  
Analysis of the CD34+CD38- population revealed that the addition of low-stiffness 
gels or hypoxia significantly reduced proliferation or expansion of this population 
when compared to the cells only control and PEA FN BMP-2 -gel, in all 3 media 
conditions (Figure 6-5). Both cells only and PEA FN BMP-2 -gel led to an increase 
of ~4- to 8-fold when compared to the number of CD34+CD38- cells input at day 
0. Interestingly, in cells only, when cytokine concentration in the media was 
reduced there was a significant decrease in proliferation of this population. 
Whereas for the PEA FN BMP-2 -gel system the opposite is true – reducing cytokine 
concentration significantly increased CD34+ CD38- numbers, this was 
indistinguishable between 10% and 0% media. This data suggests that both the 
cells only control and the PEA FN BMP-2 -gel system cause robust proliferation or 
expansion of the CD34+CD38- population, whereas in the presence of low-stiffness 
gels or hypoxia, proliferation appears to be lowered.  
Further to this, although not significant, a similar trend was observed in the PEA 
FN +gel and PEA FN BMP-2 +gel to PEA FN BMP-2 -gel in response to cytokine 
concentration in the media (Figure 6-5). In these conditions in 10% and 0% media, 
the CD34+ CD38- population appears to be maintained (i.e. 1-fold change), yet 
numbers slightly reduce in the presence of 100% cytokine concentrations. This 
suggests that in the presence of pericytes in the PEA systems, it is perhaps 
beneficial to reduce or remove the supplemented cytokines in the culture media 
(Figure 6-5).  
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Figure 6-5 Fold increase of CD34+CD38- cells at day 5 in 3 media types.  Data shows 
proliferation/maintenance of CD34+CD38- population, represented as a fold change to the 
number of CD34+CD38- cells added at day 0. Data shows that cells only control and the PEA 
FN BMP-2 -gel system lead to significant proliferation of this population. When in the 
presence of pericytes in the PEA systems, the addition of cytokines in the media is not 
beneficial to proliferation or maintenance of this population. Whereas the opposite is true for 
cells only. Data also suggests that the addition of low-stiffness gels does not induce 
proliferation, but instead leads to maintenance of the population. Graph shows mean ±SEM. 
N = 3, with 3 HSCs donors and one pericyte donor. Two-way ANOVA followed with multiple 
comparisons, Tukey’s post-test, *= p£0.05, **= p£0.01, ***= p£0.001, ****= p£0.0001. Unless 
otherwise indicated, black * compared to cells only, red * compared to PEA FN BMP-2 -Gel.  
We then analysed the CD34+ CD38+ subset to assess expansion of early committed 
progenitors (this population contains the CMP and CLP compartment) (Figure 
6-6A). Similar to Figure 6-5, the PEA +gel systems in 0% media did not lead to 
expansion or proliferation of this population compared to starting numbers at day 
0, but only when there were no additional cytokines in the media (Figure 6-6A). 
Addition of full (100%) or dilute (10%) media significantly increased proliferation 
of progenitors in the PEA FN BMP-2 +gel system. PEA FN BMP-2 -gel displayed a 
similar trend, with additional cytokines leading to increased proliferation of this 
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population, although this system also significantly increased the progenitor 
population when compared to +gel and hypoxia. Hypoxia was the only condition 
that significantly reduced the number of cells in this compartment. Overall, this 
data further suggests that removing or reducing cytokines in media when in PEA 
systems is beneficial, in that proliferation of this early committed population is 
reduced. However, only when in the presence of low-stiffness gels is the 
population maintained, as no significant expansion is observed (Figure 6-6A). 
The CD34- CD38+ subset represents lineage committed cells with little/no 
progenitor activity remaining (Chao et al., 2008). We saw significant levels of 
proliferation of these cells in all PEA conditions except hypoxia, reflecting their 
highly proliferative nature (Figure 6-6B) (Passegué et al., 2005). Although 
proliferation was observed, similar results regarding supplemental cytokines were 
observed. In PEA FN BMP-2 -gel, PEA FN +gel and PEA FN BMP-2 +gel systems, there 
was a significant reduction in proliferation of this population when cytokines were 
reduced or removed. There were no significant differences between the +gel and 
-gel, however hypoxia and cells only systems had significantly lower numbers of 
cells in this population. This suggests that the mechanical environment does not 
directly influence this compartment, but that reducing or removing exogenous 
cytokines from the media helps to reduce its proliferation (Figure 6-6B).  
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Figure 6-6 Fold increase of CD34+CD38+ and CD34-CD38+ cells at day 5 in 3 media types.  
100% media leads to an increase in proliferation of early and committed progenitors in both 
(A) CD34+CD38+ and (B) CD34-CD38+ populations, when compared to 10% or 0% media. (A) 
demonstrates maintenance of this population in PEA +gel systems, but only when exogenous 
cytokines are removed from culture media. PEA FN BMP-2 -gel leads to proliferation of this 
compartment, yet this is also reduced in 10% and 0% cytokine media. (B) demonstrates 
expansion of this highly proliferative compartment in PEA -gel/+gel systems, however 
removal of cytokines from the media reduced significantly this expansion. Graph shows mean 
±SEM. N = 3, with 3 HSCs donors and one pericyte donor. Two-way ANOVA followed with 
multiple comparisons, Tukey’s post-test, *= p£0.05, **= p£0.01, ***= p£0.001, ****= p£0.0001. 
Unless otherwise indicated, black * compared to cells only, red * compared to PEA FN BMP-
2 -gel, grey * compared to PEA FN BMP-2 hypoxia. 
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Overall, this data suggests that the PEA FN BMP-2 -gel co-cultures and the cells 
only control led to increases in fold changes of the number of the most 
phenotypically naïve cells identified by expression of CD34+CD38- (Figure 6-5). 
The PEA FN BMP-2 -gel system also influenced proliferation of both early 
progenitors (CD34+CD38+) and lineage committed cells (CD34-CD38+). However, 
when exogenous cytokines were removed from the media, the expansions were 
more favourable – that is increased CD34+CD38- (naïve compartment) (Figure 6-5), 
but reduced CD34+CD38+ and CD34-CD38+ (early and committed progenitors) 
(Figure 6-6). A similar trend was also observed for PEA +gel conditions, however 
these systems appeared to maintain the population rather than induce 
proliferation. The systems with gels maintained the CD34+CD38- and CD34+CD38+ 
populations similar to that input at day 0, however this was only when in the 
absence of supplemental cytokines, suggesting this system could be limiting cell 
proliferation thus maintaining - but not expanding - HSCs in culture (Figure 6-5 
and Figure 6-6). The PEA FN BMP-2 hypoxia system displayed the lowest fold 
changes of all systems, displaying no proliferation or expansion in any 
compartment. This is in line with quiescent HSCs residing in hypoxic niches (Ito 
and Suda, 2014). 
6.3.2 Low-stiffness gels support LT-HSCs  
To assess the ability of these systems to maintain or expand functional LT-HSCs in 
culture, we carried out LTC-IC assays followed by CFU assays (outlined in Figure 
6-2). These assays were carried out on PEA FN BMP-2 systems -/+gel in both 100% 
and 0% media types, with cells only in gold standard 100% media used as the 
control (Kumar and Geiger, 2017). Gold standard medium with 0% cytokines was 
also tested but insufficient cell numbers were obtained after LTC-IC to perform 
reliable CFUs. We selected these conditions as they showed the most pertinent 
changes in CD34+ subset numbers during co-culture, in the presence or absence 
of exogenous cytokines.  Hereafter PEA FN BMP-2 -gel and PEA FN BMP-2 +gel will 
be referred to as -gel and +gel, respectively. 
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Figure 6-7 Total number of colonies maintained from niche systems. CD34+ cells were 
harvested from PEA FN BMP-2 -/+ gel niche systems after 5 days culture in 0% or 100% 
medias. CD34+ cells were then added to LTC-IC assays for 6 weeks and resulting LTC-ICs 
subject to CFU assay. Total number of colonies were counted and are represented as CFUs 
per 1 x 104 CD34+ cells. The resulting data indicates PEA FN BMP-2 +gel 0% media is able to 
maintain the highest number of CFUs. Graph shows mean ±SD. One-way ANOVA with Tukey’s 
post-test with multiple comparisons, **= p£0.01, ****= p£0.0001, n.s. (non-significant). Data 
from 2 donors, n=3.  
After transfer to methylcellulose, the total number of colonies were counted after 
5 days to reveal the number of long-term repopulating, colony-forming cells that 
were present in the cell population used to inoculate the assay. The +gel 0% media 
significantly produced the highest average number of CFUs per 1 x 104 CD34+ cells 
(245 ± 55) (Figure 6-7). The total number of CFUs was significantly higher than 
that maintained by the cells only control in 100% media (165 ± 47). Interestingly, 
+gel 100% media led to a significant decrease in CFUs (28 ± 22), indicating the 
pericytes in the +gel system possess HSC maintenance activity that is dampened 
when high concentrations of cytokines are added (Figure 6-7). The -gel systems 
followed a similar trend, where more CFUs were observed in 0% (108 ± 21) 
compared to 100% media (75 ± 13), although this was significantly less than CFUs 
supported by +gel and by the control. This is in line with the data presented in 
Figure 6-6, where increase in the committed progenitor compartment was 
observed in 100% media conditions, and robust expansion of progenitor 
compartments is associated with loss of the naïve HSC compartment (Morrison and 
Kimble, 2006).  
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Progenitor lineage potential was further assessed from CFUs. Each CFU was 
identified by specific morphological features as one of the 6 colony types 
described in Table 6-4 and represented in Figure 6-8. Quantification of the number 
of colonies associated with discrete fate specification events allowed us to assess 
if there was a degree of lineage bias as a function of matrix environment and 
cytokine concentration. The colonies correspond to stages of myeloid, 
granulocytic and erythroid/megakaryocytic specification.  
Table 6-4 Colony types counted in colony-forming unit assay 
Abbreviation Colony type Represent 
CFU-E Colony-forming unit – erythroid Late stage myeloid 
progenitors restricted to 
single lineage 
CFU-G Colony-forming unit – 
granulocyte 
Myeloid progenitors 
restricted to single lineage 
CFU-GM Colony-forming unit – 
granulocyte, macrophage 
Myeloid specification 
BFU-E Burst-forming unit -erythroid  Primitive erythroid 
progenitors 
CFU-M Colony-forming unit – 
macrophage  
Late stage myeloid 
progenitors restricted to 
single lineage 
CFU-GEMM Colony-forming unit – 
granulocyte, erythrocyte, 
macrophage, megakaryocyte 
Early stages of myeloid 
specification 
 
 
Figure 6-8 Representative colony types in CFU assay after 7 days.  Cells harvested from LTC-
IC assay were added to CFU assay, and colonies counted after 7 days. CFU-E; contain ~8-200 
haemoglobinised erythroblasts. BFU-E; clusters of erythroid progenitors with high 
proliferative capacity. CFU-G; homogenous population of granulocyte progenitors. CFU-M; 
homogenous population of macrophage progenitors. CFU-GM; heterogenous population of 
macrophages and granulocytes. CFU-GEMM; multilineage progenitors that give rise to 
erythroid, granulocyte, macrophage and megakaryocyte lineages.  
CFU-E CFU-G CFU-GM
BFU-E CFU-M CFU-GEMM
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The cells only population represents a control distribution of lineage specification 
with each of the 6 lineage specifications represented (Figure 6-9). This distribution 
of specification is closely resembled only by +gel 0% media, which also retains 
specification for all 6 lineages. Whereas, +gel 100% media has lost all BFU-E colony 
forming capacity and shows an increase in CFU-Es compared to control and +gel 
0% media. Both conditions -gel also show a marked decrease in BFU-E colonies. 
Similarly, to +gel 100% media, -gel 100% media shows increased specification to 
CFU-E (Figure 6-8).  
Overall the CFU assays indicate that +gel 0% media is able to support LTC-ICs that 
also retain multipotency in terms of lineage specification comparable to the same 
capacity as the current gold standard media control. 
 
Figure 6-9 Lineage specification state of CD34+ cells cultured in niche systems. CFU assay 
was used to assess myeloid and erythroid lineage specification of the CD34+ cells cultured 
in PEA FN BMP-2 -/+gel niche systems in 100% and 0% cytokine medias. CD34+ cells cultured 
in 100% media were used as the control (cells only). PEA FN BMP-2 +gel 0% media (+Gel 0%) 
retains commitment to all lineages at similar distribution to the control. +gel 100% shows 
preference to CFU-E commitment and has lost BFU-E activity. Both -gel 0% and 100% similarly 
showed a decrease in BFU-E commitment. Data is represented as percentage (%) of total 
CFUs counted for each condition. 1 biological replicate, 3 technical replicates.   
6.4 Discussion 
This chapter investigated the response of HSCs co-cultured in the niche systems. 
The aim was to assess if the MSPC phenotypes observed in previous chapters to 
retain BM niche-like properties were able to support HSC activity.  
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6.4.1  PEA FN BMP-2 systems support proliferation (-gel) or 
maintenance (+gel) of the CD34+ CD38- population 
Analysis of HSC phenotype by flow cytometry after pericyte co-culture revealed 
significant proliferation of the CD34+ CD38- population when cultured with 
pericytes seeded in PEA FN BMP-2 -gel systems and in the cells only control (Figure 
6-5). Whereas in PEA +gel and hypoxic systems the population was maintained at 
numbers similar to those input at day 0. This proliferation with pericytes on PEA -
gel is consistent with previous work using adipose-derived CD146+ pericytes as a 
feeder layer to successfully expand CD34+ cells ex vivo (Corselli et al., 2013). This 
2013 study highlighted that the pericytes, which expressed key niche markers such 
as CXCL12 and nestin, were able to support human Lin- CD34+ cells in long-term 
culture that retained CFU activity. This was significantly higher than CD146- MSCs 
which had lost all CFU capacity by week 6, suggesting that within heterogeneous 
populations of MSCs the ability to support HSCs may be confined to the CD146+ 
perivascular cells. This is consistent with previous observations from our group 
that used a similar PEA+GF based system to co-culture HSCs with Stro1+ MSCs 
(Sweeten, 2019). After co-culture with Stro1+ MSCs, large degrees of variability 
were observed between patient samples upon analysis of HSC phenotype, which 
could be explained by populations of Stro1+ MSCs that may retain CD146+ 
expression (Lv et al., 2014; Tormin et al., 2011).  
Interestingly, proliferation of the CD34+ CD38- population was significantly 
increased on PEA FN BMP-2 -gel when cytokines supplemented in the media were 
reduced (10%) or removed (0%) (Figure 6-5). A similar trend was observed in the 
PEA +gel systems regarding maintenance of the population (Figure 6-5). Whereas 
the opposite was observed in the cells only control, removing cytokines decreased 
proliferation. Although it should be noted, although proliferation was reduced, 
the cells only control was able to support relative expansion of both CD34+ CD38- 
and CD34- CD38+ populations even in the absence of maintenance cytokines 
(Figure 6-5 and Figure 6-6). This was unexpected as it is well accepted in the field 
that HSC culture requires complex media formulations. However after the LTC-IC 
assay, insufficient cell numbers were obtained to perform CFU assays, indicating 
the supplemented GFs are required to support the LT-HSC population. The length 
of culture for this system may also help explain this observation, as perhaps 5 days 
is too short to significantly effect HSC behaviour in these conditions, and a longer 
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time in culture would be required to observe phenotypic changes in response to 
absent cytokines.  
We then went on to investigate the differentiation state of these cells by analysing 
both the CD34+ CD38+ and CD34- CD38+ populations. CD34+ CD38+ cells still retain 
differentiation capacity in accordance with the HSC hierarchy (Figure 6-1) whereas 
this capacity is lost in the CD34- CD38+ population. Interestingly, analysis of these 
compartments also revealed in the PEA -/+gel systems, it is favourable to remove 
exogenous cytokines from the media (Figure 6-6). These populations are highly 
proliferative but lack long-term functionality, hence reduced proliferation or 
expansion of them is desirable. The 0% PEA +gel systems maintained the CD34+ 
CD38- population, and significantly reduced CD34- CD38+ proliferation in the 
absence of exogenous cytokines compared to the PEA +gel system with 100% 
cytokines. 
This analysis suggests that overall, removal of exogenous cytokines from media is 
beneficial in co-cultured systems using PEA ‘primed’ pericytes. Further, the PEA 
FN BMP-2 -gel system leads to robust proliferation of all populations investigated, 
including the most naïve CD34+CD38- population. Whereas the addition of low-
stiffness gels and hypoxia to the system appears to reduce excess proliferation 
and maintain the naïve compartment, whilst reducing expansion of committed 
progenitors.    
6.4.2 Low-stiffness gels and fibronectin networks support 
maintenance of LT-HSCs in the absence of supplemented 
cytokines 
We used flow cytometry to assess changes in numbers of CD34+ subsets, then to 
show a functional effect in the niche systems an LTC-IC and CFU assay was used 
(Figure 6-7). Interestingly, this revealed the CD34+ CD38- proliferation induced in 
the PEA FN BMP-2 -gel system did not result in an increase in the number of 
functional LT-HSCs (CFUs). Whereas, the PEA FN BMP-2 +gel 0% that in the flow 
cytometry analysis maintained the most naïve compartment, resulted in 
significantly increased number of CFUs (~1.5-fold compared to the gold standard 
cells only control, and ~2.3-fold compared to -gel 0% cytokines) (Figure 6-7). The 
CFUs from this system were also able to retain lineage specification comparable 
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to the control (Figure 6-9). This capacity was only seen in the absence of 
additional HSC maintenance cytokines in the medium, as use of 100% cytokine 
media had a detrimental effect on the number of CFUs (Figure 6-7) and led to 
aberrant lineage specification (Figure 6-9). Taken together this data demonstrates 
the PEA FN BMP-2 +gel system is able to effectively maintain a significant 
population of LT-HSCs, but only in the absence of additional maintenance 
cytokines.  
This data implies that the PEA FN BMP-2 +gel system that we have shown to 
support a population of nestin+ MSPCs, retains HSC support activity. It is able to 
maintain a population of HSCs that retain self-renewal capacity long-term in 
culture, without the addition of exogenous support cytokines in the media. 
Although the system with -gel resulted in expansion of the desirable CD34+ CD38- 
phenotype, these cells were not retained long term, suggesting loss of self-
renewal capacity.  
The results presented in Chapter 4 demonstrate that the PEA FN BMP-2 +gel system 
supports a nestin+ MSPC phenotype. In vivo these nestin+ MSPCs are present in 
close proximity to HSCs and express high levels of HSC maintenance factors, and 
have been shown in standard TCP in vitro culture to form mesenspheres that self-
renew, expand in serial transplantation and support HSC activity (Méndez-Ferrer 
et al., 2010; Nakahara et al., 2019; Pinho et al., 2013). However, the Frenette 
group identified when nestin+ MSPCs were cultured, downregulation of HSC 
maintenance genes was observed. This loss of ‘stemness’ as a result of removal 
from the native niche, leads to limited success in long-term HSC co-cultures 
(Nakahara et al., 2019). The data presented in this chapter has demonstrated that 
use of biomaterial strategies can support the niche-like activity of nestin+ MSPCs 
during in vitro culture. These nestin+ MSPCs retain HSC supporting activities that 
are able to maintain a population of naïve CD34+CD38- progenitors which contain 
a higher frequency of LT-HSCs in co-culture than current gold standard culture 
conditions.  
As biomaterial strategies have advanced, there has been a focus on engineering 
the BM niche microenvironment, moving away from simpler traditional Dexter-
style co-culture stromal cells types and instead incorporating one or more material 
properties (Lee-Thedieck and Spatz, 2012). Results, however, are varied, with 
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similar systems leading to diverse findings. For example, reports on the use of 
perfusion cultures have demonstrated HSC expansion (Bourgine et al., 2018), 
maintenance (Torisawa et al., 2014) and differentiation (Rödling et al., 2017). Yet 
several biomaterial strategies have demonstrated differences in HSC location and 
homing within the engineered systems. The study by Bourgine et al, used porous 
HA-based scaffolds populated with MSCs and CD34+ cells in perfusion culture. They 
reported an increase in HSCs and progenitor cells in this system, and interestingly, 
identified the most naïve HSCs (CD34+CD38-) localised and adhered to the MSC-
seeded scaffold surface whereas committed cells remained in the perfused 
supernatant (Bourgine et al., 2018). Similar to this, a study by Leisten et al, used 
a collagen hydrogel seeded with MSCs and HSCs seeded above the gel in suspension 
(both the collagen gel and HSC seeding method are akin to that used in this thesis). 
After 14 days culture they identified two sub-populations of HSCs, more 
differentiated HSPCs were identified to have remained in suspension above the 
collagen gel (CD34+CD38+), whereas more naïve HSCs (CD34+CD38-) had migrated 
into the MSC-seeded gel (Leisten et al., 2012). Both of these reports indicate HSC-
MSC homing, or cell-cell contact is important for retaining the most desirable 
population of HSCs in culture. It would be of interest to investigate the migration 
of the HSCs in our gel system and identify if the LT-HSCs maintained in this system 
are homing to the nestin+ MSPCs at the gel-FN network interface. It may also be 
of interest to investigate other methods of HSC seeding to ensure closer proximity 
of the stromal layer and the HSCs - encapsulation of the HSCs within the gel was 
not possible with our system as we used a 14 day priming period for the stromal 
compartment, however future work may consider this.  
With the aim of engineering supportive MSPC-based environments, the study by 
Nakahara et al, induced retention of HSC maintenance factors by targeting Nestin+ 
MSPC transcriptional machinery (Nakahara et al., 2019). RNA sequencing was used 
to identify transcription factors that were downregulated in mouse Nestin+ MSPCs 
after in vitro culture compared to freshly isolated Nestin+ MSPCs. From a list of 
28 genes, a combination of 5 genes was subsequently identified to elevate HSC 
maintenance factor genes upon viral integration (Ostf1, Xbp1, Irf3, Irf7 and Klf7). 
The transfected, or ‘revitalised’, cells exhibited significant elevation of niche 
genes such as Scf, Cxcl12, Vcam1 and Angpt1. Upon in vitro co-culture of the 
revitalised MSPCs a 1.7-fold expansion of HSCs was observed (Nakahara et al., 
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2019). After co-culture with the revitalised MSPCs, HSCs were expanded and 
transplanted into lethally irradiated mice. This demonstrated functionality of 
these HSCs through their ability to reconstitute multilineages long-term in the 
irradiated recipient mice. They found higher repopulation capacity for all the 
mature lineages in HSCs from the co-cultures, an ability that was retained even 
after secondary transplantation. The study went further to investigate if these 
revitalised mouse niche cells were able to confer similar effects when co-cultured 
with human HSCs. The system was increasingly effective, as demonstrated by the 
significant 28-fold expansion of the human HSCs, corroborated by an increased 
repopulating capacity. Demonstrating and ability of these revitalised mouse MSPCs 
to expand both mouse and human HSCs (Nakahara et al., 2019).  
The above technique relies on lentiviral vectors for insertional mutagenesis, and 
although results are promising there are large safety risks that will need to be 
addressed before launching clinical trials. Whereas, the work presented in this 
thesis similarly engineers a MSPC phenotype that retains HSC support activity, yet 
by using only material and ECM-based cues. Optimisation of biomaterial-based 
strategies to maintain a more efficient feeder layer have the potential to 
circumvent the safety concerns associated with e.g. genetic transformations.  
Over the past decade, small molecules that target multiple transcription factors 
have also been a focus for ex vivo HSC expansion. The use of small molecules to 
target cellular signalling evades the use of potentially dangerous strategies 
required by genetic manipulation. Nicotinamide (Horwitz et al., 2014), 
prostaglandin E2 (PGE2) (North et al., 2007), StemRegenin 1 (SR1) (Boitano et al., 
2010) and a PPAR-γ antagonist GW9662 (Guo et al., 2018) have all been identified 
through chemical genetic screens or screening of large small molecule libraries. 
They have all demonstrated in vitro potential to induce robust proliferation of 
CD34+ cells, summarised in Table 6-5. Three of these molecules - PGE2, 
nicotinamide and SR1 - have resulted in relatively successful phase I clinical trials, 
where the safety of ex vivo expanded cells were confirmed (Cutler et al., 2013; 
Horwitz et al., 2014; Wagner et al., 2016).  
Perhaps of greatest success is SR1, an agonist of the aryl hydrocarbon receptor 
(AhR) which regulates genes that are involved in haematopoiesis, thus blocking 
HSC differentiation (Boitano et al., 2010). Treatment of CD34+ cells with SR1 in 
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combination with the standard HSC cytokine cocktail (SCF, Flt3, TPO and 
interleukin-6 (IL-6)) led to a remarkable >300-fold expansion of human umbilical 
cord blood (UCB) CD34+ cells in vitro after 15 days treatment (Boitano et al., 
2010; Wagner et al., 2016). In a phase I/II clinical trial these expanded cells were 
transplanted into patients alongside an untreated unit of UCB (Wagner et al., 
2016). SR1 treatment demonstrated successful, safe and rapid engraftment in all 
patients. However, simple manipulation of HSCs expansion in this way often does 
not provide the correct combination of signals to promote naïve, multipotent, 
undifferentiated therapeutically useful stem cells. The expansion observed from 
SR1 treatment is predominantly in the progenitor compartment, and upon HSCT a 
transient burst of myeloid cells was observed after 7 days. It is also of note that 
the most naïve CD34+ (LT-HSC) fraction that engrafted was derived not from the 
SR1 treated UCBs, but from the untreated UCB unit that was co-administered. 
Suggesting the SR1 cells may contribute more to the progenitor pool than to the 
long-term repopulating fraction (Wagner et al., 2016). 
Table 6-5 Summary of current small molecules used for ex vivo HSC expansion. 
Compound Biological 
rationale 
Media 
cytokines 
Cultur
e Time 
Effect Referenc
e 
PGE2 Enhanced 
prostaglan
din E2 
synthesis  
None  24–48 
h 
Enhanced 
neutrophil 
recovery, leading to 
enhanced homing, 
survival and 
proliferation of 
HSCs.  
(Cutler et 
al., 2013; 
Goessling 
et al., 
2009) 
SR1 Inhibits 
AhR  
SCF, Flt3, 
TPO, IL-6 
7-21 
days 
>300-fold increase 
in CD34+ cells. 
Blocks 
differentiation. 
Enhanced 
neutrophil recovery 
and engraftment. 
(Boitano 
et al., 
2010; 
Wagner 
et al., 
2016) 
Nicotinamide SIRT1 
inhibitor 
SCF, Flt3, 
TPO, IL-6 
21 
days 
Inhibits HSC 
differentiation, 
facilitates HSC 
homing and 
engraftment. 
(Horwitz 
et al., 
2014; 
Peled et 
al., 2012) 
PPAR-γ 
 antagonist 
Enhanced 
glycolysis 
SCF, Flt-3, 
TPO 
4 days 3-fold expansion of 
HSCs. Contained LT 
repopulating 
potential. Decrease 
in differentiation 
associated genes. 
(Guo et 
al., 2018) 
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Although some of these small molecule strategies have seen success in early stage 
clinical trials, culturing HSCs in this manner remains a double-edged sword; robust 
proliferation will undoubtedly always be accompanied by differentiation and a 
resulting loss of stemness (Pollard and Kranc, 2010). These molecules may provide 
the correct biochemical signal to stimulate HSC expansion, however virtually all 
other niche constituents are removed from these culture methods (Table 6-5). It 
could therefore be easily envisioned that a combinatorial approach using small 
molecule strategies employed in tandem with biomaterial approaches, that 
recapitulate physical aspects of the BM niche microenvironment (discussed in 
Table 1-5) could be beneficial. This could have the potential to drive the robust 
proliferation achieved through small molecule addition, whilst integrating the 
multiple signalling components that make up the BM microenvironment to reduce 
differentiation.  
Future work could investigate this in our PEA FN BMP-2 +gel system, as we have 
demonstrated the ability to maintain LT-HSCs using this strategy in the absence 
of maintenance cytokines, the addition of e.g. SR1, could be used to drive 
expansion whilst providing cues for long term maintenance. Further investigation 
into longer culture periods of HSCs in this system, and into HSC proliferation and 
cell cycle should also be investigated. Additionally, the resulting CD34+ cells 
should be investigated for repopulation capacity and in serial transplantation 
studies in irradiated recipient mice, considered the gold standard test for 
functionality (Domen et al., 2006).  
6.4.3 Summary 
HSC expansion is an area of great focus due to an increased demand for HSCTs to 
treat increasing blood-related disorders and insufficient donor availability 
(Brunstein et al., 2010; Lane et al., 2014; Radaelli et al., 2014). Successful HSCT 
require higher numbers of HSCs than are usually successfully obtained, revived or 
engrafted from single donors (Kumar et al., 2017). Understanding the cell-intrinsic 
mechanisms and extrinsic niche-regulatory mechanisms that are fundamental to 
HSC homeostasis are essential for establishing effective and safe methods for 
expanding HSCs ex vivo for clinical use. As insights into these properties have been 
gained over the past decade, strategies for HSC expansion are now promising, with 
encouraging results from some later stage clinical trials (Wagner et al., 2016). 
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However, many of these studies rely on HSC control using genetic manipulation or 
small molecule stimulation, the widespread intrinsic effects of which are not yet 
fully understood (Boitano et al., 2010; Nakahara et al., 2019; North et al., 2007). 
Large risks associated with the safety of these processes will need to be addressed 
before these cells find their way into the clinic. 
Our study presents a method to maintain a population of LT-HSCs in culture using 
only physiological-mimetic matrix cues. Although the co-culture period used was 
relatively short, the results are promising and indicate optimisation of the system 
could be investigated for long-term HSC culture (outlined in Chapter 7). Further 
to this, if future work were able to manipulate this engineered environment to 
promote expansion of this LT-HSC population, the risk associated with cells from 
this system would potentially be significantly less than that of, for example, 
insertional mutagenesis strategies (Nakahara et al., 2019). The results from this 
chapter suggest that currently the system offers a platform in which multiple 
niche properties can be manipulated, constructed and de-constructed, and their 
intrinsic and extrinsic effects on both MSPCs and HSCs studied in detail. Platforms 
such as this would allow for more in vivo-like study of downstream effects of small 
molecule strategies, genetic engineering and drug toxicity testing.  
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Chapter 7 Discussion 
7.1 Project Summary  
As outlined in Chapter 1, this thesis aimed to recapitulate aspects of the BM niche 
microenvironment. The system was then used to investigate key regulatory 
mechanisms for maintaining niche-like phenotypes in MSPCs, and for maintaining 
a population of HSCs in vitro. Key achievements are described below: 
• Cell source: pericytes derived from adipose tissue were used throughout 
this project. Adipose tissue is deemed clinical waste and as such is more 
easily acquired than e.g. BM samples. Although it would be of interest to 
assess the use of BM pericytes in this model, adipose-derived cells were 
demonstrated to express key BM niche markers and ultimately maintain LT-
HSCs in culture.  
• The rationale for using a low-stiffness matrix in the form of the collagen 
hydrogel to drive nestin expression was effective.  
• Preformed FN networks presented on the PEA substrates in combination 
with low-stiffness gels also led to increased expression of key phenotypic 
niche markers. The system supported an MSPC population that was nestin+ 
CD146+ CD51+ and NG2+. This population was supported to degrees on 
other substrates, such as PMA, however the PEA FN +gel systems were the 
only systems able to support expression of the 2 key maintenance factors, 
CXCL12 and SCF. 
• The modular nature of the system allowed detailed investigation into 
metabolic mechanisms in response to each niche component. From this we 
identified a ‘hypoxic-like’ mechanism induced by the use of low-stiffness 
gels. This may be important for regulation of the nestin+ MSPCs maintained 
by this system.  
• The PEA FN BMP-2 +gel system was able to maintain a population of LT-
HSCs in vitro, in the absence of additional maintenance cytokines in the 
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media. This was significantly increased compared to the current gold 
standard method for in vitro HSC maintenance.  
In conclusion, the in vitro BM niche model developed here was capable of 
maintaining and supporting populations of MSPCs and HSCs in niche-like states. 
The system allowed easy construction and deconstruction of multiple niche 
properties, providing a platform on which to investigate their impact on 
fundamental cell processes and contribution to the desired niche phenotype. 
However, the ultimate goal for in vitro BM models will be to achieve HSC 
expansion, or maintenance in culture for longer time periods. As such, further 
work is needed to achieve these goals.  
7.2 Recommendations for Future Work 
Along with the experiments detailed in chapter discussions, considerations for 
future work are detailed below.  
The use of glass coverslips as a control surface would be changed to a more 
appropriate surface, such as TCP and TCP +FN. As discussed, glass was used as a 
control as a result of the method of substrate fabrication. PEA was coated onto 
glass coverslips by spin coating and hence plain glass was chosen as the control. 
Although, when comparing cell behaviour in standard culture conditions, plain TCP 
options would be more appropriate and allow comparison against stem cell 
behaviours in standard culture conditions, and should be used in future work.   
In this thesis, we employed MSPCs, or pericytes, isolated from human adipose 
tissue, which is considered clinical waste and thus is easily sourced. There is 
evidence for this cell source containing HSC supportive properties in vitro (Corselli 
et al., 2013), and much evidence for adipose-sourced stem cells retaining similar 
properties to BM isolated counterparts (da Silva Meirelles et al., 2015; Paduano et 
al., 2017; Sá da Bandeira et al., 2016), although there are also reports on 
discrepancies in potency for e.g. osteogenic differentiation (Herrmann et al., 
2016; Im et al., 2005). For future work, it would be of interest to employ BM-
derived MSPCs in this system. This would more closely mimic the native in vivo 
compartment, which could lead to different, or perhaps more potent effects, on 
both the support of the MSPC phenotype, and HSC regulation.  
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Future work may also consider investigations into different levels of hypoxia. In 
this thesis we used 1% O2, this was based on current studies both measuring BM 
oxygen (Spencer et al., 2014) and what is widely used in similar studies 
investigating ex vivo BM niche recapitulation and HSC culture (Antebi et al., 2018; 
Danet et al., 2003; Guarnerio et al., 2014; Kobayashi et al., 2019; Lee et al., 2018; 
Shima et al., 2009). However, some studies have demonstrated beneficial effects 
on HSC regulation at slightly higher oxygen tensions, still within that measured for 
the BM niche cavity, ranging from 2-5% O2 (Hammoud et al., 2012; Mantel et al., 
2015; Roy et al., 2012). It may also be considered that due to the distinct locations 
and thus oxygen tensions of the endosteal and sinusoidal niches, that altering 
oxygen tension may be used to replicate specific niches that ultimately will have 
implications on HSC behaviour.  
Investigation into using the PEA FN system to efficiently present GFs focussed only 
on the use of BMP-2. However, as discussed, often no significant results were 
obtained when compared to the FN network alone. We know from our previous 
work that using this system to present GFs to cells is effective (Cheng et al., 2018; 
Llopis-hernández et al., 2016; Moulisová et al., 2017), however the addition of 
other major cues, such as hypoxia and low-stiffness gels, may have dampened 
effects of the GF. However, it is also of consideration that the FN GF binding 
domain has high affinity to many other GFs and some HSC regulatory cytokines, 
which may be increasingly effective in promoting the niche-like phenotype we 
aimed to engineer in this thesis (Martino and Hubbell, 2010; Pelletier et al., 2000). 
Some of these are discussed in Table 7-1 below. Future work would investigate 
these factors independently and in combination, with the aim to achieve a more 
mimetic niche environment. The system could also offer a platform in which to 
study the different GF/cytokine signals contribution to MSPC and HSC phenotypes 
within the niche environment.  
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Table 7-1 GFs and cytokines to be considered for future model development. 
Growth 
Factor/Cytokine 
Rationale References 
NGF Likely secreted by sympathetic 
nerve fibres in the BM niche. 
NGFR (CD271) expressed by a 
population of naïve MSCs.  
Previous work from our group 
demonstrated a niche-
phenotype promoting effect in 
MSPCs. 
(Álvarez-Viejo et al., 
2015; Lv et al., 2014; Mo 
et al., 2016; Sweeten, 
2019) 
VEGF Present in the BM niche. VEGFR 
highly expressed by endothelial 
cells in the vascular niche. 
(Kunisaki et al., 2013) 
PDGFa PDGFRa is expressed by 
pericytes in vivo but is quickly 
lost in culture.  
PDGFRa is associated with the 
nestin+ MSPC phenotype. 
(Pinho et al., 2013; Sá 
da Bandeira et al., 2016) 
CXCL12 Important HSC maintenance 
cytokine. Produced in the niche 
by MSPCs and CAR cells. 
(Sugiyama et al., 2006) 
TGF-B Secreted by nonmyelinating 
Schwann cells in the niche and 
leads to regulation of HSC 
dormancy. This could be added 
to a PEA system with HSCs only.  
(Yamazaki et al., 2011) 
 
A limitation to investigation into different GFs and cytokine combinations is 
acquisition of materials, leading to time constraints. A strategy to overcome this 
is, however, easily envisaged; our group has developed and characterised a plasma 
polymerisation method for PEA coatings (Cheng et al., 2018). This method is both 
time effective and permits coating of a range of 2D and 3D surfaces and 
constructs. Using plasma PEA polymerisation 96-well plates could be coated, FN 
adsorbed, and FN networks formed. Combinations of GFs and cytokines discussed 
in Table 7-1 could then be tethered and presented in a physiological-like manner 
to the cells, in an efficient multi-well microarray style format.  
The 96-well plate style format would also offer other critical benefits. The 
coverslip-based system used in this thesis was limited in terms of length of HSC 
co-culture due to an inability to exchange media during periods of co-culture. 
Typically, HSC culture is performed in 96-well plates that can be centrifuged and 
media exchanged without disrupting HSCs (Corselli et al., 2013). Transferring the 
system to a PEA coated 96-well plate would therefore not only allow the user to 
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test multiple conditions, but the ability to exchange media would permit longer 
culture periods for investigation.  
The plasma polymerisation technique also has the ability to PEA coat 3D scaffolds. 
The use of 3D printed scaffolds such as those used in our previous work (Cheng et 
al., 2018) would offer a viable strategy to take this system into 3-dimensions. One 
recent study reported MSCs seeded onto 3D scaffolds in a perfused bioreactor 
system resulted in increased nestin expression when compared to static culture 
(Bourgine et al., 2018). The lattice structures, coated with PEA FN and GF 
combinations, could easily be incorporated into such a system. Offering a platform 
on which to further investigate additional niche properties such as fluid flow.  
As will be discussed later, there is a drive towards creating NATs for both 
pharmaceutical and clinical use. The current system uses a rat-tail collagen type 
I gel to promote nestin+ MSPCs, which will inevitably suffer batch-to-batch 
variability, leading to problems with reproducibility. A next step would be to 
replace the collagen gel with a rationally designed synthetic matrix, such as PEG. 
The gel would ideally retain similar stiffness to that in the range of the BM 
microenvironment (Jansen et al., 2015), and the ability to accurately tune PEG 
matrix stiffness through various techniques make it desirable for this application 
(Caliari and Burdick, 2016; Garcia, 2014; Trujillo et al., 2019a). PEG gels also offer 
further opportunity to reproducibly tune additional biochemical and physical cues 
in a modular fashion, unpublished work from our group has demonstrated PEG can 
be functionalised with ECM molecules such as FN or laminin (Trujillo et al., 2019b). 
This would offer further sites for GF binding, where different GF/cytokine 
presentation could be applied in the hydrogel component and the underlying PEA 
coated coverslip.  
Further, the work presented in this thesis assessed MSPC phenotype in the absence 
of HSCs in co-culture. Undoubtedly HSC addition will lead to changes in 
fundamental MSPC mechanisms. MSPC-HSC co-culture and interaction more 
accurately represents the native microenvironment, investigation in to phenotypic 
and mechanistic differences of MSPCs when in contact with HSCs in this system 
would be vital to gain understanding into such important cell-intrinsic regulatory 
mechanisms. This investigation would help elucidate the beneficial signals 
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supported by MSPCs cultured in 0% cytokines in the PEA FN BMP-2 +gel system that 
permit effective LT-HSC maintenance.  
7.3 Prospective Applications of Bone Marrow Niche 
Models 
A model of the BM niche microenvironment has several potential research, clinical 
and pharmaceutical applications. These are summarised in Figure 7-1 and are 
discussed in detail below.  
 
Figure 7-1 Potential applications of an in vitro BM niche model. These include a more 
humanised method for screening pharmaceutical leads, reducing the need for animal models 
and the number of high risk fails entering costly clinical trials. Platforms on which to model 
and study HSC and MSPC processes at the molecular level, such as haematopoiesis and self-
renewal mechanisms. More humanised models of diseases such as leukaemia, modelling 
disease progression and drug efficacy. Robust ex vivo expansion would offer better cell 
sources for research and clinical use. Gene editing platforms, that would increase efficacy 
and promote expansion of the therapeutic cells. Leukaemia image from (Li et al., 2016) with 
permissions, other images from Servier Medical Art, licensed under a Creative Commons 
Attribution 3.0 Generic License. 
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7.3.1 Probing haematopoiesis and niche dynamics 
Although HSCs are the most studied, easily isolated and clinically relevant ASC, 
the problems associated with their ex vivo culture mean a greater understanding 
of their biology is needed to fully realise their potential (Eaves, 2015). Many 
signals that contribute to HSC homeostasis have been identified and are discussed 
in earlier chapters. However, many still remain incompletely defined, for 
example, the HSC self-renewal process remains to be fully elucidated at the 
molecular level (Zon, 2008). Study of HSC biology and haematopoiesis in humans 
is limited. Although mouse models have offered invaluable alternatives, 
discrepancies do exist, in part due to the differences between human and murine 
immune systems (Chao et al., 2008).  
Furthermore, MSPCs have shown great therapeutic potential in both the ability to 
regenerate damaged or diseased tissues (Dalby et al., 2018), and for their 
immunosuppressive capacity for transplant operations (Ito et al., 2010). MSPCs 
also lose their stem cell potential in in vitro culture (McMurray et al., 2011), and 
although the mechanisms of differentiation have been extensively investigated, 
relatively little is still know about how the native physical environment modulates 
self-renewal of these cells.  
An in vitro BM niche model, such as that developed in this thesis, would offer a 
platform on which to study these processes, and gain further understanding of 
fundamental regulatory processes in both HSCs and MSPCs. For example, the study 
by Roch et al, (discussed in Chapter 1.5.5) demonstrates this for HSCs, where the 
engineered niche system was used to systematically probe early HSC fate choices, 
identifying specific gene signatures associated with lineage commitment (Roch et 
al., 2017). For MSPCs, our group has demonstrated control over self-renewal using 
nanotopographies (McMurray et al., 2011). The topographical controlled system 
was then used as a platform to investigate and harness the immunomodulatory 
capacity of MSPCs (Ross et al., 2019). Studies such as these, will ultimately lead 
to the development of novel methods to harness HSC and MSPC behaviours.  
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7.3.2 Modelling disease  
Many haematological disorders involve HSCs, and are consistent with the 
regulation of haematopoiesis by the BM niche, current evidence suggests that the 
niche can also drive neoplasia, or be remodelled to support malignant cells (Pinho 
and Frenette, 2019). In leukaemias, stem or progenitor cell damage leads to 
overproduction of one type of white blood cell, fundamentally changing the 
cellular composition of the marrow. Just as healthy HSPCs can modulate the 
microenvironment, leukemic stem cells (LSCs) can remodel it further to create a 
cancer-supportive environment (Pinho and Frenette, 2019). Some of these 
modifications lead to upregulation of surface receptors that mediate cell adhesion 
and survival in LSCs, that can confer chemoresistance. LSCs also share quiescent 
and self-renewing properties with HSCs, meaning developing treatments that 
target only LSCs is difficult (Bonnet, 2005). An in vitro BM niche model could not 
only be used to study these interactions and processes in detail, but also to explore 
therapeutic targets. Furthermore, as the origin of such malignancies are 
heterogenous in terms of phenotypic changes, an in vitro model could be 
employed to model the patients’ own tumour microenvironment and identify the 
most appropriate therapeutic strategy on a personalised medicine basis. A study 
employing a co-culture with MSCs and patient derived multiple myeloma cells has 
demonstrated this, where patients could be screened for clinical response to 
therapeutic compounds (Pak et al., 2015).  
7.3.3 NAT pharmaceutical screening  
In recent decades, advances in the molecular understanding of disease processes 
has underpinned new potential therapeutic targets. However, there is a lack of 
corresponding increase in drug discovery and manufacture. It is notable that in 
small molecule drug discovery, the drive for high throughput has led to the use of 
overly simplified cell models that do not recreate aspects of native cell 
microenvironments and testing of compounds in non-human models. This has 
fuelled productivity crisis, where high numbers of drug candidates are taken 
forwards, yet the attrition rate is high with many ultimately failing in Phase I/II 
clinical trials. Almost half of fails are not predicted by traditional in vitro and pre-
clinical in vivo screens (Cook et al., 2014). In fact, AstraZeneca reported that from 
2011 to 2016, 66% of its small molecule projects failed, critically only 23% before 
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clinical trial stages (i.e. cheap fails) (Cook et al., 2014). This demonstrates that 
current techniques lack the ability to accurately predict success at the pre-clinical 
trial stage.  
This is driving Pharma to look to NATs (Ewart et al., 2018), built using human cells 
and likely requiring the tissue complexity that stem cells and tissue engineering 
strategies can produce (Donnelly et al., 2018). Systems such as these can be used 
to better predict drug mechanism, toxicity and efficacy in a biomimetic setting. 
These in vitro models would allow leads with high risk of failure to be dropped 
quickly, ultimately reducing the number of fails that reach costly clinical trial 
stages, saving the pharmaceutical industry enormous amounts of time and money.  
In this regard, organ-on-a-chip (OOC) platforms that recapitulate multifaceted 
tissue-specific microenvironments are being developed and employed. OOC 
techniques aim not to build whole living organs, but to establish the minimally 
functional units representing aspects of human physiology in a controlled system 
(Ronaldson-Bouchard and Vunjak-Novakovic, 2018). The bone marrow-on-a-chip 
developed by the Ingber group in 2014 is a promising step toward realising these 
biomimetic drug testing platforms (Torisawa et al., 2014).  
7.3.4 Cell source for clinical applications and research 
Despite the success of HSCT, the limited number of HSCs available still poses a 
major obstacle for the wider application of HSC-based therapies (Brunstein et al., 
2010). Efficient expansion of HSCs remains a major goal in the field (Kunisaki and 
Frenette, 2012). As discussed in Chapter 6, an in vitro BM model that could 
maintain HSCs in long-term culture and stimulate expansion of the population on 
demand would overcome these obstacles to getting HSCs safely and successfully 
into the clinic. These systems could ultimately be developed to induce ex vivo 
expansion of autologous patient HSCs for transplant. Currently there is a reliance 
on allogenic donors in order to achieve sufficient cell number for engraftment, 
however the patient’s own cells could be isolated, maintained and expanded in 
an in vitro BM niche system, while the patient undergoes myeloablative therapy. 
This would enable higher yields and negate the need for a donor, circumventing 
the need to find an HLA match and avoiding risks of graft-versus-host disease.  
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7.3.5 Gene editing platform 
Gene editing of HSCs is an area of particular interest, and has shown promising 
results in recent clinical trials for patients affected by primary 
immunodeficiencies, malignancies, haemoglobinopathies or inborn metabolic 
errors (Naldini, 2015). These treatments are based on the transplantation of ex 
vivo-engineered, autologous HSCs that are then transplanted back into patients. 
However, there are reports of such strategies leading to delayed recovery periods, 
that may be associated with the ex vivo culture of the cell therapy product (Aiuti 
et al., 2013; Zonari et al., 2017). As such, improved ex vivo culture conditions, 
such as biomimetic BM models, could improve the success rate of these 
procedures. Further, in vitro models that support HSC expansion could both 
provide a platform on which to successfully genetically edit patient HSCs, but also 
expand this population for implantation.  
7.4 Conclusion 
The past decade has seen extraordinary growth in the understanding of BM niches 
and the specific cellular and molecular components that regulate MSPC and HSC 
activity (Pinho and Frenette, 2019). However much still remains to be elucidated 
before the enormous potential of these cell types is fully harnessed. The 
development of in vitro models that are more permissive for human BM niche 
studies than current in vivo murine models will be beneficial, as currently it is 
difficult to recapitulate certain haematological malignancies in mice. These 
advances would enable the development of improved, chemically and physically 
defined, culture systems and the design of ex vivo MSPC and HSC expansion 
protocols that will ultimately improve research and clinical applications of these 
valuable cell types.  
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Appendices 
 
Figure 7-2 Nuclear HIF1a levels increase with low-stiffness gels in Stro1+ MSCs. HIF1a is 
active when localised to the nucleus. Immunofluorescence analysis was carried out after 3 
days, and the integrated intensity of HIF1a in cell nuclei measured. Data shows increased 
HIF1a levels were observed on PEA FN and PEA FN BMP-2 substrates, and that addition of a 
collagen type 1 gel increases HIF1a levels in glass, PEA FN and PEA FN BMP-2. Graph shows 
mean integrated intensity of nuclear HIF1a (n=3), each point represents 1 nuclei. One-way 
ANOVA followed by Kruskal-Wallis test with multiple comparisons, *= p<0.05, **= p<0.01, ***= 
p<0.001, ****= p<0.0001. 
 
Figure 7-3 TPO in cell media.  TPO concentrations in cell media measured by ELISA at (A) day 
7 and (B) 14 of culture. Data indicates no TPO was detected in most samples but shows 
variations in the technical repeats. Graph shows individual data points for technical repeats, 
average ± SEM. Statistics by one-way ANOVA with Kruskal-Wallis test for multiple 
comparisons, *=p<0.05.  
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